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THESIS ABSTRACT
MOTIVATIONAL CONTEXT
The respiratory epithelium of the lung lines the largest surface of contact with the external 
environment and it is comprised by alveolar type I (ATI) and type II (ATII) cells. ATI cells form 
the epithelial component of the air-blood barrier and their extremely thin thickness favors 
gas exchange between the alveoli and the bloodstream. Type II cells participate in a variety of 
functions, including ion transport, epithelial repair in response to lung injury and synthesis and 
secretion of surface-active material. Pulmonary surface-active material or pulmonary surfactant 
(PS), lowers surface tension at the air-liquid interface of the alveoli, preventing collapse of the 
lung on expiration and stabilizing the respiratory surface along compression-expansion breathing 
cycles. Besides its biophysical functions, PS is involved in lung host defense against inflammation 
and infection, exerting a direct antimicrobial activity as well as facilitating pathogen uptake and 
killing by immune cells. 
Compositionally, PS is constituted by approximately 90 % lipids and 8-10 % of some specific 
proteins. Phospholipids (80 % surfactant mass) , mainly dipalmitoylphosphatidylcholine (40 %) 
and phosphatidylglycerol (10-15 %) are the main surface active agents, but the presence of 
hydrophobic surfactant proteins SP-B and SP-C is strictly required to facilitate phospholipid 
dynamics during surface film formation and stabilization. Complementarily, hydrophilic proteins 
SP-A and SP-D are mainly related to the defence functions of PS, enhancing bacterial clearance 
and the regulation of the inflammatory response of the lung. The integrated regulation of 
surfactant synthesis, secretion and metabolism is vital for air breathing and ultimately, survival. 
Indeed, pulmonary surfactant dysfunctions are associated with severe respiratory pathologies, 
such as neonatal respiratory distress syndrome in preterm infants or acute respiratory distress 
associated with lung injury.
During the process of PS biosynthesis in ATII cells, lipid and protein components are assembled 
into complexes that are stored as tightly packed membranes in intracellular vesicles called 
lamellar bodies (LBs). Upon physiological stimulation, PS is exocyted in the form of lamellar 
body-like particles (LBPs), which disintegrate in a very cooperative manner once reached the 
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air-water interface. The spontaneous and rapid adsorption and transfer of active material into 
the air-liquid interface to form the surface active film leads to the dramatic reduction in surface 
tension. Besides the interfacial film, other related membranous structures are also present in 
the alveolar hypophase, although their functions are still not fully understood. 
Up to now, most of surfactant research has been carried out studying PS as isolated from 
animal bronchoalveolar lavages (BAL). Although this material has been taken as a reference for 
the elucidation of structural determinants and representative of optimal surfactant function, 
we hypothesize that it contains not only active structures but also a mixture of less functional 
membranes from extracellular already “spent” surfactant as well as non surface-related 
structures. Taking this into account, we postulate that the study of the components and properties 
of membranes and films originated from freshly secreted PS might more closely represent the 
real behaviour of surfactant in its native environment.
On the other hand, our current knowledge about PS biogenesis is still incomplete and 
important gaps in the understanding of protein processing and lipid traffic as well as in the 
packing and storage of PS complexes into LBs, still remain. To investigate these questions, much 
research has been performed taking advantage of primary cultures of ATII cells isolated from 
animal lungs. Primary cells are often the first choice since they represent a closer option for 
mimicking the in vivo conditions. However, primary cultures are heterogeneous and they require 
the use of animals. In this respect, in vitro models can be contemplated as a suitable alternative, 
considering that they are more stable and homogeneous, providing with a good reproducibility 
and potential to replace animal experimentation. However, at present, surfactant-producing 
established cell-lines are still unavailable. The development of a reliable in vitro model of ATII 
cells would permit to gain further insight into the biological mechanisms of PS that still remain 
as open questions. Additionally, this approach may also result in a prospective tool for the 
screening of novel drug formulations intended to be pulmonary administrated. For this purpose, 
the possibility of generating alveolar epithelial cells throughout the specific differentiation of 
stem cells looks promising. As a matter of fact, this strategy is currently being implemented for 
multiple applications, such as the study of lung development or in regenerative medicine.  
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GENERAL AIMS
In general terms, the goals of the present PhD Thesis are:    
1. Study of the micro- and nanostructural organization of surfactant membranes stored in 
intracellular LBs as well as freshly secreted in the form of lamellar body-like particles (LBPs) in 
comparison with native surfactant (NS) complexes purified from BAL (Chapter 1).        
2. Examination of the structural and functional diversity present in NS complexes isolated from 
BAL (Chapter 2 and its appendix).       
3. Development and characterization of a new cellular model based on the differentiation of 
human placental mesenchymal stem cells into ATII-like cells (ATII-LCs) (Chapter 3).
4. Optimization of ATII-LC cultures under physiological conditions mimicking the native alveolar 
microenvironment. Implementation of the cellular model for biopharmaceutical applications 
(Chapter 4). 
MAIN OUTCOMES AND CONCLUSIONS
In the present PhD Thesis, we have investigated the organization of lipids and proteins in PS 
membranes as intracellularly assembled in LBs as well as freshly secreted as LBPs from primary 
ATII cells upon induction of exocytosis with secretagoges, in comparison with NS purified from 
BAL (Chapter 1). First, we have analyzed phospholipid packing and hydration by means of 
fluorescence, polarization and infrared spectroscopy/microscopy. As previously proposed, PS 
membranes either in the form of LBs or as LBPs exhibit properties that are very different from 
those of membranes from NS material. LBs display a distinctive structural organization manifested 
in a highly packed and dehydrated state of the surfactant phospholipids at the head group level, 
which is preserved when LBs are exocyted to the extracellular medium. Furthermore, when 
LBPs are subjected to high temperatures, they still maintain a considerable packed/dehydrated 
state, whereas membranes from NS are totally unpacked and hydrated. In addition, analysis 
with polarized-light microscopy also corroborate this particular organization demonstrated 
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by crystalline-like highly ordered structures in LBs/LBPs, also resistant to supraphysiological 
temperatures. 
On the other hand, the information provided by infrared spectroscopy about phospholipid 
acyl chains order and dynamics suggests that, despite the highly dehydrated state at the polar 
heads, acyl chains are relatively disordered in LBPs, pointing to the existence of geometrical 
phospholipid organizations different from lamellar phases. In general, the remarkable differences 
in the thermotropic profiles of NS and LBPs suggest the presence of additional levels of structural 
complexity in LBPs that could impose restrictions to temperature-dependent hydration as 
associated with potential phase transitions in membranes.  
Additionally, the peculiar micro- and nanometer scale organization of membranes derived 
from LBPs has been further confirmed in terms of lateral phase structure by means of the 
generation of giant unilamellar vesicles and the detection of particular lipid domain segregation 
patterns. Direct observation of spread LBPs under atomic force microscopy also points to the 
existence of a remarkable internal complexity present in the membranes of these corpuscles. 
From a functional point of view, freshly secreted LBPs display a superior adsorption efficiency 
and a significantly higher resistance to inhibitory agents, even at high concentrations of those, in 
comparison with NS complexes. In view of these results, we conclude that the particular complex 
internal organization of lipids and proteins in LBPs likely confers them critical properties for the 
maximum efficacy in the formation of interfacial films and therefore for surfactant function. At 
present, the extremely low amount of freshly secreted surfactant material yielded by primary 
cell cultures is a challenging limitation that precludes the application of additional techniques 
to address some of the unanswered questions and thus, alternative sources of material have to 
be explored.
On the other hand, as we had initially hypothesized, a more detailed examination of NS 
complexes corroborated the heterogeneous nature of the preparations purified from BAL 
(Chapter 2). By means of density gradient centrifugation, different subfractions have been further 
purified from NS lipid-protein complexes and analyzed from a morphological, biochemical and 
functional point of view. We have confirmed that despite the fact that NS contains a major part 
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of highly active structures, morphologically consistent with LBPs, it also comprises fractions 
of less efficient material, with a marked diminished biophysical performance correlated with 
a different ultrastructure and biochemical composition. The less dense portions, presumably 
corresponding with different populations of LBPs, would be related to the traditionally termed 
“large aggregates” (LA) or “heavy fractions”, the most active structures in PS. However, in view 
of our results, we postulate that LA are not homogeneous in nature but a collection of different 
structures that can be further subfractioned.  
The less active part of NS has been found in the heaviest fractions, and its content in surfactant 
proteins and cholesterol is significantly different from that of the most efficient structures, 
exhibiting a reduced amount in SP-B whereas its levels of SP-A, aggregated forms of SP-C and 
cholesterol are particularly high. The interpretation of these results is not totally clear, although it 
is tempting to think that the less active material corresponds to already “spent” or “deactivated” 
surfactant which might coexist in the alveolus with surfactant-like structures. Furthermore, the 
co-existence in NS of structures with roles different than surface tension reduction, like surfactant 
regulation or alveolar homeostasis, should not be discarded. Obviously, we have to take also into 
consideration that BAL might contain not only alveolar material, but also structures extracted 
from other locations of the airways, likely participating in other functions.
We have taken advantage of cryo-preservation techniques to examine the ultrastructure of 
the morphological diversity contained in NS material under close-to-native conditions, avoiding 
the potential influence of artifacts resultant from sample preparation (Chapter 2: appendix). We 
have imaged NS under cryo-electron and cryo-soft x-ray tomography, unveiling unprecedented 
structural details in tomographic reconstructions, particularly from LBPs. This structural analysis 
has allowed us to propose a model for the process of progressive unravelling of LBPs, from the 
intact highly condensed state to unpacked forms.
In spite of the usefulness and reliability demonstrated by primary ATII cells, they fail to sustain 
a differentiated phenotype in culture as they progressively transform into ATI cells and they 
are unable to synthesize surfactant de novo, precluding their use for the study of surfactant 
biogenesis. In view of the necessity of a well-established ATII cell model, we have developed and 
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characterized a new cellular model of ATII cell based on the differentiation of Decidua-derived 
Mesenchymal Stem Cells (DMSCs) isolated from human placenta into cells with phenotypical 
features of ATII cells, that we have termed ATII-like cells (ATII-LCs) (Chapter 3). ATII-LCs display 
membranous cytoplasmic organelles resembling LBs, and accumulate disaturated phospholipid 
species, a surfactant hallmark. Importantly, we have demonstrated that throughout their 
differentiation process, ATII-LCs increase their content in mRNAs involved in pulmonary 
development (TTF1, FOXA1 and FOXA2), alveolar homeostasis (GPR116, CFTR) or those encoding 
for surfactant-related proteins (SPA-D, ABCA3) and for their processing enzymes (Cathepsin H, 
Napsin A). At a protein level, the expression of SP-A, SP-B and SP-C is also manifestly enhanced 
in ATII-LCs. Mimicking the response of ATII cells to secretagoges, ATII-LCs are able to exocytose 
lipid-rich assemblies, which exhibit faster interfacial adsorption kinetics than standard NS, even 
in the presence of inhibitory agents.
However, despite of these interesting properties, we presume that ATII-LCs are still in a less 
differentiated state than “true” ATII cells as seen in vivo in the alveolar epithelium or in isolated 
primary cultures. We speculate that subjecting DMSCs to differentiation under a more complete 
lung environment mimicking the native situation may facilitate further progress in pneumocyte 
phenotypes (Chapter 4). For instance, we assume that in the real situation, alveolar cells are 
exposed to the close proximity of an air-liquid interface (ALI) or in direct contact with components 
of the extracellular matrix (ECM). Bearing this in mind, we have implemented advanced culture 
techniques, differentiating DMSCs under the influence of an ALI taking advantage of the Transwell 
systems technology. In addition, we have also tested the possible enhancive effect of components 
of the alveolar ECM, incorporating collagen and fibronectin in culture substrates. Unfortunately, 
the implementation of these factors does not significantly promote further differentiation in ATII-
LCs, at least in terms of morphology, expression of surfactant proteins or barrier properties. Our 
results suggest that whole cell differentiation may still require of a complex synergistic signaling, 
integrating not only physical and/or chemical factors, but also the active interaction with other 
cell types naturally present in the alveolar epithelium. Nevertheless, we consider that our cellular 
model of ATII-LCs, as it currently stands, may constitute a valuable tool, not only for the study 
of surfactant biosynthesis but also for toxicological or metabolic studies. As a proof of concept, 
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we have exposed differentiated ATII-LCs to different engineered nanostructured materials 
intended to be used in biopharmaceutical applications, to evaluate their potential cytotoxic 
effects. In addition, the uptake behaviour of ATII-LCs has been also tested upon exposure of 
nanoparticles by means of an innovative ALI system optimized to provide a simulated in vivo 
drug-delivery scenario, and subsequently subjected to microscopical examination. Considering 
the wide interest raised by lung administration of therapeutical nanoparticles, ATII-LCs could be 
implemented as a drug screening tool to detect potential hazards of nanopreparations in their 
first stages of their development.
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CONTEXTO MOTIVACIONAL
El epitelio respiratorio del pulmón recubre la mayor superficie del organismo expuesta al 
medio externo y está formado principalmente por células alveolares de tipo I (ATI) y de tipo II 
(ATII). Las células ATI constituyen el componente epitelial de la barrera aire-sangre y su reducido 
grosor favorece el intercambio gaseoso entre el alvéolo y el torrente sanguíneo. Las células ATII 
participan en varias funciones, incluyendo el transporte de iones, la reparación del epitelio en 
respuesta a daño pulmonar así como la síntesis de material tensioactivo. El material tensioactivo 
del pulmón, conocido como surfactante pulmonar (pulmonary surfactant, PS), reduce la tensión 
superficial en la interfase aire-líquido (air-liquid interface, ALI) de los alvéolos, previniendo el 
colapso del pulmón durante la espiración y estabilizando la superficie respiratoria a lo largo de 
los ciclos respiratorios de compresión-expansión. Además de sus funciones biofísicas, el PS está 
implicado en la defensa del pulmón frente a procesos de inflamación e infección, ejerciendo una 
acción antimicrobiana directa, así como facilitando la eliminación de patógenos por las células 
del sistema inmunitario.
Desde un punto de vista composicional, el PS está constituido por un 90 % de lípidos y un 8-10 
% de proteínas específicas. Los fosfolípidos (80 % de la masa del surfactante), particularmente 
dipalmitoilfosfatidilcolina (40 %) y fosfatidilglicerol (10-15 %), son los principales agentes 
tensioactivos, pero la presencia de las proteínas hidrofóbicas SP-B y SP-C es estrictamente 
necesaria para facilitar la acción dinámica de los fosfolípidos durante la formación y estabilización 
de la película tensioactiva interfacial. Complementariamente, las proteínas hidrofílicas SP-A y 
SP-D están relacionadas esencialmente con las funciones de defensa del PS, promoviendo la 
eliminación de bacterias y la regulación de la respuesta inflamatoria del pulmón, entre otras 
funciones. La regulación integrada de la síntesis, secreción y metabolismo del PS es vital para la 
respiración y en último término, para la supervivencia del individuo. De hecho, deficiencias en 
el sistema PS están asociadas con patologías respiratorias severas, tales como el síndrome de 
dificultad respiratoria neonatal o el síndrome de dificultad respiratoria aguda asociado a daño 
pulmonar en adultos.
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Durante el proceso de biosíntesis del PS en las células ATII, los componentes lipídicos y 
proteicos del surfactante son ensamblados en complejos que son almacenados en forma de 
membranas densamente empaquetadas en vesículas intracelulares llamadas cuerpos lamelares 
(lamellar bodies, LBs). Como resultado de cierta estimulación fisiológica, el PS es exocitado en 
forma de cuerpos lamelares particulados (lamellar body-like particles, LBPs), los cuales sufren un 
proceso de desintegración cooperativa una vez alcanzan la ALI. La adsorción espontánea y rápida 
de los LBPs conduce a la transferencia de material activo hacia la ALI para formar la película 
tensioactiva, generando una marcada reducción de la tensión superficial. Además de la película 
interfacial, otras estructuras relacionadas con carácter membranoso están también presentes en 
la hipofase alveolar, aunque sus funciones aún no son completamente comprendidas.
Hasta la fecha, gran parte de la investigación en el campo del surfactante se ha llevado a 
cabo estudiando el PS aislado a partir de lavados broncoalveolares (bronchoalveolar lavage, 
BAL) de animales. Si bien es cierto que este material ha sido tomado como referencia para 
la elucidación de determinantes estructurales y como representante de una óptima función 
tensioactiva, sospechamos que contiene no solo estructuras activas sino también una mezcla de 
membranas menos funcionales procedentes de material extracelular ya gastado o no relacionado 
con funciones surfactantes. Teniendo esto en consideración, postulamos que el estudio de los 
componentes y películas originadas a partir de PS recién secretado podría representar más 
fielmente el comportamiento del PS en su ambiente nativo.
Por otra parte, el conocimiento actual acerca de la biogénesis del PS es aún incompleto y 
existen importantes lagunas en la comprensión de diversos procesos como el procesamiento 
proteico y el tráfico lipídico de los componentes del PS así como su empaquetamiento y 
almacenamiento en los LBs. Para abordar esta clase de estudios, el empleo de cultivos primarios 
de células ATII aisladas de pulmones animales ha tenido una gran importancia. De hecho, las 
células primarias son a menudo la elección de referencia, puesto que representan una opción más 
próxima a simular las condiciones in vivo. Sin embargo, los cultivos primarios son heterogéneos y 
requieren del uso de animales para su obtención. A este respecto, los modelos in vitro pueden ser 
contemplados como una adecuada alternativa, teniendo en cuenta su mayor reproducibilidad y 
estabilidad fenotípica así como su potencial para reemplazar el uso de animales. Sin embargo, 
22
Resumen de la tesis
actualmente no existen líneas celulares establecidas productoras  de surfactante. Es por ello que 
el desarrollo de un modelo in vitro fiable de células ATII permitiría profundizar en el estudio de 
ciertos mecanismos biológicos del PS aún desconocidos. Además, esta aproximación podría ser 
de interés para su utilización en el screening o cribado de nuevas formulaciones farmacéuticas 
diseñadas para ser administradas por la vía pulmonar, una estrategia en pleno desarrollo en la 
actualidad. Con este propósito, la posibilidad de generar células epiteliales alveolares a partir 
de la diferenciación específica de células madre parece prometedora, y dicha estrategia está 
siendo ya actualmente aplicada en diversos campos como el estudio del desarrollo pulmonar o 
en medicina regenerativa. 
OBJETIVOS GENERALES
En términos generales, la presente Tesis Doctoral está enfocada hacia la consecución de los 
siguientes objetivos:
1. Estudio de la organización estructural micro- y nanoscópica de las membranas de PS 
almacenadas intracelularmente como LBs así como secretadas en forma de LBPs, en comparación 
con el surfactante nativo (native surfactant, NS) purificado de BAL (Capítulo 1).
2. Análisis de la diversidad estructural y funcional presente en los complejos de NS aislados de 
BAL (Capítulo 2 y su apéndice).
3. Desarrollo y caracterización de un nuevo modelo celular basado en la diferenciación de células 
madre mesenquimales aisladas de placenta humana hacia células con un fenotipo similar a la de 
las células ATII o ATII-LCs (alveolar type II-like cells) (Capítulo 3).
4. Optimización de cultivos de ATII-LCs simulando las condiciones fisiológicas que tienen lugar 
en el ambiente nativo alveolar. Implementación del nuevo modelo celular para aplicaciones de 
interés biofarmacéutico (Capítulo 4).
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PRINCIPALES RESULTADOS Y CONCLUSIONES
En la presente Tesis Doctoral se ha investigado la organización de los lípidos y proteínas 
presentes en las membranas de PS, tanto almacenadas intracelularmente como LBs así 
como secretadas como LBPs, tras la inducción de exocitosis mediante secretagogos, en 
comparación con el NS aislado de BAL (Capítulo 1). En primer lugar, se ha analizado el grado de 
empaquetamiento e hidratación de los fosfolípidos del PS mediante espectroscopía/microscopía 
de fluorescencia y de polarización. Como se había hipotetizado inicialmente, las membranas de 
PS tanto en forma de LB como de LBP presentan propiedades muy diferentes de las presentes 
en el NS. Los resultados de esta Tesis han revelado que los LBs presentan una característica 
organización estructural manifestada en un estado altamente empaquetado y deshidratado al 
nivel de la cabeza polar de los fosfolípidos, que se mantiene cuando los LBs son secretados 
al medio extracelular. Además, cuando los LBPs son sometidos a altas temperaturas, éstos 
mantienen un considerable estado empaquetado/deshidratado, mientras que las membranas 
de NS están totalmente desempaquetadas/hidratadas. Un análisis mediante microscopía de luz 
polarizada también ha corroborado esta particular organización, revelando estructuras de tipo 
cristalino altamente ordenadas en los LBs/LBPs, que también resultan ser altamente resistente a 
temperaturas elevadas. Por otro lado, la información aportada por espectroscopía de infrarrojos 
sobre el grado de orden de las cadenas de acilo de los fosfolípidos sugiere que, a pesar del 
estado altamente deshidratado al nivel de la cabeza polar, las cadenas de ácidos grasos están 
relativamente desordenadas en los LBPs, apuntando a la existencia de organizaciones geométricas 
de los fosfolípidos distintas a las típicas de fases lamelares. En general, las acentuadas diferencias 
en los perfiles termotrópicos del NS y de los LBPs sugiere la presencia de niveles adicionales 
de complejidad estructural en los segundos, que serían responsables de las restricciones en el 
proceso de hidratación asociado a potenciales transiciones de fase de las membranas. Asimismo, 
la peculiar organización de las membranas derivadas de los LBPs ha sido también confirmada 
en términos de estructura lateral de fase mediante la generación de vesículas unilamelares 
gigantes, lo que ha permitido detectar un particular patrón de segregación de dominios lipídicos. 
Además, la observación directa mediante microscopía de fuerza atómica de LBPs desplegados 
también apunta a la existencia de una notable complejidad interna presente en las membranas 
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de estos corpúsculos. Desde un punto de vista funcional, los LBPs recién secretados demuestran 
una superior eficiencia en términos de adsorción así como una significativa resistencia a agentes 
inhibitorios, incluso a altas concentraciones de éstos, en comparación con los complejos de NS. 
En vista de estos resultados, se concluye que la particular complejidad interna que adoptan los 
lípidos y proteínas dentro de los LBPs podría conferirles propiedades críticas para una eficacia 
máxima en la formación de películas interfaciales y por tanto para la función surfactante. 
Actualmente, la extremadamente reducida cantidad de PS que puede ser obtenido recién 
secretado por cultivos primarios es una importante limitación que dificulta e impide la utilización 
de las técnicas adicionales necesarias para abordar ciertas preguntas aún sin respuesta, lo que 
plantea por tanto la exploración de fuentes alternativas de material.
Por otro lado y como también se había hipotetizado, un detallado análisis de los complejos 
de NS ha corroborado la naturaleza heterogénea de las preparaciones purificadas a partir de 
BAL (Capítulo 2). Mediante centrifugación en gradiente de densidad, los complejos lipoproteicos 
de NS han sido subfraccionados y analizados desde un punto de vista morfológico, bioquímico 
y funcional. Se ha confirmado que a pesar de que el NS contiene una parte mayoritaria de 
estructuras altamente activas, consistentes morfológicamente con la presencia de LBPs, también 
recoge material menos eficiente, que muestra una reducida actividad biofísica correlacionada 
con una diferente ultraestructura y composición bioquímica. Las porciones menos densas 
del gradiente, posiblemente distintas poblaciones de LBPs, estarían relacionadas con los 
denominados agregados grandes o fracciones pesadas, las estructuras más activas del PS. Sin 
embargo, a la luz de estos resultados, se postula que los agregados grandes no son tampoco 
entidades homogéneas, sino una recopilación de diversas estructuras que pueden ser a su vez 
subfraccionadas.
La fracción menos activa del NS ha sido encontrada en el material más denso, y su contenido 
en proteínas del surfactante y colesterol es significativamente diferente de la de las estructuras 
más eficientes, exhibiendo una cantidad reducida de SP-B y unos niveles incrementados de SP-
A, de formas agregadas de SP-C y de colesterol. La interpretación de estos resultados no está 
totalmente clara, aunque es posible que el material menos activo corresponda a surfactante ya 
“gastado” o “desactivado” que podría coexistir en el alvéolo con material surfactante funcional. 
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Asimismo, tampoco se descarta la existencia de funciones alternativas en el material contenido 
en el NS más allá de la reducción de la tensión superficial, como puede ser lo relacionado con 
la regulación de los niveles de surfactante o la homeostasis alveolar. Obviamente, también ha 
de tenerse en cuenta que el BAL no solo contiene material alveolar, sino también procedente 
de otras localizaciones del sistema respiratorio, posiblemente participando en otras funciones.
Adicionalmente, se han implementado las más recientes técnicas de crio-preservación para 
examinar la ultraestructura de la diversidad morfológica contenida en el NS, en condiciones 
similares a las nativas y evitando la potencial influencia de artefactos resultantes de la 
preparación de las muestras (apéndice del Capítulo 2). Así, se ha visualizado el NS mediante crio-
tomografía electrónica y de rayos X, desvelando detalles estructurales mediante reconstrucciones 
tomográficas, particularmente de los LBPs. Esta estrategia ha permitido proponer un modelo 
del proceso de desempaquetamiento de los LBPs, desde estados altamente condensados hasta 
formas desempaquetadas. 
Sin embargo, a pesar de la utilidad y fiabilidad demostradas por los cultivos primarios de células 
ATII, éstas tienen la desventaja de perder su fenotipo diferenciado en cultivo y progresivamente 
desdiferenciarse dando lugar a células tipo I. Además, las células ATII primarias son incapaces 
de sintetizar surfactante de novo una vez son extraídas del pulmón, lo cual impide llevar a cabo 
estudios sobre la biogénesis del PS. En vista de la necesidad de un modelo bien establecido de 
célula ATII, en esta Tesis se ha desarrollado y caracterizado un nuevo modelo celular basado en 
la diferenciación de células madre humanas mesenquimales derivadas de la decidua placentaria 
(Decidua-derived mesenchymal stem cells, DMSCs), hasta dar lugar a unas células que hemos 
denominado ATII-LCs (Capítulo 3). Las ATII-LCs exhiben orgánulos citoplasmáticos membranosos 
que recuerdan a los LBs, y acumulan especies fosfolipídicas disaturadas, un rasgo distintivo 
del surfactante. Se ha demostrado que a través del proceso de diferenciación, las ATII-LCs 
incrementan su contenido en mRNAs implicados en desarrollo pulmonar (TTF1, FOXA1, FOXA2), 
homeostasis alveolar (GPR116, CFTR) o codificantes para proteínas relacionadas directamente 
con el PS (SPA-D, ABCA3) o las enzimas que catalizan su procesamiento (Cathepsin H, Napsin A). 
A nivel de proteína, la expresión de SP-A, SP-B y SP-C está incrementada de manera patente en 
las ATII-LCs. Del mismo modo, simulando la respuesta de las células ATII a los secretagogos, las 
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ATII-LCs son capaces de exocitar complejos ricos en lípido, los cuáles exhiben una rápida cinética 
de adsorción interfacial superior a la de los complejos de NS, incluso en presencia de agentes 
inhibitorios.
Sin embargo, a pesar de estas interesantes propiedades, se presume que las ATII-LCs se 
encuentran en un estado no totalmente diferenciado en comparación con las “verdaderas” 
células ATII que se encuentran in vivo en el epitelio pulmonar o aisladas como cultivos primarios. 
En este contexto, se ha planteado exponer las células a un ambiente que simule el entorno 
pulmonar nativo, como posibilidad de aumentar el grado de diferenciación (Capítulo 4). Por 
ejemplo, se propone que en la situación real, las células alveolares están próximas a una 
interfase aire-líquido (air-liquid interface, ALI) o en contacto directo con componentes de la 
matriz extracelular (extracellular matrix, ECM). Se han implementado así técnicas avanzadas de 
cultivo, diferenciando las DMSCs bajo la influencia de una ALI, aprovechando la tecnología de los 
sistemas Transwell. Además, se ha examinado el posible efecto potenciador de componentes de 
la ECM alveolar, incorporando colágeno y fibronectina en los sustratos de cultivo. No obstante, la 
implementación de estos factores no parece aumentar el nivel de diferenciación de las ATII-LCs, 
al menos en términos de morfología, expresión de proteínas del surfactante o propiedades de 
barrera. Los resultados sugieren que la diferenciación celular completa podría requerir de una 
compleja señalización sinérgica, que integre no sólo factores químicos y físicos, sino también 
posiblemente la interacción activa con otros tipos celulares presentes en el epitelio alveolar de 
manera natural. No obstante, el modelo celular de ATII-LCs, en su actual estado, podría ser aún una 
herramienta útil, no sólo para el estudio de la biosíntesis del PS sino también como herramienta 
para estudios toxicológicos o metabólicos. Como prueba de concepto, se han expuesto ATII-LCs 
a diferentes materiales nanoestructurados de interés biofarmacéutico, con objeto de evaluar 
sus potenciales efectos citotóxicos. Además también se ha analizado la capacidad de las ATII-LCs 
para interaccionar e internalizar nanopartículas empleando un nuevo sistema de exposición que 
simula la situación in vivo y un posterior examen mediante microscopía confocal. Teniendo en 
consideración el interés creciente en la administración pulmonar de nanopartículas terapéuticas, 
las ATII-LCs podrían ser implementadas como herramienta de cribado para detectar potenciales 
riesgos de nanofármacos en sus primeras etapas de desarrollo.





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1. Physiology of the lung
Most of living cells obtain their energy from chemical reactions involving oxygen. Just as 
crucial is the elimination of carbon dioxide, the major end product of an oxidative metabolism. 
The process of exchange of oxygen and carbon dioxide between an organism and the external 
environment known as respiration can be directly performed by a unicellular organism. However, 
this is impossible for most cells of a complex organism like a vertebrate. Consequently, the 
evolution of large animals has required the development of a specialized respiratory system, 
although it substantially differs in structure, embryological origin and function between 
vertebrate groups (Daniels and Orgeig 2003). In humans, the respiratory system is principally 
constituted by lungs, airways and the muscles of breathing.  Lungs consist of the three lobes of 
the right lung and two lobes of the left lung. The bronchi, blood vessels, and nerves leave and 
enter at the hilum of each lung. The airways 
comprise the trachea, right and left main 
bronchi, smaller bronchi, bronchioles and 
alveoli. Also part of the respiratory system are 
the pleural membranes and the respiratory 
muscles that form the chest cavity, diaphragm 
and intercostal muscles, which are key in 
the generation of the forces that control 
the inflation and deflation of the lung and 
so the flow of air between them and the 
atmosphere. Within the lungs, there are more 
than 20 branching generations, each resulting 
in narrower, shorter and more numerous 
tubes to finally reach the tiny air-containing 
sacs called alveoli, where gas exchange occurs 
(Figure 1).               
Figure 1. Airway branching in humans. 
Scheme of the more than 20 generations of 
branching in the human respiratory system 
divided in two zones: a conductive zone 
from where air flows towards the respiratory 
zone which contains alveoli and where the 
exchange of gases with the blood takes 
places. Diameters are not drawn to scale. 
Modified from (Widmaier, Raff et al. 2014).
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The alveolar number is closely related to total lung volume, with larger lungs having 
considerably more alveoli, although mean values are about 300-500 million and 200 µm of 
diameter (Daniels and Orgeig 2001; Ochs, Nyengaard et al. 2004) exposing an exchange area of 
50 to 100 m2, roughly the size of a tennis court (Coxson and Hogg 2001). The thickness of the 
alveolar capillary barrier (500 nm thick) coupled to the extensive surface area permit the rapid 
exchange of large quantities of oxygen and carbon dioxide by diffusion. Gas exchange takes place 
through a complex physical barrier composed by a thin aqueous film lining the alveolus, alveolar 
epithelial cells, the interstitial layer, endothelial cells forming the blood capillaries, the blood 
plasma and finally the erythrocyte membrane (Figure 2). 
With respect to the epithelial cells, most of the air-facing surfaces of the alveolar walls are lined 
by a continuous layer, one cell thick, of flat cells termed alveolar type I (ATI) cells, which comprise 
around 90 % of the respiratory surface area (Crapo, Barry et al. 1982). Interspersed between these 
Figure 2. Structure of the alveolar respiratory units. A. Relationship between blood vessels and the 
clusters of alveoli at their end. Red represents oxygenated blood; blue represents deoxygenated blood. B. 
An enlargement of a small section of A (square) representing the alveolar structure showing type I-II cells 
and macrophages as well as the alveolar-capillary barrier through which gases must pass as they diffuse 
from air to blood (oxygen) or from blood to air (carbon dioxide). Adapted from (Scanlon V.C. and T. 2015) 
and (Widmaier, Raff et al. 2014).
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cells are thicker, specialized cells termed alveolar type II (ATII) cells. These are more abundant but, 
because of their cuboidal shape, only account for around 10  % of the alveolar surface area (Mason 
and Williams 1977) and secrete the so called pulmonary surfactant (PS), a lipid protein complex 
that lines the surface of alveoli and reduces their surface tension, increasing lung compliance, 
thereby making easier for the lungs to expand. Besides, alveolar macrophages are the third cellular 
type present inside alveoli, involved in preserving a clean and pathogen-free respiratory surface.
   
2. Surface tension at the alveoli and pulmonary surfactant
The surface of these alveolar cells is moist, so the alveoli can be pictured as air-filled sacs 
lined with an aqueous fluid consequence of cell metabolism. A typical molecule in the bulk of a 
liquid is attracted equally in all directions by its nearest neighbors. However, a molecule in the 
interfacial region has a relative lack of attraction from the dilute gas phase and thus, there is an 
unbalanced attraction on surface molecules toward the bulk of the liquid (Figure 3). This causes 
the surface to minimize its area generating 
the energetically-optimized spherical 
shape, as a result of the force called surface 
tension (ɣ). This force makes the alveolar 
water lining like a stretched balloon that 
constantly lends to shrink and resists 
further stretching. Thus, expansion of the 
lung requires energy not only to stretch the 
connective tissue of the lung but also to 
overcome the surface tension of the water 
layer lining the alveoli. In fact, the surface 
tension of pure water, which is around 70 
mN/m at 37 °C, is so high that if the alveoli 
were lined with pure water, lungs would 
Figure 3. Molecular forces leading to surface 
tension. A bulk liquid molecule 1 is equally 
attracted by its neighbors being all the forces 
compensated in all space directions. However, 
molecule 2 is located at an interfacial region in 
contact with the gas phase, which is much more 
diluted than the liquid. Gas molecules exert a 
negligible attraction on interfacial molecules 
and this unbalanced inward attractive force on 
interfacial molecules causes the surface to seek a 
minimal area as a result of surface tension.
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require exhausting muscular effort and they would tend to collapse. 
Idealizing the alveoli shape as spherical cavities, the law of Laplace-Young (ΔP = 2 ɣ / r), 
which enounces that the pressure (P) inside an alveolus is directly proportional to surface 
tension (ɣ) and inversely proportional to the alveolar radius (r), can be applied. Lung alveoli can 
be considered as very small and interconnected bubbles and given their heterogeneous size, 
the smaller ones would be subjected to higher pressures and would tend to collapse earlier into 
large alveoli, especially at the end of expiration (Figure 4). 
However, the presence of PS molecules interposed between water molecules at the alveolar 
surface permits maintaining an opened interface compensating the water-water interactions 
that cannot be established at the interface. The reduction in surface tension helps to maintain a 
pressure in smaller alveoli approximately equivalent to that in the larger ones, providing stability 
to alveoli of different sizes. This specialized function of PS comes from its particular biochemical 
composition, which has been evolutionarily tuned to optimize the surfactant activity (Daniels 
and Orgeig 2003). 
Figure 4. Stabilizing effect of surfactant. Application of the Law of Laplace to two alveoli (a 
and b) next to each other sharing an alveolar duct, being the radius of a greater than the 
radius of b. P is pressure inside the alveoli, ɣ is the surface tension and r is the radius of the 
alveolus. Adapted from (Widmaier, Raff et al. 2014).
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As stated above, the optimized complex mixture of lipids and proteins constituting PS is key to 
understand the basic molecular mechanisms that underlie its singular properties. Lipids account 
for more than 90 % of surfactant by mass and its qualitative and quantitative composition varies 
among different species (Lang, Postle et al. 2005), exhibits particular adaptations to environmental 
conditions, such as body temperature (Suri, McCaig et al. 2012), and varies in response to 
physiological constraints or pathological situations (Gunther, Schmidt et al. 1999). On the other 
hand, approximately 10 % of surfactant in mass is constituted by proteins, including specific 
surfactant proteins, which can be classified with respect to their water affinity: hydrophilic 
proteins (SP-A and SP-D) and hydrophobic proteins (SP-B and SP-C). SP-A and SP-D belong to 
the collectin protein family and they are involved in immune innate defense and inflammatory 
responses in the lung as well as in the maintenance of alveolar homeostasis, whereas SP-B and 
SP-C are crucial for the biophysical function of surfactant (Crouch and Wright 2001; Weaver and 
Conkright 2001).
3. Pulmonary surfactant: components and functions
3.1. Lipids
3.1.1. Lipid structure
Lipids, and predominantly phospholipids, make up the bulk of PS. These are amphipathic 
molecules formed by a polar hydrophilic head and a non-polar or hydrophobic acyl chains 
(Figure 5). Glycerol-based phospholipids are the principal lipid species and they are 
characterized for containing a glycerol molecule and a negatively charged phosphate group 
bonded to a variable polar group.  Phospholipids classes are defined by the structure of the 
polar group which comprise: zwitterionic groups (with zero overall net charge at physiological 
pH), such as phosphatidylcholine (PC) and phosphatidylethanolamine (PE) and anionic 
groups (with negative net charge) including phosphatidylglycerol (PG), phosphatidylserine 
(PS*) and phosphatidylinositol (PI). The glycerol molecule is esterified by two fatty acids, 
which are hydrocarbon chains of different length and saturation (number of double bonds). 
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Lysophospholipids have the same structure but have only one fatty chain. An additional class of 
phospholipid is sphingomyelin (SM), which possess a PC head group, sphingosine, and a fatty acid. 
The amphipathic character of phospholipids make them to adopt an energetically favorable 
orientation at the air-liquid interface, with the polar heads pointing toward the aqueous phase 
whereas the apolar chains are oriented toward the air, minimizing the contact between the 
hydrophobic region and water molecules (Marsh 2012). 
Figure 5. Structure of glycerophospholipids. A. Representation of the molecular structure of 
phosphatidylcholine, including the hydrophilic moiety constituted by the polar head group and the 
hydrophobic acyl chains. Modified from (Sadava, Heller et al. 2012). B. Presentation of the most 
common phospholipids in pulmonary surfactant:  phosphatidylcholine (PC), phosphatidylglycerol 
(PG), phosphatidylinositol (PI), phosphatidylserine (PS), phosphatidylethanolamine (PE); chemical 
formula of their head groups and net electric charge at a neutral pH. 
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Despite  the  fact that PS composition differs among animal species, as mentioned above, 
similarities are more perceptible than differences and in general it is considered to be highly 
conserved among mammals (Veldhuizen, Nag et al. 1998; Agassandian and Mallampalli 2013). A 
typical lipid surfactant composition mainly contains PC (around 60-70 %) and PG (approximately 
9 %) species (Figure 6). Among PC species, dipalmitoylphosphatidylcholine (DPPC, 16:0/16:0) 
represents 40 % of the total surfactant mass and it is essential for producing the extremely low 
surface tensions observed during expiration; its saturated acyl chains can adopt a highly lateral 
packed state occupying smaller area per molecule compared to unsaturated phospholipids 
(Hawco, Davis et al. 1981; Batenburg 1992). Besides DPPC, other saturated PC species can be 
found in PS such as palmitoylmirystoyl-PC (PMPC, 16:0/14:0), and unsaturated PCs, such as 
palmitoyloleoyl-PC (POPC, 16:0/18:1) or palmitoylpalmitoleoyl-PC (PPPC, 16:0/16:1). Anionic 
phospholipids  such  as PG and PI are thought to take part in selective interactions with the 
cationic hydrophobic proteins (Pérez-Gil, Tucker et al. 1992; Pérez-Gil, Casals et al. 1995). The 
other minor phospholipids such as PE, PI, SM, as well as lysophosphatidylcholine comprise the 
remainder of the phospholipid pool. Additionally, neutral lipids are also present in PS membranes 
and account for approximately 13 % by mass, being cholesterol the most abundant (around 8 % 
by mass). Other neutral lipids such as cholesterol esters, triglycerides, diglycerides and free fatty 
acids exist in small quantities (Goerke 1998).
Figure 6. Lipid composition of pulmonary surfactant. Pulmonary surfactant obtained from bronchoalveolar 
lavages of mammalian lungs typically comprises around 8-10 % of proteins and 90-92 % of lipids: 
dipalmitoylphosphatidylcholine (DPPC), unsaturated phosphatidylcholine (PC), phosphatidylglycerol (PG) 
as well as a minor proportion of other phospholipids (PL). Besides phospholipids, other lipid constituents 
are cholesterol (Chol) and other neutral lipids (NL). 
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3.1.2. Lipid polymorphism
The ability of lipids to adopt distinctive structural configurations from one shape to another, 
or lipid polymorphism, becomes key to understand the interactions and properties exhibited 
by PS membranes. As we explained before, lipids display a self-assembly capacity when they 
are exposed to an aqueous environment due to a hydrophobic effect, giving rise to aggregates 
and organizations of high complexity levels (Figure 7). Additionally, the generation of these 
Figure 7. Lipid polymorphism. A. Overall shape that lipid molecules exhibit according to the relationship 
between the cross-sectional areas of the head group and the acyl chains: inverted cone (left), cylindrical 
(middle), and cone (right).  B. Schematic illustration of the large variety of mutually related structures 
that lipids adopt as a function of their chemical structure and of external variables such as water 
content, temperature, pressure and aqueous phase composition. Phospholipids typically assemble 
as bilayers forming planar lamellar structures (6), liposomes (7) or disks (3). Non lamellar structures 
such as micelles (1) and inverted micelles (2) give rise to bidimensional cylinders in which the lipid 
acyl chains are oriented inward (4) or outward (5), respectively. These cylinders configure hexagonally 
coordinated macromolecular HI (8) or inverted HII (9) phases. Upon certain conditions, lipids can be 
also organized as inverted (10) and bicontinuous (11) cubic phases. Adapted from (Lee, Jamgotchian et 
al. 2008),  www.particlesciences.com and www.cbmn.u-bordeaux.fr.
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structures is also defined by the geometrical shape of the molecules constituting the lipid 
system (van den Brink-van der Laan, Killian et al. 2004). Most of the phospholipid species, such 
as PCs, are considered to have a rather cylindrical shape, since the cross-sectional area of the 
head group and the acyl chains are equivalent. These lipids dominating in biological membranes 
are arranged primarily as bilayer structures, the so-called lamellar phases, whose curvature 
is close to zero. Phospholipids that form flat bilayers spontaneously stack when hydrated, and 
form repeating spherical lamellae or multillamelar vesicles (MLVs) to avoid edges exposed 
to water. When the cross-sectional areas of the lipid head group and acyl chains differ, other 
aggregate structures are preferred constituting non-lamellar phases. If the cross-sectional 
area of the head group is larger than that of the acyl chains (type I lipids such as detergents 
or lysophospholipids), structures with a positive curvature, such as micelles, are favored, 
giving rise to hexagonal phases HI. On the other hand, when the cross-sectional area of the 
head group is smaller, it results in an overall conical shape (type II lipids, such as diacylglycerol 
or PE) forming negatively-curved structures termed inverted hexagonal phases HII and cubic 
phases. In the hexagonal phases, lipids are packed together to form hollow cylinders. The most 
common kind of hexagonal phase formed in water is the HII phase, where the methyl ends 
of the acyl chains form the exterior of a lipid cylinder filled with water. These cylinders are 
packed together with hexagonal symmetry in which each cylinder is surrounded by six other 
cylinders, hence the name hexagonal phase. With respect to cubic phases, these can be divided 
in two general classes: inverted micellar and bicontinuous. In the first case, lipids are packed 
into spherical aggregates, with each sphere representing a unit cell that packs together with 
other unit cells in a cubic array. In bicontinuous cubic phases, both lipid and water channels are 
continuous in space and the arrangement is accomplished with several different morphologies, 
all of which have cubic symmetry but belong to different space groups (Luzzati 1997). 
However, within the shape-structure concept of lipid polymorphism, the overall shape of the 
lipid is not only function of its chemical structure but also of external parameters like temperature, 
pH, salt concentration, presence of divalent cations, pressure or hydration (Cullis and de Kruijff 
1979; Tate, Eikenberry et al. 1991). The lipid phases shown in Figure 7 are mutually related and 
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transform into each other via phase transitions driven by temperature, pressure, lipid composition 
and so on (Koynova and Tenchov 2013). Besides environmental conditions, particular interactions 
of lipids with proteins (i.e.: amphiphilic or membrane-lytic peptides) can also lead to the promotion 
of non-lamellar phases modulating the activity of diverse biological systems (Epand 1998).
3.1.3. Lateral organization
When assembled in bilayers, phospholipids present different levels of molecular ordering 
and mobility as a function of temperature. At temperatures above a threshold, known as the 
gel-to-fluid transition temperature or Tm (melting temperature), the bilayers melt from an 
ordered state (gel phase or L
β
) to a disordered, more fluid state (liquid-crystalline phase, L
α
). 
In the gel phase, molecules have little rotational or translational mobility and adopt quasi-
crystalline order with homogeneous well-defined intermolecular distances and extensive 
packing of their acyl chains. However, in the liquid-crystalline phase, lipid molecules are 
relatively disordered as a result of the trans-gauche isomerization which takes place at their 
C-C bonds (Pérez-Gil 2008). The melting temperature of a given phospholipid depends on 
the number of double bonds and length of its acyl chains, with long, fully saturated chains 
undergoing ordered-to-disordered transitions at much higher temperatures than shorter or 
unsaturated chains. In the particular case of PS, it seems to have evolved to contain around 
50 % saturated and 50 % unsaturated species as a result of a particular modulation in the lipid 
biosynthesis pathways in ATII cells (Pérez-Gil and Weaver 2010). Saturated species such as DPPC, 
the main component of PS, melt from ordered to disordered phase at 41 °C, whereas POPC, 
one of the most abundant unsaturated species, melts at -2 °C. The coexistence of ordered and 
disordered phases at a wide range of temperatures, including physiological values, manifests 
in a high stability of surfactant layers at high compression sustained by saturated molecules 
(mainly DPPC) and enough fluidity and dynamics, which are facilitated by unsaturated species. 
The gel and fluid phases in bilayers have some correspondence with the order and packing 
of phospholipids in interfacial monolayers. In fact, in addition to temperature, changes in 
lateral compression can define lipid packing at the air-liquid interface. At low compression 
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levels, areas per lipid molecule 
are large and the configurational 
freedom of the acyl chains is also 
high and monolayers constitute 
what is called a liquid-expanded 
(Le) phase, qualitatively equivalent 
to the L
α
 in bilayers (Nag, Boland et 
al. 1991). When compressed enough 
at the interface, phospholipid 
can reach a highly packed state, 
the liquid condensed (Lc) phase, 
whose low mobility is comparable 
to that of L
β
 in bilayers (MacDonald 
and Simon 1987). Beyond this, 
an extreme packing state can be 
achieved producing solid-ordered (So) phases which are not compressible any further and 
behave as real two-dimensional solids. Molecules in So phases have no translational mobility 
and if the compression exceeds a certain threshold the film collapses and the material present 
in the interface is expulsed into the air or water bulk phases (Discher, Maloney et al. 1996). 
Besides temperature and compression, the incorporation of cholesterol has a profound 
effect in the modulation of the lateral organization and dynamics of surfactant membranes 
(Figure 8). Intercalation of enough cholesterol molecules into phospholipid bilayers and interfacial 
monolayers reduces packing and increases mobility of phospholipids in the ordered phases (L
β
, 
Lc) giving rise to phases with a certain molecular order but maintaining a relatively fluid state. 
On the other hand, disordered phases gain order when cholesterol molecules are inserted 
reducing the conformational freedom of the acyl chains. Presence of cholesterol defines an 
organization of a particular phase termed liquid-ordered (Lo), where phospholipids may retain ordered 
states with high packing and low hydration, as occurs in L
β
 phases, but associated with significantly 
higher lateral and rotational mobility (Casals and Cañadas 2012; López-Rodríguez and Pérez-Gil 2014). 
Figure 8. Cholesterol-induced liquid ordered 
phase. When added to lipids in the gel phase (L
β
) at 
temperatures below Tm, cholesterol tends to liquefy 
the membrane structure by disrupting the highly 
ordered tilted structure of the hydrocarbon chains and 
inducing them to be fully extended, but not tilted. At 
temperatures above Tm, cholesterol tends to rigidify 
lipids in the liquid disordered (Ld) phase also leading to 
the formation of the intermediate phase Lo, where the 
lipid tails are more ordered similarly to the L
β
 phase, but 
maintain lateral fluidity similar to the Ld.
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The Lo phase transforms into a liquid-disordered (Ld) phase at temperatures above the Tm. This 
coexistence of ordered and disordered phases in PS, which have been confirmed by a number 
of evidences (Bernardino de la Serna, Oradd et al. 2009; Bernardino de la Serna, Vargas et 
al. 2013) results in the segregation of lipid membrane domains. This lateral heterogeneity, 
which takes place in both surfactant bilayers and monolayers, might imply changes in 
surfactant macroscopic properties and in addition to its compositional complexity, would 
contribute to maintain PS membranes at the critical point between two fluid states permitting 
fluctuations and interactions that are essential for its function (Parra and Pérez-Gil 2015).
3.2. Proteins
Besides lipids, to accomplish 
its biophysical function as 
well as to participate in the 
alveolar homeostasis and the 
lung defense against pathogens, 
pulmonary surfactant requires the 
presence of four specific proteins 
in the alveolar hypophase: SP-
A, SP-B, SP-C and SP-D (Figure 
9). SP-A, SP-B and SP-C, but not 
SP-D, are membrane-associated 
proteins and occur in surfactant 
in small amounts (3-5 % by 
mass in the case of SP-A, 0.5-1 % by mass for SP-B and SP-C). SP-D is not usually associated with 
surfactant membranes and it constitutes less than 0.5 % by mass (Serrano and Pérez-Gil 2006).
Figure 9. Surfactant proteins associated with lipid 
multilayers. Schematic representation of the structural 
models of octadecameric SP-A and dimeric SP-B, the 
resolved structure in organic solvent of SP-C and a structural 
model of a dodecameric SP-D. Orange bands represent 
monolayer/leaflets. Modified from (López-Rodríguez and 
Pérez-Gil 2014).
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3.2.1. Hydrophobic proteins: SP-B and SP-C
SP-B is a 17.4 kDa homodimer containing around 52 % of hydrophobic amino acids and a 
mainly α-helical secondary structure (40-50 %) oriented parallel to the membrane surface, 
establishing hydrophobic interactions between the helical segments and the membrane surface 
(Pérez-Gil, Cruz et al. 1993; Johansson and Curstedt 1997). SP-B belongs to the saposine-like 
family of proteins, characterized by containing 6 cysteines in strictly conserved positions that 
establish 3 intrachain disulphide bonds (Olmeda, García-Álvarez et al. 2013). An additional 
cysteine is involved in an intermolecular disulphide bond, which is responsible for the covalent 
dimerization of the protein (Johansson, Curstedt et al. 1991). SP-B sequence possesses 
eight conserved positively-charged residues and one conserved negatively-charge residue, 
which confer to the protein a net positive charge that enhances its interactions with anionic 
phospholipids, primarily PG (Pérez-Gil, Casals et al. 1995). SP-B has been proposed to favor 
the promotion of membrane interconnections through supradimeric oligomerization of the 
protein (Baoukina and Tieleman 2011; Olmeda, García-Álvarez et al. 2013) as well as to induce 
permeability and aggregation of lipid membranes (Ryan, Qi et al. 2005; Parra, Moleiro et al. 
2011; Parra, Alcaraz et al. 2013). These processes are thought to be related with the canonical 
properties exhibited by an operative surfactant including 1) promoting a rapid adsorption of 
phospholipids into the air-liquid interface and 2) facilitating the refinement of the interfacial film 
during compression and 3) an efficient re-extension of the material from the reservoirs during 
expansion (Serrano and Pérez-Gil 2006; López-Rodríguez and Pérez-Gil 2014). Moreover, it has 
been recently proposed that the interconnection of membranes mediated by SP-B might permit 
the formation of a continuous network highly conductive for hydrophobic molecules, such as 
oxygen, facilitating oxygen diffusion though the alveolar barrier (Olmeda, Villén et al. 2010). 
SP-C is another small (3.7 kDa) hydrophobic peptide of 35 residues and it appears to be the only 
constituent which is almost unique to PS, indicating important and specific functions (Weaver and 
Whitsett 1991; Johansson 1998). SP-C forms a single α-helix rich in branched aliphatic residues, 
mostly valine, which upon insertion in phospholipid membranes adopts a transmembrane 
orientation with a ~70° tilt relative to the plane of the membrane (Vandenbussche, Clercx et 
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al. 1992; Johansson, Szyperski et al. 1994). The SP-C N-terminal tail includes two palmitoylated 
cysteine residues and 3 positive charges that favor a preferential interaction with anionic 
phospholipids (Pérez-Gil, Casals et al. 1995). The palmitic chains seem to play an important role 
by anchoring the N-terminal segment to the membrane, strengthening the association of the 
protein to the interfacial film preventing its exclusion during compression (Bi, Flach et al. 2002) 
and being key in the modulation of SP-C-lipid interactions in lung surfactant multilayers (Roldán, 
Goormaghtigh et al. 2015).  Although palmitoylation is not essential to promote a rapid interfacial 
adsorption of phospholipids, it has been proved to be required to reach and maintain the lowest 
surface tensions of the films at high compression rates, in the presence of SP-B and cholesterol 
(Baumgart, Ospina et al. 2010).  SP-C is thought to promote and stabilize membrane-membrane 
and membrane-interface contacts (Ross, Krol et al. 2002), facilitating lipid exchange between 
bilayers or between bilayers and monolayers, particularly at highly compressed states (Klenz, 
Saleem et al. 2008). Additionally, recent investigations suggest that SP-C might have a protective 
role specifically interacting with cholesterol through its palmitoylated segment, preventing its 
deleterious effect in surfactant activity (Gómez-Gil, Schürch et al. 2009).
Figure 10. Functions of hydrophobic proteins. Graphic representation of the main functions related to 
SP-B and SP-C: promotion of molecular interactions between the membranes associated to the surface 
and the reservoir (A), perturbation of bilayered structures to favour transfer of surface active molecules 
into the air-water interface (B), facilitate the enrichment of the surface films in DPPC (C) and permit the 
re-extension of the interfacial film during inspiration. Modified from (Pérez-Gil 2010).
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In general, the hydrophobic proteins SP-B and SP-C are considered mainly responsible for 
the biophysical activity of PS and their presence is vital for an efficient interfacial adsorption, 
film stability and re-spreading processes of surfactant along the multiple compression-expansion 
breathing cycles (Serrano and Pérez-Gil 2006) (Figure 10). Currently, their concerted action is 
thought to be key to create and stabilize the structure of multilayered film that PS adopts at the 
air-liquid interface (Pérez-Gil and Weaver 2010).
3.2.2. Hydrophilic proteins: SP-A and SP-D
SP-A is the most abundant surfactant-associated protein synthesized by ATII cells. The protein 
monomer has a molecular mass of ~ 28-36 kDa, although in lung lavage this protein exists as a 
650 kDa oligomeric glycoprotein constituted by 18 subunits (Hawgood and Shiffer 1991). SP-D 
is a 43 kDa glycoprotein and it is assembled as homotrimeric subunits which form a cruciform 
structure in which four trimeric subunits self-associate to form highly ordered SP-D dodecamers 
(~ 520 kDa) (Crouch 2000). Both hydrophilic proteins belong to the collectin family of proteins 
and present a common structural pattern particularly optimized for their function, including a 
N-terminal collagen-like region and a C-terminal globular lectin domain. The globular domains 
are able to recognize and bind carbohydrates (CRDs, carbohydrate recognition domains) present 
at the surface of numerous types of microorganisms, including viruses, bacteria and fungi. 
Thus, these proteins are in charge of recognizing and opsonising pathogens, presenting 
them to immune cells such as alveolar macrophages and monocytes (Wright 2003). However, 
in the absence of immune cells, they still exhibit intrinsic antimicrobial activity by increasing 
the permeability of the microbial cell membrane (Wu, Kuzmenko et al. 2003). In particular, SP-A 
binds lipopolysaccharides preferentially from Gram-negative bacteria, whereas SP-D binds also 
to peptidoglycans and lipoteichoic acid (Kingma and Whitsett 2006).  Additionally, SP-A has been 
shown to specifically bind DPPC via the CRD domain (Kuroki and Akino 1991) and it can also 
promote vesicle aggregation in the presence of calcium (Casals 2001). This feature might be 
related to the action of the protein of enhancing the adsorption of surfactant complexes into 
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the alveolar air-water interface (Poulain, Allen et al. 1992; Sáenz, Cañadas et al. 2007) and to 
the generation of tubular myelin, an intermediary structure in surfactant metabolism (see page 
52 for further details). In addition, the interaction of SP-A trough CRDs with phospholipids can 
also lead to the recycling and clearance of surfactant by ATII cells and alveolar macrophages. 
On the other hand, SP-D is also involved in surfactant homeostasis by regulating the surfactant 
pool in the alveolar spaces, although the mechanisms underlying this function remain still unclear 
(Wert, Yoshida et al. 2000). In general terms, the hydrophilic section of surfactant proteins is 
specialized in the clearance of pathogens from the alveolar spaces by binding and agglutinating 
microorganisms and molecules such as allergens or environmental inorganic particles as well 
as in the modulation of the inflammatory cellular response in the lung (Figure 11). As a matter 
of fact, the interaction of the surfactant collectins with macrophages has a profound effect 
in the regulation of a variety of processes such as phagocytosis, the production of reactive 
oxygen species or the release of proinflammatory cytokines (Sano and Kuroki 2005). Besides 
the presence of SP-A and SP-D in the lung environment, both proteins have been detected in a 
Figure 11. Functions of hydrophilic proteins. Pulmonary surfactant collectins SP-A and SP-D bind 
to a variety of bacteria, viruses, fungi or allergens and thereby function as opsonins to enhance the 
phagocytosis of cells and particles by alveolar macrophages via interaction with specific receptors 
for the collagenous parts of SP-A and SP-D. Some pathogens can be agglutinated by SP-A and/
or SP-D to favour their removal by macrophages or their elimination through the upper airways. 
SP-B and SP-C also possess intrinsic antibiotic activity and they also participate in host-defense 
functions. Modified from (Pérez-Gil 2010).
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number of non-pulmonary contexts, such as uterus, ovary, lacrimal gland (Akiyama, Hoffman 
et al. 2002), ear mucosa (Dutton, Goss et al. 1999) or in amniotic fluid (Miyamura, Malhotra et 
al. 1994) and placental membranes (Sun, Brockman et al. 2006), principally involved in immune 
regulatory responses. 
4. Pulmonary surfactant biology: biogenesis and metabolism
In the alveolar epithelium, ATII cells are in charge of synthesizing and assembling 
the lipid and protein constituents of PS into structures that are stored as tightly packed 
membranous complexes called lamellar bodies (LBs) until they are exocyted into the 
airspaces (Goerke 1998). After a number of respiratory cycles, the “spent” secreted 
surfactant material is internalized by ATII cells and other cell types to avoid accumulation 
in the alveolar spaces. These processes are subjected to a strict modulation and defects 
in their regulation lead to pathophysiological manifestations, being some of them lethal.
4.1. Biosynthesis of PS components
4.1.1. Surfactant lipids
Lipids constituting PS are synthesized in the endoplasmic reticulum (ER) of ATII cells 
(Figure 12). De novo synthesis of PC predominantly occurs by the choline pathway and is 
catalyzed by the sequential activities of choline kinase, cholinephosphate cytidyltransferase 
and cholinephosphotransferase (Goss, Hunt et al. 2013).  Although DPPC can be also 
formed by de novo synthesis, this is predominantly produced (75 %) via deacylation-
reacylation of existing PC species, participating a calcium-dependent phospholipase A2 
and lysoPC acyltransferase 1 (LPCAT 1) (Bridges, Ikegami et al. 2010). PG and PI are obtained 
from the common precursor CDP-diacylglycerol and cholesterol is mostly supplemented 
by serum lipoproteins, particularly VLDL (Guthmann, Harrach-Ruprecht et al. 1997). 
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Upon their biosynthesis in the ER, surfactant lipids are thought to be transported via 
different pathways, including vesicular tranport, non-vesicular transport and diffusion at 
membrane contact sites, although the specific weight of either of the routes is still unclear 
(van Meer, Voelker et al. 2008; Pérez-Gil and Weaver 2010).  Vesicular transport through 
Golgi apparatus and multivesicular bodies (MVBs) is believed to play an important role. 
MVBs are organelles containing numerous internal unilamellar vesicles and are supposed 
to be the organelles preceding the final assembly and storage of surfactant (Pérez-Gil 2008). 
Besides the vesicular route,  a direct traffic from ER to the LBs is also plausible, being involved 
the participation of transport proteins to facilitate the connection between both structures.
Figure 12. Biosynthesis and trafficking of surfactant components. Scheme illustrating the processing and 
secretion of the main constituents of PS. Left: Domain structure and assembly of the hydrophilic proteins 
SP-A and SP-D. N, NH2-terminal domain; CD, collagenous domain; Nk, neck domain; CRD, carbohydrate 
recognition domain. Middle: Lamellar body (LB)-independent (SP-A and SP-D) and LB-dependent (SP-B, SP-
C, and phospholipids) secretion. *The secretion of SP-A via LB-dependent is still under debate. Recycling 
of surfactant components is also shown, followed by either degradation or recycling to multivesicular 
bodies (MVBs) and eventually re-secretion. ER, endoplasmic reticulum; GA, Golgi apparatus; TGN, trans-
Golgi network; EE, early endosomes; Lys, lysosomes; CB, composite bodies. Right: Domain structure and 
processing of the hydrophobic proteins SP-B and SP-C. Processing products are shown at the level of their 
presumed locations in the organelles of secretory pathways. Modified from (Andreeva, Kutuzov et al. 
2007) and (Ochs 2010).
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4.1.2. Surfactant proteins
Whereas secretion of phospholipids is mediated solely by LBs, secretion of surfactant proteins 
is more complex (Figure 12).
SP-A and SP-D are translated from their mRNA as propeptides that contain a signal peptide 
which leads them to the ER, where they are subjected to postranslational modifications such as 
glycosilations and hydroxilations before secretion to the alveolus.  Whether the secretion occurs 
either as a regulated process via LBs or as a constitutive release by a different pathway  has been 
a matter of debate for many years. Indeed, it has been previously assumed that SP-A is exocyted 
to the extracellular media not associated to LBs, probably joining and interacting with surfactant 
membranes once in the alveolar spaces (Ochs, Johnen et al. 2002).  However, recent evidences 
seem to indicate that newly synthesized SP-A can be targeted to LBs for storage and subsequent 
secretion by controlled exocytosis (Fisher, Dodia et al. 2010). 
SP-B and SP-C are produced as soluble proproteins with N- and C- flanking domains (proSP-B 
and proSP-C) that are subjected to multiple proteolytic cleveage steps before reaching their 
mature forms probably sharing  processing enzymes (napsin A, cathepsin H, pepsinogen C) 
in a progressive acidificated environment along the exocytic pathway. SP-B initally contains a 
signal peptide that mediates the translocation of the protein to the ER (Brasch, Johnen et al. 
2004), whereas SP-C does not contain a classic cleavable signal sequence, acting the mature SP-C 
domain itself as an anchoring motif sufficient for translocation (Russo, Wang et al. 1999). Both 
proteins follow a parallel pathwaty from the ER, reaching MVBs through the Golgi apparatus. 
Before entering to the LBs, they are transferred through different endosomal compartments 
as composite bodies (Weaver 1998). In human ATII cells there have been identified not only 
proSP-B, processing intermediates of proSP-B, and mature SP-B, but also fragments of the 
N-terminal propeptide. In fact, both mature SP-B and the N-terminal propeptide seem to be 
transported together to the LBs (Brasch, Johnen et al. 2004). ProSP-C is translocated to the ER 
for a proper folding and post-translational addition of covalent palmitic acid. Once released from 
the Golgi, the proprotein suffers the cleavage of the flanking domains to yield the mature SP-C 
module that is subsequently transferred to the lumen of LBs (Beers and Mulugeta 2005). The 
processing of SP-C to its mature form strictly needs the correct expression of SP-B, probably 
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related to the SP-B lytic and fusogenic activities, which might facilitate the access of proteases to 
the lumen of MVBs (Weaver and Conkright 2001).
4.2. Biogenesis of LBs
The LBs are the specialized organelles where PS is packed and stored in ATII cells, and their 
biogenesis is tightly reliant on the involvement of two proteins: SP-B and the recently described 
specific ATP-binding cassette transporter A3 (ABCA3). 
On the one hand, SP-B seems to be key for the accumulation and packing of membranes in 
LBs, and its absence results in a deficit of LBs and a subsequent accumulation of their precursors, 
the MVBs (Stahlman, Gray et al. 2000). Furthermore, the membrane-membrane interactions 
that SP-B promotes in vitro (Cruz, Casals et al. 1997; Cruz, Worthman et al. 2000), might be 
responsible for the tight packing of membranes observed in LBs since, when SP-B is not present, 
LBs result loosely packed. Concerted with SP-B action, the acidic pH present in LBs has been also 
proposed as a complementary force to trigger full membrane packing, by permiting the proper 
conformation and state of charge of surfactant lipids and proteins (Ruano, Pérez-Gil et al. 1998). 
On the other hand, the relevance of the role that ABCA3 plays on the LB biogenesis has been 
extensively discussed in the latest years. This protein belongs to the family of ABC transporters, 
which bind and hydrolise ATP coupled to the transport of different molecules, like phospholipids, 
through membranes. Recent evidences suggest that DPPC and PG are directly transferred to the 
LB through a vesicle independent mechanism in wich ABCA3 is involved. ABCA3 would act as 
a flippase, significantly enhancing the catalysis of the transmembrane movement of saturated 
phospholipid species, originating an asymmetric character of the LB limiting membrane (Pérez-
Gil 2008). Indeed, other ABC-type flippases have been previously described to maintain the 
assymetry of most cellular membranes, performing a selective pumping of certain lipid species 
from one leaflet of membranes to the other (Pomorski and Menon 2006). The progressive 
accumulation of phospholipids into the inner leaflet could only be relaxed upon the creation of 
membrane folds, generating a driving force to produce and accumulate membrane structures 
into the lumen of MVBs, which in a later stage would be tightly packed as LBs, thanks to the 
action of SP-B and the fluidizing effects of cholesterol/minor phospholipids (Pérez-Gil 2008; 
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Pérez-Gil and Weaver 2010). Furthermore, a putative location of ABCA3 in inner membranes 
could promote additional membrane vesiculation at different levels, what could explain the 
onion-like morphology typical of LBs. In addition, it has been proposed that most of these 
membranes could form a single interconnected structure that might facilitate its rapid and 
cooperative unravelling observed upon secretion (Pérez-Gil 2008; Ravasio, Olmeda et al. 2010).
4.3. Secretion and unpacking of LBs  
A burst in secretion of surfactant occurs at birth with the first breath, and afterwards, the 
requirement for synthesis becomes lower (Agassandian and Mallampalli 2013). Surfactant 
turnover is considerably low, between about 4 and 11 hours (Wright and Clements 1987), 
but it is accelerated under conditions of physical exercise, even though a single deep breath 
or a yaw is sufficient to trigger the process (Dietl, Haller et al. 2012). Surfactant secretion is a 
highly regulated event and it involves the concerted action of a number of proteins and other 
constituents throughout the exocytotic pathway  (Dietl and Haller 2005). 
4.3.1. Stimuli of surfactant secretion
Presumably because this process is vital for the survival of the organism, there are several 
independent pathways for stimulating secretion, which work through different cell surface 
receptors and signalling mechanisms (Mason and Voelker 1998). Indeed, surfactant exocytosis 
can be triggered by numerous chemical and physical stimuli, although the two probably most 
potent and physiologically important are alveolar stretch and extracellular ATP (Dietl, Liss et 
al. 2010). A number of agonists have been reported to activate ATII cells, including β2-mimetic 
drugs (Dobbs and Mason 1979), ATP and other purinergic receptor agonists (Gilfillan and Rooney 
1987) as well as para- or endocrine mediators such as gastrin-realising peptide, prostaglandin 
derivatives, vasopressin and endothelin-1 (Dietl and Haller 2005). However, under experimental 
conditions, lung distension or ATII cell stretch have been considered so far to be the most 
physiologically relevant factor and it is likely that the increase of surfactant release, which is 
detected after only a single inflation of isolated perfused lungs, is the result of a related epithelial 
cell mechanical stretch (Nicholas, Power et al. 1982).  
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4.3.2. Fusion of LBs with plasma membrane
Numerous evidences indicate that Ca2+ is a pivotal factor to trigger the LB fusion event in 
the ATII cell. It is known that β2-adrenergic stimulation induces the formation of cAMP, but also 
elicits a transient increase of intracellular calcium, whereas ATP involves P
1
receptor-dependent 
cAMP formation as well as P2receptor-dependent phosphoinositide hydrolysis and subsequent 
Ca2+ mobilization (Haller, Ortmayr et al. 1998). The actions of Ca2+ and those of cAMP are 
additive, consistently with the concept that surfactant exocytosis is independently regulated at 
various sites (Gobran, Xu et al. 1994).  A model can be conceptualized from analyses of secretion 
stimulated by ATP and use the P2Y2 purionoreceptor as an example of a seven membrane spanning 
G-protein coupled receptor (see 
Figure 13 for details). Additionally, 
among Ca2+ permeable channels, 
which might be involved in 
stretch-induced Ca2+  entry in ATII 
cells,  mechanosensitive channels 
like those from the transient 
receptor potential (TRP) channel 
family have been proposed to play 
a potential role (Dietl, Liss et al. 
2010). On the other hand, besides 
calcium signaling pathways, 
other powerful stimulus is the 
treatment with phorbol esters, 
which activate protein kinase 
C (PKC) and does not cause 
increments in intracellular Ca2+, 
althougt  the process seems to be 
not completely Ca2+ independent 
(Frick, Eschertzhuber et al. 2001). 
Figure 13. Physical/chemical stimulation of surfactant 
exocytosis. Schematic representation of purinergic and 
mechanosensitive signaling, which trigger surfactant 
exocytosis in ATII cells. ATP binds P2Y2 receptor, leading 
to activation of phospholipase C. Cleavage of PIP2 by 
phospholipase C yields IP3 and DAG. After diffusion through 
the cytosol, IP3 interacts with and opens Ca
2+ channels in 
the membrane of endoplasmic reticulum, causing release of 
stored Ca2+ ions into the cytosol. Rapid, cell stretch-induced 
Ca2+ entry can take place via the transient receptor potential 
(TRP) channel. Adapted from (Dietl, Haller et al. 2012).   
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In general, an elevated concentration of calcium is assumed to facilitate LB transfer to and 
docking with the plasma membrane by cytoeskeletal elements and molecular motors (Dietl and 
Haller 2005; Dietl, Haller et al. 2012). 
When LBs are close to the plasma membrane, they connect with the extracellular space 
through a single pore, formed by the limiting membrane of the vesicles and the plasma 
membrane. Among the bioactive lipid metabolites result of the purinergic stimulation that might 
promote LB fusion, phosphatidic acid (PA) appears specially promising thanks to its ability to 
change lipid topology. PA is known to induce negative plasma membrane  curvature thanks to its 
small head group combined to two fatty-acyl side chains, likely promoting lipid merging with the 
vesicle membrane and hemi-fusion (Zeniou-Meyer, Zabari et al. 2007).
The fusion pores generated during surfactant exocytosis are about half of the average 
diameter of the associated LBs, and this imposes a deformation of LBs during secretion, which 
might be significant for unraveling of LB material, or even for the transformation into its active 
forms (Haller, Dietl et al. 2001). This restriction could be also responsible for the slowered kinetics 
observed in LB exocytosis, since once the fusion pore is formed, it still takes some time for the 
packed membranes to be completely expelled out of the cell (Singer, Frick et al. 2003). 
4.3.3. Postfusion and unravelling of LBs
The contact of the internal medium of LBs with the extracellular environment via the fusion 
pore is thought to prompt modifications in membrane packing, due perhaps in part to re-hydration 
but also likely to pH neutralization and other potential changes in the ionic environment (Pérez-
Gil 2008), including a decrease in the levels of Cl- or Ca2+, which are known to be considerably 
higher inside LBs (Eckenhoff and Somlyo 1988).  
The unpacking of LBs is a cooperative and almost instantaneous event and frequently, it seems 
to be originated from a defined peripheric point of the secreted structure, with inner layers 
being expelled out of the LB preceding the more external ones (Haller, Dietl et al. 2004). The 
presence of a pressure gradient towards the center of the LB result of the progressive pumping 
activity of ABCA3 might be a tentative explanation to this observation, although the possibility 
of local protein-protein interactions forming valve-operating structures to favor a cooperative 
unravelling could not be discarded either (Pérez-Gil 2008). 
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4.4. Extracellular surfactant
4.4.1. Membrane organization in tubular myelin 
In the alveolus, a number of potential elements are believed to participate in the unravelling 
of LBs, to give rise to the definitive lipid-protein networks in charge of accomplishing the multiple 
activities of PS. On the one hand, strong evidences suggest that the highly packed membranes 
constituting secreted LBs are adsorbed spontaneously to the interface whithout passing through 
any unpacked intermediary (Haller, Dietl et al. 2004). However, on the other hand, some 
extracellular structures have been found in the alveolar hypophase, rearranged in a lattice-like 
structure of elongated proteolipid tubes termed tubular myelin (TM) and electron micrographs 
have shown a continuity between LB and these structures (Williams 1977). In the aqueous 
hypophase, SP-A is thought to contribute to LB unpacking mainly through the conversion of 
multillamelar arrays into TM. According to this, the square membrane lattices typical of TM are 
proposed to be sustained by SP-A/SP-A interactions via their headgroups, since the molecular 
size of the SP-A complexes coincide with that of the periodic lattice, around 40 nm (Nag, Munro et 
al. 1999) and their presence at the corners of the lattice has been confirmed by immunolabeling 
(Voorhout, Veenendaal et al. 1991). In the current model, besides SP-A, the presence of SP-B/
SP-B interactions would be crucial in the TM architecture by favoring membrane-membrane 
interactions, probably followed by membrane fusion (Pérez-Gil 2008) (Figure 14). Furthermore, 
lipids are not considered passive structures but instead can play an important role in determining 
the three-dimensional organization of TM (Palaniyar, Ridsdale et al. 1999). Interestingly, it is 
possible to reconstruct TM in vitro by combining synthetic lipids (DPPC and PG), SP-A, SP-B and 
calcium (Suzuki, Fujita et al. 1989), although the manner in which this structure is formed is 
still not clearly understood, neither its specific function in surfactant activities. In this regard, 
some authours interprete TM as the major reservoir of surfactant material in the alveoli whereas 
others support an antimicrobial function, in which TM would act as a high density SP-A lipid 
network in the first line of defense against pathogens (McCormack and Whitsett 2002).
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Figure 14. Extracellular surfactant structures. A freshly secreted lamellar body (LB) on top of the alveolar 
epithelium is partially unravelling to form tubular myelin (TM), which transfers surfactant to the air-liquid 
interface to generate the surface film (SF) (left). Model to explain the possible role of SP-A (middle and 
right) and SP-B (right) in the assembly of tubular myelin network (see text for discussion). Adapted from 
(Ochs 2010) and (Pérez-Gil 2008).
4.4.2. Surfactant at the air-liquid interface
Once the surfactant material is secreted and unpacked in the aqueous hypophase, it adsorbs 
onto the air-liquid interface to form the active surface film. The adsorption process occurs very 
rapidly in order to stabilize the interface against the mechanical forces that tend to collapse 
the alveolus. The surface film consists of a monolayer highly enriched in DPPC and lipid-protein 
stuctures attached to it. The further enrichment in DPPC is believed to be achieved by selective 
desorption of non-DPPC lipids during repetitive breathing cycles (Veldhuizen and Haagsman 
2000). With regard to the multilayered stacks associated to the monolayer, they are thought 
to be a reservoir of surface active molecules involved in the respiratory dynamics, including 
the contribution of SP-B and SP-C in its formation, stability and recycling (Pérez-Gil and Keough 
1998). Additionally, and as we stated above, TM could also feed the monolayer and can be part 
of the surface film.
A number of evidences support the notion that both SP-B and SP-C favor reversible 
compression-driven transitions from bilayers to interfacial films, prompting the generation 
of the multilayered films at the interface. Therefore, SP-C would facilitate the formation of 
multilayers associated to the surface monolayer, which would contribute to the lipid pool for the 
compression-expansion cycles (Kramer, Wintergalen et al. 2000). In parallel, SP-B would promote 
the creation of bilayer patches connected to the interface (Krol, Ross et al. 2000) as well as large 
membrane-membrane interactions in multilayered structures that, in the presence of phase 
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segregation, exhibit a considerable cohesivity (Bernardino de la Serna, Vargas et al. 2013). In 
general, the combined effect of both proteins supports the required tension reduction and a 
proper film stability whithout compromising the dynamic character of the lipid multilayers.
4.5. Surfactant recycling and homeostasis
Sucessive compression-expansion cyling of PS provokes a progressive appearance of less active 
fractions, result of the detachment of small particulate entities from the interface, changes in 
lipid/protein organization, and oxidation of lipid and protein species due to a repetitive exposure 
to air (Ueda, Ikegami et al. 1994; Pérez-Gil and Weaver 2010). Thus, to maintain a fully functional 
surface film, a proper refinement via efficient removal and clearance of spent surfactant and 
incorporation of fresh material is required.  Surfactant components can be recycled by ATII cells 
that uptake them to be reincorporated into LBs, for new secretion. This recycling is promoted 
by SP-A via specific interaction with a receptor present in the cell surface, although its identity 
is still unknown (Agassandian and Mallampalli 2013). Phospholipids and SP-A are internalized 
together and sorted to early endosomes. However, some uptaked surfactant is directly degraded, 
largely by alveolar macrophages (Abe, Hiraoka et al. 2004) and the degradation products are 
reutilized to synthesize new components. Additionally, a small amount of surfactant moves up 
the airways through the mucociliary scalator and it is also removed through the epithelium-
endothelium barrier into the blood (Wright 1990). To maintain the intracellular pool size, new 
synthesis of surfactant must be coupled to its depletion. Surfactant proteins may be involved in 
regulating pool size by modulating both secretion and uptake rates (Wright and Dobbs 1991). In 
this regard, SP-D seems to be particularly involved in the regulation of surfactant homeostasis 
altering surfactant structure by unknown mechanisms. SP-D preferentially binds PI, causing lysis 
of surfactant membranes and converting the lipid forms into simpler structures that seem to be 
critical for surfactant uptake by ATII cells and normal surfactant homeostasis (Ikegami, Grant et 
al. 2009).   
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5. Surfactant deficiencies and inactivation 
PS is an essential complex for life and its absence, deficiency or inactivation affects lung 
compliance and gas exchange and contributes to the development and outcome of severe 
respiratory disorders in neonates and adults. Surfactant inactivation can be arosen from 
endogenous defects like genetic disorders associated to mutations at genes related to surfactant 
or from the deleterious action of exogenous effectors.  
5. 1. Endogenous defects
The presence of SP-B is absolutely essential for breathing and certain mutations in the gene 
codifying SP-B (SFTPB ) are lethal in newborn infants, which develop neonatal distress respiratory 
syndrome (NRDS) and other severe respiratory diseases such as congenital alveolar proteinosis 
(Nogee, Garnier et al. 1994; Williams, Christodoulou et al. 1999). Partial SP-B deficiencies also 
leads to a dysfunctional surfactant that exhibits a poor interfacial adsorption, inability to reach 
minimal surface tensions and to sustain proper dynamics upon the expansion-compression 
cycles as well as an intrinsic mechanical instability of the surface films (Schürch, Ospina et al. 
2010; López-Rodríguez and Pérez-Gil 2014). 
With respect to SP-C, although its deficiency  is apparently compatible with an operative 
surfactant, mutations in its coding gene (SFTPC) seem to have more subtle long term effects, 
related to the appearance of interstitial lug diseases (Brasch, Griese et al. 2004) and chronic 
pathologies such as idiopathic pulmonary fibrosis (Korfei, Ruppert et al. 2008).
As expected, given the role of the pulmonary collectins in the alveolar spaces, their partial or 
total absence mainly results in lungs with a diminished innate immune response. SP-A null mice 
exhibit a defective clearance of pathogens and increased susceptibility to infections (LeVine, 
Gwozdz et al. 1999). Besides the immunological impairment, absence of SP-D also leads to 
accumulation of lipids, acute pulmonary alveolar proteinosis, foamy alveolar macrophages and 
emphysema (LeVine, Gwozdz et al. 1999; Guo, Lin et al. 2001).
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In addition to deleterious mutations in surfactant proteins, deficiencies in other related 
proteins have been also associated to lung pathologies; i.e fatal surfactant deficiency related to 
mutations in ABCA3 (Shulenin, Nogee et al. 2004). 
5.2. Inactivation by external agents
Under pathological conditions, PS may encounter exogenous substances with a potential 
capacity to impair its surface activity. In general terms, the exogenous inactivation of PS relies 
on two distinct mechanisms: competition with other surface-active molecules for the air-liquid 
interface or insertion of membrane-perturbing molecules that disrupt the structure of surfactant 
(Zuo, Veldhuizen et al. 2008). 
The first case may result of leakage from the vascular endothelium and the subsequent 
release of serum proteins (i.e.: albumin) into the alveolar lumen, as a consequence of lung injury 
or edema. In this situation, the rate of surfactant adsorption is strongly affected by both the 
presence of the serum proteins at the surface (steric impediment) and the competitive adsorption 
of serum proteins  (Fernsler and Zasadzinski 2009). Acute respiratory distress syndrome (ARDS), 
is a worldwide public health problem with a baseline mortality risk of 40-45 % (Phua, Badia 
et al. 2009), where serum and plasmatic surface-active proteins reach the interface provoking 
surfactant inactivation as well as alveolar collapse and alterations in gas exchange, yielding to 
hipoxemia and organ failure (Dushianthan, Grocott et al. 2011). 
An example of the second mechanism is the direct exposition of surfactant complexes to 
meconium that occurs during meconium aspiration syndrome (MAS), in which a newborn 
inhales his first stool before or during delivery due to prenatal stress. Meconium is basically 
constituted by bile acids and cholesterol, which, once incorporated in excess into surfactant 
membranes induces important alterations in their structure and dynamics (López-Rodríguez, 
Echaide et al. 2011).
Supplementation with exogenous surfactant preparations, obtained from animal sources, 
have proved to be highly efficient in preterm newborns affected by neonatal respiratory distress 
syndrome (Blanco and Pérez-Gil 2007). Surfactant administration may also partially reduce the 
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severity of the respiratory illnesses such as ARDS or MAS although the relative efficacy and clinical 
benefit is insufficient in cases of critical lung injury (Spragg, Taut et al. 2011). In this context, 
recent investigations have shown that exposure of PS complexes to hyaluronan results in an 
improved resistance to inactivation by serum or cholesterol (López-Rodríguez, Cruz et al. 2013). 
Interestingly, even after removal of the polymer,  PS membranes persist in a highly activated 
and resilient state, suggesting that transient exposure to hyaluronan or similar polymers could 
constitute a potential strategy for the production of more efficient clinical surfactant materials 
(López-Rodríguez and Pérez-Gil 2014).
6. Modeling the alveolar type II cell
In the previous sections we have briefly introduced the most important hallmarks of the 
biogenesis of pulmonary surfactant in ATII cells, including the biosynthesis and intracellular 
traficking of its constituents as well as its assembly and secretion into the alveolar airspaces 
to accomplish its different functions. However, despite the fact that ATII cells have been object 
of extensive investigation over the years, understanding of the alveolar epithelial phenotypic 
expression and surfactant metabolism in vivo in either healthy or diseased lungs is not completely 
fulfilled. Thus, given their importance, a large number of different animal models have been 
used to study ATII cell phenotype in vivo and ex vivo.   
6.1. Primary cultures
Since the first method of isolating ATII cells was published in 1974 (Kikkawa and Yoneda 
1974), much light has been shed on ATII cell characteristics upon their isolation from a variety of 
species, mainly adult rodents and rabbit. As with all primary cell isolations, either viability and 
purity can vary substantially among different purifications. Nevertheless, optimization of the 
isolation protocols has been pursued over the last years, and recent protocols report purities > 
90 % (Roper, Staversky et al. 2003) or even > 99 % (Vanderbilt, González et al. 2015). Despite they 
represent the closer option for mimicking the in vivo condition, the primary culture of ATII cells 
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has disadvantages in that it requires recurring cell isolations or in that cells undergo different 
extents of phenotipic drift in culture, acquiring some characteristics of type I cell (Fuchs, Hollins 
et al. 2003; González, Yang et al. 2005; González and Dobbs 2013). As an alternative, for example, 
human primary ATII cells obtained from lung resection have been subjected to immortalization, 
but the produced cells show a phenotype similar to that of ATI cells (Kemp, Thorley et al. 2008). 
In spite of their handicaps, cultivation of primary cells is still the preferred approach for a number 
of researchers to investigate molecular biology, biochemistry and genetics of ATII cells.
6.2. Cell lines
There have been many attempts to establish passaged cell lines as ATII cell models but none 
display the full range of morphologic, biochemical and molecular characteristics of freshly 
isolated alveolar epithelial cells (González and Dobbs 2013).
To date, the A549 cell line is probably the most extensively used cell model for ATII cells. This 
tumor-cell line was initiated in 1972 from a human alveolar cell carcinoma (Giard, Aaronson et al. 
1973) and it was reported to have morphologic and biochemical features of ATII cells,  including 
multillamelar cytoplasmatic inclusion bodies as well as secretion of disaturated PC in response 
to secretagoges (Lieber, Smith et al. 1976; Smith 1977; Shapiro, Nardone et al. 1978). A549 cells 
have been used as a in vitro model for ATII cell dysfunction (Balis, Bumgarner et al. 1984) and 
drug metabolism (Ning, Yu et al. 2015) as well as to study surfactant production and regulation 
(Salmona, Donnini et al. 1992)  and as a transfection host (Giavedoni and Yilma 1996).  
However, the suitability of the A549 cell line as a model for ATII cells has been questioned by 
researchers since, for example, the surfactant produced by A549 cell cultures differ significantly 
from that of primary cells (Mason and Williams 1980). In addition, recent findings suggest that 
A549 are more similar to differentiated ATI than to undifferentiated ATII cells, casting furter 
doubt on the use of A549 cells to represent ATII cells (Swain, Kemp et al. 2010).  
Besides A549 and with a minor significance, other cell lines like L2 have been also used to 
model ATII cells. L2 is a permanent non tumor-derived epithelial cell line and it was first described 
in 1974 (Douglas and Kaighn 1974). L2 cells have been shown to enclose osmiophilic lamellar 
inclusions in both early and later passages (Hoffmann, Grote et al. 1995). 
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Interestingly, L2 cells have been described to express inducible nitric oxide synthase and thus, 
to generate nitric oxide (Hoffmann, Grote et al. 1995; Su, Day et al. 1996). This fact has been 
related to a putative contribution of distal airway epithelial cells to pulmonary host defense 
mechanisms and to pulmonary vasoregulation.
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Pulmonary surfactant (PS) membranes, as defined from their biogenesis in the alveolar type II (ATII) 
cells, are assembled into lamellar bodies (LBs) as a particularly dense structure which is preserved 
upon secretion but is rapid and cooperatively unpacked once in contact with the air-liquid interface. 
We presume that interfacial films formed by freshly secreted surfactant have structural features 
and surface properties that are different from those originated from partially “spent” surfactant as 
purified from animal lungs. In fact, we hypothesize that in whole native surfactant (NS) purified from 
bronchoalveolar lavage (BAL), considered so far as the “gold standard” of an optimized biophysical 
surface behaviour, coexist active membrane fractions with deactivated surfactant or other surfactant-
like structures playing different roles in other locations of the respiratory airways different than alveoli. 
To get deeper insight in the way in which PS is packed into lamellar bodies as well as to collect freshly 
secreted material for its structural and functional assessment, the use of in vitro models representing 
ATII cells become indispensable. Considering the lack of reliable surfactant-producing cell lines, we 
have taken advantage of primary cells isolated from animal sources. However, as mentioned in the 
introduction, primary ATII cells have important handicaps, including the necessity of an extensive use of 
animals and the progressive lack of type II features. In this context, we have also explored the potential 
of differentiation of mesenchymal stem cells isolated from human placenta into cells with a phenotype 
consistent with ATII-cells, to be useful not only for the study of surfactant biogenesis but also as an in 
vitro model for drug metabolism and other biopharmaceutical applications.  
Taking all this into consideration, the specific objectives addressed in the present Thesis include:
1. Study of the micro- and nanostructural organization of surfactant membranes stored in 
intracellular LBs as well as freshly secreted in the form of lamellar body-like particles (LBPs) in 
comparison with native surfactant complexes purified from BAL. This includes the analysis of phospholipid 
packing/hydration and acyl chain order/dynamics, and the characterization of temperature-dependent 
packing, order, phase and lipid polymorphism (Chapter 1).
2. Examination of the structural and functional diversity present in NS complexes isolated from 
BAL. This will be possible upon fractionation of NS into discrete subtypes for morphological, biochemical 
and functional characterization (Chapter 2).  
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3. Differentiation of human placental mesenchymal stem cells into ATII-like cells (ATII-LCs). The 
characterization of this process will include the determination of expression of ATII cell markers at 
a gene and protein levels, the investigation of the capacity of ATII-LCs to generate surfactant-like 
assemblies and exocyte them upon physiological stimulation, and the assessment of the biophysical 
properties of material freshly secreted to the extracellular medium (Chapter 3).
4. Optimization of ATII-LC cultures under physiological conditions mimicking the native alveolar 
microenvironment. This will include the characterization of surfactant-related markers, barrier 
function and type II morphological features after differentiation in advanced cultures. The utility of this 
model will be explored in cytotoxicity studies and by evaluation of the responsiveness of ATII-LCs to 
nanoparticle preparations and molecule uptaking (Chapter 4). 
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MATERIALS
Cell cultures
Isolation and culture of rat alveolar type II cells 
Alveolar type II cells (ATII cells) were isolated from the lungs of anesthetized male Sprague-
Dawley rats  based on a protocol previously described (Dobbs, González et al. 1986) with 
minor modifications (Figure 15). Anaesthesia consisted on a mixture of 110 mg/kg ketamine 
(Ketamidor 10 %; Merial, France) and 12 mg/kg xylazin (Rompun 2 %; Bayer, Germany) and was 
administered intraperitoneally to rats weighting about 200 g (Fig. 15A). The abdominal cavity 
was opened and a heparin solution (400 IU/kg body weight) (Chiesi, Italy) was injected into the 
vena cava inferior with a 0.30x12 mm BL/LB needle (Fig. 15B). Then, before opening the thoracic 
cage, a small hole in the diaphragm was made in order to deflate the lungs. After incising the 
neck, the submandibular tissue and the thyroid gland were removed, passing a suture under the 
trachea, nicking it and cannulating it with a tracheal catheter, fixing it tightly with the suture (Fig. 
15C). The chest wall was then incised along the entire length of the sternum and the anterior 
portions of the diaphragm so that the chest was opened. Once exposed the heart and the lungs, 
the auriculum of the right atrium of the heart was cut off and an additional catheter was placed 
into the pulmonary artery (Fig. 15D) connected to a perfusion bottle containing phosphate 
buffered saline. At this point, the perfusion system was opened to get the lungs free of blood and 
concomitantly, air was injected through the tracheal catheter to inflate the lungs. The lungs were 
inflated several times to total lung capacity (7-10 mL) using a 10 mL syringe in order to expand 
them and allowing perfusion to clear the lungs completely of blood (Fig.15E). In this step, the heart 
should still be spontaneously beating for a proper clearance of blood from the lungs. A successful 
perfusion can be noted when the lungs look completely white, without red or pink areas. Then, 
lungs were excised and washed via the trachea 8 times with solution “B” containing 1 M NaCl, 40 
mM KCl, 0.1 M phosphate buffer, 75 mM HEPES, 8 mg/mL glucose and 0.6 mg/mL EGTA, 2 times 
with solution “A” containing 0.14 M NaCl, 5 mM KCl, 0.1 M phosphate buffer, 10 mM HEPES, 2 
mM CaCl
2
, 2.5 mM MgCl
2
, 1 mg/mL glucose, pH 7.4 and 1 time with solution “C” containing 0.25 
mg/mL elastase (Elastin, USA) and 0.05 mg/mL trypsin (Sigma-Aldrich, Germany) in solution “A”. 
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Figure 15. Critical steps in the surgical procedure for the isolation of rat alveolar type II cells. 
A. Male Sprague-Dawley rat anesthetized with ketamine/xylacine. B. Injection of heparin 
through vena cava. C. Placement and fixation of the tracheal catheter. D. Insertion of the heart 
catheter into the pulmonary artery to initiate the perfusion. E. Filling of the lungs with washing 
and enzymatic solutions through the tracheal catheter. F. Filtering of the homogenized lung 
tissue with gauze and nylon meshes. Photographs have been extracted with permission from a 
video recorded by Dr. Thomas Haller (Innsbrück University).   
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During the incubation with solution “C”, the excised lungs were immersed in physiological NaCl 
solution, in a water bath maintained at 37 °C during 15-20 min. The elastase solution was added 
continuously at 5 cm H
2
O pressure. The timed intratracheal instillation of elastase results in an 
enrichment of alveolar epithelial cells since they are effectively liberated from the underlying 
basement membrane, leaving most of the interstitial and vascular compartments intact.  After 
enzymatic digestion, trachea and large airways were cut away and discarded. The lungs were 
minced with sharp scissors to tissue cubes of a final size of approx. 1 mm, in the presence of 
solution “D” containing 1.3 mg/mL DNAse I (Roche, Germany) in solution “A”. After mincing, 
5 mL fetal bovine serum (FBS) (Lonza, Germany) were added to stop the Dnase reaction. At 
this point, the cell suspension was filtered sequentially through meshes of different diameters 
coupled to falcons: 2 layers of gauze, 1 layer of gauze, and then nylon meshes of 150, 20 and 7 µm 
(Fig. 15F). Filtering occurred by gravity, and additional filters were used as needed when flow 
decreased due to filter clogging. Then, the suspension was centrifuged at 130 x g for 8 minutes, 
the supernatant was discarded and the pellet containing the cells was resuspended in 30 mL 
Dulbecco’s Modified Eagle’s Medium (DMEM) (Lonza, Germany) without FBS. The cells were 
put in an IgG-coated plate and maintained for 15 min in an incubator, to separate ATII cells by 
negative selection from most of the rest of cell types which interact with IgG molecules attached 
to the bottom of the plate. After shaking the plates gently, the cell suspension was returned to a 
Falcon tube and was centrifuged again. Cells were resuspended in DMEM with 10 % FBS and 1 % 
penicillin/streptomycin and seeded in culture plates for cultivation.
Isolation and culture of human alveolar type II cells
Human alveolar type II epithelial cells were freshly isolated from non-tumor lung resections 
under approval by the Saarland State Medical Board (Germany) according to an adapted protocol 
(Fuchs, Hollins et al. 2003; Ehrhardt, Kim et al. 2005; Daum, Kuehn et al. 2012) and with the 
generous technical assistance of Marius Hittinger, from Saarland University. Lung tissue was 
digested after chopping with trypsin type I (Sigma) and elastase (CellSystems, St Katharinen, 
Germany) in balanced salt solution for 40 min at 37°C. Purification of ATII cells was performed 
by consecutive steps of differential cell attachment, Percoll density gradient and magnetic cell 
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sorting. Purified ATII cells were seeded at a density of 6 x 105 cells/cm2 on collagen (Sigma-
Aldrich) and fibronectin (BDBioscicences, Belgium) coated plastics and cultured in SAGM (Lonza, 
Belgium). ATII cells were used 24 h post-seeding.
Isolation and culture of human Decidua-derived Mesenchymal Stem Cells (DMSCs) 
Human placentas were provided by the Department of Obstetrics and Gynecology from healthy 
mothers under written consent approved by the Ethics Committee from Hospital Universitario 12 
de Octubre. DMSCs were isolated and cultured from extraembryonic membranes as described 
previously (Macías, Grande et al. 2010). First, placental membranes were dissected and washed 
in phosphate-buffered saline (PBS) including 100 IU penicillin and 100 µg/mL streptomycin in 
order to remove red blood cells. Afterwards, tissue was digested with trypsin-versene (Lonza, 
Spain), twice and cells suspensions were centrifuged at 400 x g for 10 minutes, resuspended 
in PBS plus 2 mM EDTA and 0.5 % human serum albumin, and subsequently lysed in 0.8 % 
ammonium chloride solution for 15 minutes to further eliminate any remanent erythrocytes. 
Finally, cells were seeded at a density of 1.16 x 10 5 cells/cm2 and cultured at 37 °C, 5 % CO
2
 
and 95 % humidity in Dulbecco’s modified Eagle Medium (Lonza) supplemented with 2 mM 
L-glutamine, 0.1 mM sodium pyruvate, 55 μM of β-mercaptoethanol, 1 % non-essential amino 
acids, 1 % penicillin/streptomycin, 10 % fetal bovine serum and 10 ng/ml of Epidermal Growth 
Factor (Sigma-Aldrich Química, Spain). Non-adherent cells were washed off and adherent cells 
were grown to confluence and passaged at a density of 4-5 x 104 cells/cm2. 
Differentiation of DMSCs into ATII-Like Cells (ATII-LCs)    
DMSCs grown at confluence were differentiated in Small Airway Epithelial Cell Growth 
Medium bullet kit (Lonza) for 4-5 days. This media was supplemented with the following 
factors: bovine pituitary extract, hydrocortisone, human epidermal growth factor, epinephrine, 
transferrin, insulin, retinoic acid, triiodothyronine, gentamycin and bovine serum albumin, as 
indicated by the manufacturer. Fresh medium was carefully added to prevent cell detachment 
every 3 days. Differentiation was assessed analyzing the morphological changes of the cells by 
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phase-contrast microscopy using a Leica DMIL microscope (Leica Microsistemas SLU, Barcelona, 
Spain).
In addition to the use of the conventional submerged cultures (SC), DMSCs were also 
differentiated under the influence of an air-liquid interface (ALI) exposing their apical part to 
the air. For cultures at the ALI, cells were grown on Transwell Clear Inserts (6.5, 12 or 24 mm 
in diameter, pore size 0.4 µm; Corning, VWR, Dublin, Ireland). Transwell inserts are permeable 
supports with independent access to both sides of a monolayer and in which the cells are fed 
only from the basolateral side, keeping the apical part exposed to the air (Figure 16). Apical 
and basolateral fluid volumes were 500 and 1500 µL to grow undifferentiated DMSCs and for 
differentiation in SC (Fig. 16B). For differentiation under the ALI, the apical fluid volume was 
removed maintaining the initial fluid volume in the basolateral compartment.
Additionally, transwell filters were precoated with a mixture of fibronectin and collagen 
in order to at least partially mimic the extracellular matrix.  To this end, 100 µL of fibronectin 
(Becton Dickinson, Heidelberg, Germany) at a concentration of 1 mg/mL and 100 µL of a 3 mg/
ml collagen (Sigma) solution were added to 10 mL of sterile water. The final concentration was 
10 µg/mL and 30 µg/mL for fibronectin and collagen, respectively. 200 µL of this coating solution 
was deposited onto each insert (0.33 cm2 growth area) and incubated for 2 h at 37 °C. 
Figure 16. Transwell systems for cell culturing. A, Top. 6 well-plate for holding tranwell inserts 
(taken from “www.e-shop.vitaris.com”). A, Bottom. 24 mm Transwell inserts containing 
PTFE membrane with pore size of 0.4 µm (taken from “www.eandkscientific.com”). B, Top. 
Schematic view of DMSCs under submerged culture conditions prior to differentiation. B, 
Bottom. Derivation of DMSCs into ATII-LCs  under  SC conditions, with differentiation SAGM in 
both basolateral and apical compartments (left) and under ALI culture conditions, with SAGM 
exclusively in the basolateral compartment (right).
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Afterwards, the coating solution was removed from the cell culture plastic and coated surfaces 
were allowed to dry in the sterile bench. 
A549 cells           
    Human lung epithelial A549 cells, derived from lung adenocarcinoma, were generously 
provided by Dr. Claus-Michael Lehr and were used between passages 15 and 30. A549 cells were 
cultured in RPMI-1640 medium (PAA Laboratories GmbH, Pasching Austria) supplemented with 
5 % fetal bovine serum, 100 U/mL penicillin and 100 µg/mL streptomycin (all from Sigma-Aldrich 
Chemie GmbH, Steinheim, Germany). 
Surfactant preparations 
Native surfactant purified from bronchoalveolar lavages 
Native surfactant from bronchoalveolar lavages (BALs) of slaughtered porcine adult fresh lungs 
was purified and separated from blood components by NaBr density-gradient centrifugation as 
reported (Taeusch, Bernardino de la Serna et al. 2005). Porcine lungs were filled several times 
with a NaCl 0.9 % solution until completing total lung volume, and then the resultant lavage 
was collected, filtered with a gauze and centrifuged at 1000 x g for 5 min in order to remove cell 
debris. For total surfactant isolation, BALs were ultracentrifuged at 100000 x g for 1 h at 4 °C to 
pellet the membrane fraction and then this was centrifuged in a discontinuous density gradient 
at 120000 x g for 2 h at 4 °C. Three solutions to generate the gradient were used containing 16 % 
NaBr  0.9 % NaCl , 13 % NaBr  0.9 % NaCl  and 0.9% NaCl. The material concentrated between the 
last two density solutions is the so called “native surfactant” consisting of lipids and associated 
proteins described in the composition of the lung surfactant system, including phospholipids, 
neutral lipids and surfactant proteins A, B and C, and some others eventually associated to 
surfactant such as hemoglobin or immunoglobulins.   
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Organic extraction of NS         
     The organic extract (OE) of native surfactant was obtained by chloroform/methanol extraction 
(Bligh and Dyer 1959). In this procedure, 1 volume of the aqueous native surfactant was mixed 
with 2 volumes of methanol and 1 volume of chloroform, homogenizing the mixture with vortex 
for 30 s. For precipitation of the water soluble proteins, the mixture was incubated for 30 min at 
37 °C. Then, 1 volume of chloroform and 1 volume of distilled water were added resulting in the 
formation of two phases, which were separated by centrifugation at 2000 g for 5 min at 4 °C. The 
aqueous phase was subsequently extracted by addition of 1 volume of chloroform as many times 
as needed (normally two more times) to improve the yield of the lipid extraction, collecting 
the resultant organic phases. To obtain aqueous suspensions of OE, the required volume of the 
extract was first dried under nitrogen and then under vaccum in UNIVAP for 2 h to remove traces 
of solvent, and then hydrated in buffer 5 mM Tris pH 7, 150 mM NaCl for 1 h at 45 °C. 
Isolation of subfractions from NS
Native surfactant (NS) complexes 
purified from bronchoalveolar lavage 
were subjected to subfractioning by a 
method adapted from an unpublished 
protocol generously provided by Dr. 
Andrea Ravasio.  This method was based 
on the principle of upward flotation 
on a discontinuous sucrose gradient 
consisting of 3 mL of 0.32 M, 5 mL of 
0.55 M, 3mL of 0.7 M layered above a 
mixture of 2 mL of 2 M and 0.25 M (1:1) 
containing 500 µL of NS. Each sucrose solution was prepared with a buffer containing 10 mM 
Tris-HCl, 1 mM CaCl
2
, 2 mM MgCl
2
, 150 mM NaCl, pH 7.4. Prior to centrifugation, a fine layer of 
buffered solution without sucrose was deposited on top of each gradient.                                                              
Figure 17. Isolation of native surfactant 
subfractions. Image depicting the result of 
subjecting the band of native surfactant isolated 
with the standardized NaBr gradient (left) to further 
purification by a discontinuous sucrose density 
gradient centrifugation (right) yielding five discrete 
subfractions termed from N1 to N5 in order of 
increasing density.
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Then, the gradients were spun in a Beckman SW 40Ti rotor at 116000 x g for 2 h at 4 °C without 
brake. After centrifugation, five different fractions could be distinguished (termed N1, N2, N3, 
N4 and N5; Figure 17) and they were collected manually and stored separately, discarding the 
interfaces. Each fraction was concentrated by centrifugation for 1 h at 100000 x g at 4 °C, diluting 
the samples with buffer to diminish the percentage of sucrose in order to avoid the formation 
of additional density gradients and potential interferences. Finally, the pellets were suspended 
in buffer composed by 5 mM Tris-HCl, 150 mM NaCl pH 7.4, aliquoted in plastic tubes and then 
frozen in liquid nitrogen and stored at -80 °C until use. The band corresponding to N1 did not 
yield sufficient material hampering a proper analysis and it was not included in the experiments.
Surfactant harvested from cell cultures      
     Exocytosis of surfactant was stimulated by incubation of rat ATII cells or 4 day-differentiated 
ATII-LCs with 100 μM ATP and 100 nM phorbol 12-myristate 13-acetate (PMA)  (both from Sigma, 
Spain) for 6 h at 37 °C, in buffered solution (containing, in mM: 140 NaCl, 5 KCl, 1 MgCl
2
, 2 
CaCl2, 10 HEPES, pH 7.4 supplemented with 1 % penicillin/streptomycin) as previously described 
(Haller, Dietl et al. 2004).  Supernatants containing freshly secreted surfactant were harvested, 
aliquoted and stored at -20 °C until use. Supernatants of DMSCs treated in the same manner, 
were also collected and used as negative controls. Before use, supernatants were concentrated 
by ultracentrifugation at 100000 x g.
Preparation of  nanoparticles
Anionic fluorescent PLGA nanospheres       
     Fluorescent poly(d,l-lactide-co-glycolide) (PLGA) nanospheres were prepared using a technique 
of emulsion-diffusion-evaporation adapted from a protocol previously described (Horisawa, 
Kubota et al. 2002; Ravi Kumar, Bakowsky et al. 2004; Weiss, Schaefer et al. 2006) (see figure 
18). PLGA (75:25, lactide:glicolide), Fluoresceinamine isomer I (FA) and  poly(vinyl alcohol) (PVA) 
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were purchased from Wako Pure Chemicals Ind. (Osaka, Japan), MoWiol  (Germany) and Sigma, 
respectively. For preparation of fluorescently labeled PLGA, PLGA (3.07 g) and FA (0.0583 g) were 
dissolved completely in 30 mL of acetonitrile with 0.0408 g of 1-ethyl-3-(3-Dimethylaminopropyl)-
carbodiimide hydrochloride (DMAP), and incubated at room temperature for 24 h.  The resultant 
FA-PLGA was washed with distilled water and separated by centrifugation. Then, the compound 
was dissolved in acetone and precipitated with ethanol (1 min, twice), followed by lyophilization. 
For the preparation of nanoparticles, 100 mg of FA-PLGA was dissolved in 10 mL of ethyl acetate 
at room temperature. This organic phase was added dropwise (aprox. 150 µL/min) to 5 ml 
water phase containing 125 mg PVA under stirring. This primary emulsion was stirred at room 
temperature for 1 h at 1000 rpm before homogenizing in a Ultrathurax T25 homogeneizer (Janke 
and Kunkel GmbH KG, Staufen, Germany) at 17500 rpm for 10 min for nano-precipitation. The 
homogeneized emulsion was transferred into a glass beaker and the volume was expanded to 
Figure 18. Scheme representing the different steps in the emmulsion-diffusion-evaporation method 
to prepare fluorescent PLGA nanospheres. An AFM image of PLGA nanospheres is shown (left bottom). 
Scale bar in image represents 500 nm. Modified from (Kumar et al. 2004). 
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45 mL by adding purified water. Stirring was continued at 40°C in a hood to evaporate the organic 
solvent.
Cationic chitosan modifed-PLGA nanospheres
Cationic nanoparticles were prepared using a self-asembling mechanism previously reported 
(Jornada and Beck 2012; Dimer, Pohlmann et al. 2013). The preparation  consisted  of the 
interfacial deposition of preformed polymer by adding 100 mg of PLGA (50:50), 170 µL of caprylic/
capric trigliceride and 60 mg of Lipoid S-75® dissolved in 22 mL of acetone and 3 mL of ethanol. 
This organic phase was injected into 50 mL of a water phase containing 80 mg of Tween 80 
and 10 mg of chitosan under magnetic stirring at 40°C. Then, the suspension was concentrated 
under reduced pressure to a final volume of 10 mL. Nanoparticles containing clarithromycin 
were prepared following the same methodoly and incorporating 10 mg of the antibiotic in the 
organic phase ( at a final drug concentration of 1 mg/ml). Cationic PLGA nanoparticles containing 
clarithromycin were shown to have a drug content of 0.99 mg/mL with an encapsulation efficiency 
of 67 % as assessed by LC/MS-MS.  
Silver nanoparticles
Silver nanoparticles (NM-300) were supplied by the Joint Research Centre Nanomaterials 
Repository. These particles consist of a colloidal 10 % w/w dispersion of silver NPs (average size 
of 15 nm) in water containing 4 % (w/w) polyoxyethylene glycerol trioleate and Tween 20 as 
stabilizing agents.
77
Materials and methods
METHODS
ANALYTICAL TECHNIQUES
Lipid analysis
Phospholipid quantitation
Phospholipid content was measured by phosphorous quantitation (Rouser, Siakotos 
et al. 1966) or by enzymatic assay (García-Verdugo, Ravasio et al. 2008). For phosphorous 
determination, samples (surfactant preparations) and standards were dried in a sand bath 
and then, percloric acid (37 %) was added for organic phosphorous mineralization, incubating 
the samples at 260 °C for 30 min. Afterwards, the samples were incubated 7 min at 100 °C in 
the presence of ammonium molibdate 2.5 % and ascorbic acid 10 % solutions, generating a 
colorimetric reaction based on the formation of phosphomolibdic acid first and then, its reduction 
to a blue-coloured phosphomolybdate after being reduced by the ascorbic acid. Absorbance at 
820 nm was measured and correlated to phosphorous concentration upon interpolation into a 
calibration curve built with standards of known concentrations of phosphate. Finally, values were 
transformed to concentration considering 734 Da as the average molecular weight of surfactant 
phospholipids.  
For the quantitation of the phospholipid (particularly phosphatidylcholine, PC) content by the 
enzymatic colorimetric assay, a commercial kit was used (Spinreact, Spain). Despite the fact that 
this assay only detects and quantitates PC species, consistently with the major proportion of these 
in surfactant samples, final values were observed to be similar to those obtained by phosphorus 
mineralization, with the advantage of a requirement of much lower sample volumes due to the 
high sensitivity of the method. In this method, PC is hydrolyzed by phospholipase D and the 
liberated choline is then oxidized by choline oxidase to betaine with the simultaneous generation 
of hydrogen peroxide. In the presence of peroxidase, the hydrogen peroxide couples oxidatively 
the 4-aminophenazone and dichlorophenol to form a coloured quinone, proportionally to the 
PC concentration. For the experimental procedure, 5 µL of sample were mixed with 1 mL of the 
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working reagent and incubated for 5 min at 37 °C. Absorbance of the sample was measured at 
505 nm and related to the absorbance of a standard of known PC concentration to calculate the 
final concentration.     
Cholesterol quantitation
The determination of the amount of cholesterol present in the isolated subfractions of NS was 
performed following the protocol of a commercial kit based on enzymatic reactions (Spinreact, 
Spain). First, after 15 min of incubation of the samples and standards with the kit reagents, 
cholesterol esters are broken down into cholesterol and fatty acids by cholesterol esterase. Then, 
the free cholesterol is subsequently oxidized by cholesterol oxidase into 4-cholestenone and 
hydrogen peroxide. Then, a colorimetric reaction is developed between hydrogen peroxide, 
phenol and 4-aminophenazone to produce a colored quinonimine. Finally, measurements of the 
absorbance at 505 nm were carried out and interpolated into a calibrate curve built with known 
amounts of cholesterol, to determine the cholesterol concentration of the samples.
Thin Layer Chromatography (TLC)
The lipid composition of the different subfractions of NS was analyzed and compared 
by TLC using silica gel 60 plates (Merck, Germany) as stationary phase and a mobile phase 
composed by chloroform, methanol and water (65:25:4, vol/vol/vol). 100 µg of each sample and 
50 µg of phosphatidylcholine (PC), phosphatidylglycerol (PG), phosphatidylethanolamine (PE), 
phosphatidylinositol (PI), sphingomyelin (Sm) and cholesterol (Ch) used as reference standards 
were applied in the same plates and the mobile phase was drawn up the plate via capillary 
action, permitting the separation of the different lipid species. Finally, the lipid bands in the TLC 
plates were visualized under development with iodine vapors. Regions corresponding to PC and 
PG bands of the samples were scratched from the plates and subjected to organic extraction with 
chloroform/methanol, determining their molar proportion with respect to total phospholipid by 
phosphorus quantitation.
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High-performance liquid cromatography (HPLC) coupled to mass spectrometry
The molecular species of the phosphatidylcholine (PC) fraction present in pellets of DMSCs, 
rat ATII cells and ATII-LCs differentiated under SC conditions were analyzed quantitatively by HPLC 
coupled to mass spectrometry (Canals, Mormeneo et al. 2009) with the technical assistance of 
Drs. Gemma Fabriàs and Josefina Casas, from the Institute of Advanced Chemistry of Catalonia 
(CSIC). The liquid chromatography–mass spectrometer consisted of a Waters Aquity UPLC system 
connected to a Waters LCT Premier orthogonal accelerated time of flight mass spectrometer 
(Waters, Millford, MA), operated in positive electrospray ionization mode. Full scan spectra from 
50 to 1500 Da were acquired and individual spectra were summed to produce data points each 
0.2 s. Mass accuracy and reproducibility were maintained by using an independent reference 
spray via the LockSpray interference.   
Nucleic acid analysis
End-point reverse transcription-polymerase chain reaction (PCR)
Total RNA extraction from DMSCs as well as ATII-LCs differentiated for 24, 48 or 96 h under 
SC conditions was performed using RNeasy mini kit (Qiagen, IZASA Distribuciones Tecnicas 
SA, Madrid, Spain).  First, cells were lysed and homogenized in the presence of a denaturing 
buffer containing guanidine-isothiocyanate for inactivation of Rnases ensuring the isolation of 
intact RNA. Cell lysates were passed through a genomic DNA eliminating spin column. Ethanol 
was added to the lysates in order to provide ideal binding conditions for RNA, facilitating 
the elimination of contaminants. RNA was then eluted in ultrapure water and quantified by 
absorbance at 260 nm using a Nanodrop spectrophotometer (ThermoScientific, Madrid, Spain). 
Integrity of RNA was determined by SYBR gold staining of a small aliquot of each sample on a 
1.5 % agarose gel. To reverse transcribe the RNA, the Transcriptor High Fidelity cDNA Synthesis 
kit was used (Roche, Roche España, Madrid, Spain). Reverse transcriptase (22 U) was mixed with 
dNTPs (1 mM each), random hexamer primers (60 µM), Rnase inhibitor (20 U), the appropriate 
volume of buffer, and with the template RNA (1 µg). Amplification was carried out in a TC3000 
80
Materials and methods
thermocycler (Techne, Staffordshire, UK) at 25°C for 10 min, followed by 37°C for 120 min and 
85°C for 5 min.  Complementary DNA (cDNA)  was then amplified using MBL Taq DNA polymerase 
(Dominion MBL) and the specific primers for genes encoding for SP-A, SP-B, SP-C, SP-D, ABCA3, 
Thyroid transcription factor 1 (TTF1), Forkhead box protein A1 and A2 (FOXA1 and FOXA2, 
respectively), Cathepsin H, Napsin A, G-protein coupled receptor 116 (GPR116) and Cystic fibrosis 
transmembrane conductance regulator (CFTR) (Table 1). GAPDH was used as a loading control. 
Primers (Sigma-Aldrich) were designed using the public online software Primer-BLAST software 
(NCBI). PCR was carried out at 94 °C for 4 minutes (enzyme activation), followed by 30 cycles of 
94°C for 30 seconds (denaturation of the DNA molecule), specific annealing temperature (55-
60 °C) for 30 seconds, and 72°C for 30 seconds (extension of the nascent DNA chain). PCR set 
up contained the following components: dNTPs (0.2 mM), Taq polimerase (2.5 U), forward and 
reverse specific primers (5 µM), buffer solution that contains Mg2+ (1.5 mM), and the template 
cDNA (200 ng). The amplified DNA was kept at 4 °C until use. PCR products were separated on 2 
% agarose gel and visualized by SYBR Gold staining.  
Quantitative real-time PCR 
Whereas in traditional end-point PCR, detection of the amplified sequences are perfomed at 
the end of the reaction after the last PCR cycle, in real-time PCR, products are measured at each 
Protein
SP-A
SP-B
SP-C
SP-D
ABCA3
Napsin A
Cathespin H
GPR116
CTFR
TTF1
FOXA1
FOXA2
GAPDH
Forward primer Reverse primer
TTCCACTGCCCATCTGTGTA
GGGGAAGTAGTCGTCAAGCA
GGAGAAGGTGGCAGTGGTAA
GCATATCAGCCCCAACCTCA
AGTAGGCCTCCTGCGTGT
GGAGGAGTAGCCCTCGG
GCCCAATACGACCAAATCC
AGACGGGACCCCTGTAAACT
CCAGGACACGATGAGGAAGT
ACACGGAGATGGTTCTGGAG
 TGTGGTCTGCGAGTTCTGAG
GCCAGTTCCCCAGTAGTCCT
TCCACATGGAGCGTGTGAAG
GCATGAGGGTCTAAGCCTTG
TTGCTCAGCTCCACACTCAT
GCCACATACGTCCCCAAGAA
CATGCTCCATCTGGGGAGGT
CTTTTTGTGGCAACGGCTCG
CTATATTCATCATAGGAAACACCAAAGATG
AGCCACATCGCTCAGACAC
CCTGTAAAAATCAGGGTGCC
CTCGAGGTTCACCTCACCTG
GGAGGGATTTGGGGAATTATTTGAGAAAGC
GCGCTTTCGGAGGGAATAAAA
ACTGTGAAGATGGAAGGGCA
CTGGTCGTTTGTTGTGGCTG
Table 1. Primers used for endpoint RT-PCRSequences of the forward and reverse primers used for 
amplification of the genes of interest by endpoint RT-PCR.
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cycle. By monitoring reactions during the exponential amplification phase of the reactions, it is 
possible to precisely determine the initial amount of target. In real-time PCR, the quantity of 
DNA is measured after each cycle via fluorescent dyes that yield increasing fluorescent signal in 
direct proportion of the number of PCR amplicons generated.  
RNA isolation and reverse transcription into cDNA from DMSCs and ATII-LCs differentiated for 
24, 48 or 96 h under SC conditions was performed as described for RT-PCR. Real-time PCR was 
carried out using an ABI 7,500 sequence detection system (Applied Biosystems, Life Technologies 
SA, Madrid, Spain). As fluorescent reporters, we used inventoried Taqman-specific probes 
(Applied Biosystems) for SP-A (Hs00831305_s1), SP-B (Hs01090658_g1), SP-C (Hs00161628_
m1), SP-D (Hs01108490_m1) and ABCA3 (Hs00975530_m1) genes. Taqman probes have specific 
gene sequences and are designed to bind the target between the two PCR primers. Attached 
to the 5’ end of the Taqman probe is the “reporter”, which is a fluorescent dye that reports 
the amplification of the target. On the 3’ end of the probe is a quencher, which quenches 
fluorescence from the reporter in intact probes. In the early PCR products, only the low, quenched 
reporter signal is detected, permitting to set a baseline. If the sample contains target, enough 
accumulated cleaved probe by the 5’ nuclease activity of the polymerase is produced allowing 
the amplification signal to emerge from the baseline.
The point at which amplification signal becomes visible (threshold) is inversely related to 
the initial target quantity. Thus, by plotting fluorescence against the cycle number, amplification 
plots representing the accumulation of product over the duration of the entire PCR reaction 
were generated. Thermal cycling conditions were: 2 min at 50 °C, 10 min at 95 °C, 40 cycles of 
15 s at 95 °C and 1 min at 60 °C. Dilution series of known template concentrations were used to 
establish a standard curve for confirmation of proper reaction efficiencies. Then, to perform the 
relative quantification of the genes, their expression in ATII-LCs at various differentiation time 
points was compared to their expression in undifferentiated cells. Data were analyzed using the 
2-ΔΔCt method (Livak and Schmittgen 2001) in which 2-ΔΔCt is the amount of target normalized 
to an endogenous reference gene (TATA Box Protein, as a control for experimental variability) 
and relative to the positive control (adult lung tissue) (ΔCt = Ct (test gene)-Ct (housekeeping 
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gene); ΔΔCt = ΔCt (sample) – ΔCt (positive control). The results were expressed as fold change in 
expression of the differentiated cells in relation to the DMSCs.
Protein analysis
Cell protein extraction
Total cell protein was extracted from undifferentiated DMSCs, differentiated ATII-LCs under 
SC or ALI conditions, A549 cells and primary human ATII cells. Cell lysis was carried out in cell 
extraction buffer containing 10 mM Tris pH 7.4, 100 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM 
NaF, 20 mM Na4P2O7, 2 mM Na3VO4, 1 % Triton X-100, 10 % glycerol, 0.1 % SDS and 0.5 % 
deoxycholate (Invitrogen, Karlsruhe, Germany) and supplemented with 1 % protease inhibitors 
composed by aprotinin, bestatin, leupeptin and pepstain A (Sigma). Cells were detached 
by trypsin and centrifuged at 1200 rpm. Cell pellets were washed with PBS, centrifuged and 
the supernatants were removed to eliminate medium remanents. After lysis buffer addition, 
samples were kept on ice and vortexed each 30 min. Then, samples were centrifuged at 13000 
rpm 4 °C for 10 min and pellets were discarded. Extracellular medium of the cultured DMSCs and 
differentiated ATII-LCs under SC conditions was also collected and concentrated by centrifugation 
using a Centripep system (Millipore Iberica SAU, Madrid, Spain) at 3000 x g and 25 °C.
Total protein quantitation
Protein content was determined with the widely used method developed by Lowry (Lowry, 
Rosebrough et al. 1951), based on a colorimetric reaction result of the reduction of the Folin-
Ciocalteu reagent (phosphotungstic and phosphomolibdic acids) by the phenol groups of the 
tyrosine residues of proteins. Under alkaline conditions, the nitrogen of the peptide bonds reacts 
with cupper ions making the tyrosine lateral chains accessible to the Folin reactive. First, samples 
and standards (albumin) were incubated with 0.5 % SDS, 0.017 % Na-K tartrate, 0.008 % CuSO
4
 
and 1.6 % Na
2
CO
3
 0.08 M NaOH for 15 min at room temperature. After subsequent incubation 
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with the Folin reagent for 30 min, the absorbance at 700 nm was measured and directly related 
to the protein concentration from a standard curve.
Electrophoresis and Western blot analysis
Prior to electrophoresis, total protein content was determined using the Lowry method, as 
described above, to load samples at equal concentrations in the gels. SDS-Polyacrylamide Gel 
Electrophoresis (SDS-PAGE) was carried out using 10 % acrylamide (for SP-A, SP-D and OCT-1) 
or 16 % acrylamide (for SP-B and SP-C) gels under reducing conditions in the presence of 5 % 
β-mercaptoethanol. After electrophoresis, proteins were transferred to PVDF membranes using a 
semidry transfer system at 280 mA for 1 h. Blocking was performed by incubation with PBS/Casein 
blocker (Bio-Rad Laboratories SA., Alcobendas, España) for 1 h at room temperature. Afterwards, 
membranes were incubated with primary antibodies at 4 °C overnight with gentle orbital 
shaking. The primary antibodies used were: rabbit anti-SP-A (1:500) (Santa Cruz Biotechnology, 
Inc., Heidelberg, Germany), rabbit anti-SP-B and anti-SP-C (1:1000), mouse anti-SP-D (1:1000) all 
from Seven Hills Bioreagents (Cincinnati, Ohio, USA) and rabbit anti-OCT-1 (1:200) from (Aviva, 
San Diego, USA). After incubation with primary antibodies, three washes with PBS-Tween for 
10 min each were performed and then, membranes were incubated with secondary antibodies 
for 1 h at RT. Secondary antibodies were swine anti-rabbit HRP conjugated (1:1000 for anti-SP-A 
and 1:2000 for anti-SP-B, anti-SP-C and anti-OCT-1 (Dako Diagnósticos, S.A., Sant Cugat del Vallés, 
Barcelona, Spain) and anti-mouse peroxidase conjugated (1:5000; Cell Signalling Technology, 
IZASA, S. A., L’Hospitalet de Llobregat, Barcelona, Spain). Anti-α-tubulin (1:10000; Cell Signaling) 
or anti-β-actin (1:10000; Invitrogen) were used as loading controls.  After 3 washes with PBS-
Tween, membranes were developed with Immobilon Western Chemiluminiscent HRP substrate 
(Millipore, Darmstadt, Germany).
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Measurement of colloidal characteristics from NPs
Anionic and cationic PLGA nanoparticles were characterized with respect to mean diameter, 
polydispersity index (PdI) and zeta-potential using the ZetaSizer Nano ZS (Malvern Instruments 
Ltd.,Worcestershire, UK), based on a dynamic light scattering technology. All measurements 
were performed in triplicates. 
SPECTROSCOPICAL TECHNIQUES
Infrared spectroscopy
Attenuated Total Reflection Fourier Transform Infrared (ATR-FTIR) spectroscopy is a powerful 
vibrational technique that provides information from a wide range of liquids, solids and gases, 
and from biological samples and biomembranes in particular, specially with respect to the 
structure and organization of membranes lipids in their various polymorphic phases (Lewis and 
McElhaney 2013) (Figure 19).   It is fast and yields a strong signal with few micrograms of sample 
and it does not require the introduction of potentially disturbing extrinsic probes. Additionally, 
because of the long IR wavelength, light scattering problems are negligible permitting the 
investigation of aggregated materials or large membranous fragments (Goormaghtigh, Raussens 
et al. 1999). In an ATR-FTIR experiment, an infrared beam is directed onto an optically dense 
crystal (generally made of germanium, zinc selenide or diamond) with a high refractive index 
at a certain angle, covered with the sample (Fig. 19A). This internal reflectance creates an 
exponentially decaying evanescent wave that extends beyond the surface of the crystal into the 
sample held in contact with the crystal. In regions of the infrared spectrum where the sample 
absorbs energy, the evanescent wave is attenuated or altered. The attenuated energy from each 
evanescent wave is passed back to the infrared beam, which then exits the opposite end of the 
crystal and is passed to the detector in the spectrometer. The different regions or bands of the 
infrared spectrum contain the frequencies corresponding to the various vibrational modes of the 
covalent bonds of the organic molecules present in the sample and are often given descriptive 
names, such as stretching, bending or rocking (Fig. 19B). Thus, the absorption of the energy of 
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the evanescent field by the sample at certain regions generates an infrared spectra that contains 
valuable information about the structure of the system. 
Oriented multilayers were formed by slow evaporation of 100 μg of NS, OE or LBPs 
suspensions, yielding a semi-dry film bearing residual water molecules onto the ATR crystal. 
Spectra were recorded in the double-sided, forward-backward mode on a FTIR Bruker IFS 66/R 
spectrophotometer (Ettlingen, Germany) equipped with a liquid nitrogen cooled mercury 
cadmium telluride (MCT) detector at a resolution of 2 cm−1 and with an aperture of 3.5 mm. 
The spectrometer was continuously purged with dry air (15 l/min) to minimize the contribution 
of atmospheric water. The internal reflection element was a trapezoidal germanium ATR plate 
(52×20×2mm, ACM, Villiers St Frédéric, France) with an aperture angle of 45° yielding 25 
internal reflections. To improve the signal/noise ratio 256 accumulations were collected for 
each measurement. Thermotropic behavior of the samples within a range from 15 to 50 °C was 
characterized analyzing the asymmetric stretching of CH
2
 vibration region, which is sensitive to 
Figure 19. ATR-FTIR spectroscopy. A. ATR system representing a sample 
deposited in direct contact with a trapezoidal germanium crystal and the 
multiple reflections of the evanescent wave. B. Vibrational modes of the 
CH
2
 molecule absorbing in the IR spectrum.  
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trans-gauche isomerization of the lipid chains. To investigate the potential lyotropic polymorphism 
present in the samples, the region corresponding to CH
2 
bending vibration, sensitive to the 
presence of non-lamellar phases, was also analyzed. Data processing was performed with the 
software MATLAB® R12 Kinetics, generously provided by Dr. Erik Goormaghtigh, from Université 
Libre de Bruxelles. Baseline corresponding with the crystal absorption in the absence of sample 
and the atmospheric water contribution were subtracted as described (Alegre-Cebollada, 
Martínez del Pozo et al. 2007). The corrected spectra were smoothed by apodization of its 
Fourier transform by the Fourier transform of a 4 cm−1 Gaussian line shape.
Fluorescence spectroscopy
Laurdan fluorescence 
Laurdan (6-lauroyl, 1-2-dimethylamino naphthalene) is a fluorescent probe that detects 
changes in membrane phase properties due to its sensitivity to the polarity of the environment 
in the lipid bilayer (Figure 20). This molecule was originally designed and synthesized in 1979 by 
Gregorio Weber (Weber and Farris 1979) to study dipolar relaxation. The fluorescent naphthalene 
moiety of the Laurdan molecule possesses a dipole moment due to a partial charge separation 
between the 2-dimethylamino and the 6-carbonyl residues. This dipole moment increases upon 
excitation and may cause reorientation of the surrounding solvent dipoles. The energy required 
for solvent reorientation decreases the excited state energy of the probe, which is reflected in 
a continuous red shift of the probe’s emission spectrum. The consequence is that the emission 
spectrum of Laurdan is sensitive to the hydration level of the lipid headgroup region and so 
detects changes in membrane phase properties (De Vequi-Suplicy, Benatti et al. 2006). The 
hydrophobic tail of the lauric fatty acid allows solubilization of the dye within phospholipid 
membranes, locating the fluorescent moiety toward the aqueous environment. Thus, the 
fluorescence emission of Laurdan is blue in ordered, packed and highly dehydrated phases (gel, 
liquid ordered) while it shifts to green in more hydrated disordered phases (liquid-crystalline, 
liquid disordered) (Parasassi, De Stasio et al. 1990; Parasassi, De Stasio et al. 1991). This shift 
of the emission spectrum has been attributed to dipolar relaxation processes taking place in 
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the phospholipid liquid crystalline phase but not in the gel phase. These polarity changes are 
quantified by calculating the generalized polarization function, GPF (GPF= (I
440
−I
490
)/ (I
440
+I
490
)).
NS, OE and suspensions of secreted LBPs were stained with the fluorescent probe Laurdan 
(Molecular Probes, USA) for 1h at 37 °C in a proportion of 1 % (mol/mol) with respect to 
phospholipids as previously described (Picardi, Cruz et al. 2011; Blanco, Cruz et al. 2012). The 
fluorescence spectra of surfactant suspensions were recorded in a thermostatized Aminco-
Bowman Series 2 luminescence spectrometer, using an excitation wavelength of 370 nm and 
recording the emission spectrum between 400 and 550 nm, within a temperature range of 10 
to 60 °C. 
Figure 20. Laurdan fluorescence in 
membranes. A. Chemical structure 
of Laurdan, underlining the two main 
components of the fluorescent probe, 
the naphthalene and lauroyl moieties. 
B. Representation of the probe located 
at the head group level of phospholipid 
(top). Upon excitation, the Laurdan 
dipoles (arrows) provoke reorientation 
of the surrounding water molecules 
(blue dots) leading the red shift 
observed in the transition from ordered 
to disordered states (bottom) (adapted 
from (Sánchez, Tricerri et al. 2007)). 
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IMAGING TECHNIQUES
Fluorescence microscopy
Laurdan microscopy
For the staining of intracellular LBs with Laurdan, rat ATII cells grown on glass coverslips were 
incubated with 100 μM Laurdan in DMEM for 1 h at 37 °C. Fluorescence of intracellular LBs 
was measured with an inverted microscope (Zeiss 35, Germany) equipped with a Polychrome V 
Monochromator (TILL Photonics, Germany) and a microscopic stage T-controller (Tempcontrol 
37, Zeiss). Excitation light (370 nm) was directed through a 420 nm dichroic mirror into a Zeiss 
Plan-Apochromat 100× NA 1.4 oil objective. Fluorescence images were taken separately by using 
two bandpass filters centered at 435 and 488 nm, respectively and a cooled 12-bit CCD-camera 
(PCO-Sensicam, Germany) operated at an acquisition rate of 1 frame/3 sec and a binning factor of 
4. The optical properties of the microscope including the filter sets were cross-calibrated against 
the spectral output of a multiplate-spectrophotometer (Tecan M200pro, Switzerland) using 
Laurdan and DMSO as a reference. Thus, after subtraction of image background, GP formula was 
modified to be GPF = (I
440
− 0.25 x I
490
)/ (I
440
+ 0.25 xI
490
). Image and data analysis from fluorescence 
measurements obtained from individual LBs were performed with Image J and Microsoft Excel. 
For the Laurdan image presentation in Fig. 2 (lower panel), the GFP function was calculated from 
the intensity corrected images using the mathematical image functions in ImageJ.
Observation of Giant Unilamellar Vesicles (GUVs) 
Aliquots of suspended LBPs were incubated with the fluorescent probes BodipyPC and DiIC18 
(Molecular Probes Inc. (Eugene, OR) for 1h at 45 °C (probe/surfactant = 1 mol/mol %). GUVs 
composed of labeled- LBPs were prepared by electroformation following a method previously 
developed by Angelova and widely used for others (Puff and Angelova 2006). 5 μl of the aqueous 
suspension were spread on the surface of a the conductive side of two indium-tin oxide coated 
glasses as small drops and dried under a stream of N
2
 avoiding a complete dehydration of the 
sample to maintain membrane integrity. Afterwards, the two slides were mounted to build 
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an electroformation chamber, with the conducting sides face to face, separated by a 2 mm 
thick Teflon spacer pre-coated with vacuum grease. Sufficient volume of a buffered solution 
containing Tris 5 mM NaCl 20 mM was added to fill the chamber and then this was completely 
sealed at both sides with moldable vinyl paste (CritoSeal, from Leica BioSystems). The chamber 
was connected to a function generator (Digimess® FG 100, Germany) and a low frequency AC 
field was applied using the following sequence: 1) From 0 to 1.5 V, increasing 250 mV every 
5 min, with a frequency of 500 Hz 2) 1.5 V for 1 h, at 500 Hz and 3) From 500 Hz to 0 Hz, reducing 
100 Hz every 10 min. After vesicle formation, the AC field was turned off, and the vesicles were 
collected with a pipette and transferred to a plastic tube. GUV preparations were observed in a 
fluorescence upright microscope Leica DM-4000B equipped with the appropriate fluorescence 
filters for observation of BodipyPC and DiIC18 fluorescence (maximum fluorescence emission 
at 488 and 543 nm, respectively) and connected to a cooled digital camera (Model C10600-10B 
ORCA-R2, Hammamatsu).
Polarization microscopy 
Polarized light microscopy is a contrast-enhancing technique with high degree of sensitivity and 
can be used for both quantitative and qualitative studies targeted at a wide range of anisotropic 
samples. The electric field vectors of the light vibrate in all planes that are perpendicular with 
respect to the direction of propagation. If the electric field vectors are restricted to a single plane 
by filtration of the beam with specialized materials, then the light is referred to as plane or linearly 
polarized with respect to the direction of propagation, and all waves vibrating in a single plane 
are termed plane-polarized. A polarized light microscope (Figure 21) is equipped with a polarizer, 
positioned in the light path before the sample, and a second polarizer (analyzer), located in 
the optical pathway between the objective rear aperture and the camera port. Image contrast 
arises from the interaction of plane-polarized light with a birrefringent sample generating two 
individual wave components that are each polarized in mutually perpendicular planes. Thus, 
anisotropic materials act as beamsplitters dividing light rays into two orthogonal components 
which are subsequently re-united along the same optical path providing structural information. 
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Polarization experiments were 
performed with an inverted 
microscope Zeiss 35 with a 
Plan-Apochromat 100× NA 1.4 
oil objective for the observation 
of freshly isolated living rat ATII 
cells and an Eclipse E600POL with 
a Plan-Apochromat objective 
10× for the visualization of 
reconstituted vesicles of 
dipalmitoylphosphatidylcholine 
(DPPC), both fitted with a 
heating and cooling stage. In 
both cases, crossed polarizers 
were placed between the DIC 
bright field condenser and the rear aperture of the objective. Initial observations were carried 
out at 30 °C and temperature was subsequently increased to 45 °C and reduced again to the 
initial values.
Scanning electron microscopy
Undifferentiated DMSCs, differentiated ATII-LCs under SC or ALI culture conditions, A549 
cells and human primary ATII cells were grown on Transwell inserts for 4 days, washed with 
phosphate buffered saline (PBS), and fixed with 1 % paraformaldehyde in 200 mM HEPES pH 7.4 
at room temperature for 60 min and then washed again three times with PBS. Afterwards, cells 
were dehydrated twice on their supporting filters through an ethanol gradient: 30, 40, 50, 60, 70, 
80, 90, 96 and 100 % for 10 min at room temperature for each ethanol concentration. Complete 
drying of the samples was performed by incubation with 3-hexamethyldisilazane (HMDS) (Fluka, 
Germany) for 10 min. HMDS was removed from the preparations by dissecation. Dried filters 
Figure 21. Polarization Light Microscopy. Configuration of 
a polarized light microscope equipped with two polarizers 
placed in the optical pathway before and after of a 
hypothetical anisotropic specimen (adapted from the Nikon 
website). 
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were cut with a scalpel and mounted on aluminium stubs and sputter coated with gold. Samples 
were observed using an EVO HD15 (Zeiss, Göttingen, Germany) equipped with a field emission 
gun at 5 kV under high vaccum conditions. 
Anionic fluorescent PLGA nanoparticles were also visualized by scanning electron microscopy 
(SEM), upon direct deposition of the sample onto aluminium stubs.  Cationic PLGA NPs could not 
be properly visualized under SEM because of its oily content.
Transmission Electron Microscopy (TEM)
Pelleted DMSCs and ATII-LCs differentiated under SC conditons, secreted material from 
ATII-LCs as well as isolated subfractions from NS complexes were firstly concentrated by 
ultracentrifugation at 13000 rpm for 15 min and then fixed with 2.5 % glutaraldehyde 0.1 M 
PBS pH 7.4 for 6 h at 4 °C. Carbon grids were used as supports and were previously subjected to 
depolarization for 30 s at 500 V. For negative staining (only in the case of NS subfractions), a small 
drop of fixed sample was placed onto the grid and leaved for 1 min in the support. Afterwards, 
the excess of material was removed with a piece of filter paper and the preparation was allowed 
to dry for 2 min. Then, for staining a small drop of uranyl acetate (2 % in the same buffer than 
fixation solution) was deposited onto the grid and was in contact with the sample for 1 min, 
eliminating the excess of fluid at the end of incubation. 
For section observations, after treatment with glutaraldehyde, samples were post-fixed with 
1 % osmium tetroxide for 1 h at room temperature and then dehydrated upon incubation with 
a graded series of acetone (30, 40, 50, 60, 70, 80, 90, 95 and 100 %) for 10 min each. Finally, 
samples were embedded in Spurr resin (Polysciences, Warrington, PA, USA) by consecutive 
incubations with mixtures resin/acetone 1:3 (1 h), 1:1 (1 h), 3:1 (2 h) and pure resin (overnight). 
Resin was polymerized by incubation at 65 °C for 24h. Finally, samples were embedded in Spurr 
resin (Polysciences, USA) and ultrathin sections of 50 nm were cut on an ultramicrotome. 
Both uranyl acetate-stained preparations and osmium tetroxide-stained sections were 
observed in a JEM-1230 (JEOL, USA) electron microscope.
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Cryo-electron microscopy  
Cryo-electron microscopy (cryo-EM) is a method in which biological samples can be imaged in 
a frozen hydrated state. Rapid cooling of aqueous samples at-178 °C prevents generation of ice 
crystals and as a result the object is preserved in native conditions without any chemical fixation 
or drying (Frank, Radermacher et al. 1996; Hrabe and Foster 2011; Pereiro and Chichón 2014).
Material secreted by ATII-LCs differentiated under SC conditons was applied to holey-carbon 
grids (Quantifoil Multi A Cu/Rh 300 mesh) for 1 min, blotted for 1 s and plunged into nitrogen-
cooled liquid ethane in a Leica EM-CPC vitrification device as previously described (Dubochet, 
Adrian et al. 1988; de la Presa, Rueda et al. 2009; Arranz, Coloma et al. 2012). The vitrified 
grids were stored at liquid nitrogen temperature in a container before data collection. The 
grids were used for image acquisition under cryogenic conditions with a Gatan side-entry cryo-
holder and transferred to a FEI Tecnai G2 F20 electron cryomicroscope operating at 200 kV. 
Images were recorded with a FEI Eagle 4x4k  charge coupled device camera at different  nominal 
magnifications of  x39000, x68.000 and x109.000. When appropriate, measurements were taken 
from the micrographs by means of histograms using the ImageJ software. 
Cryo-electron tomography
Aliquots of native surfactant complexes were applied to grids, vitrified and transferred as 
described above for cryo-EM. In cryo-electron tomography (cryo-ET), images are collected as 
the sample is tilted in the path of the beam (tilt series) and the data are then computationally 
reconstructed into a high-resolution volume (tomogram). The tilt-series were acquired with the 
FEI Xplore 3D software at a nominal defocus of -5 to -8 um using a Saxton scheme (from -65 to 
+65° with normally a set of 57-67 images). Tilt-series were processed in a Linux Fujitsu-Siemens 
Celius V810 biopteron with 16 Gb of RAM. Image stacks were preprocessed and aligned using 
the IMOD software package using gold nanoparticles as fiducials. The aligned tilt-series were 
reconstructed with TAPIR algorithm implemented in the IVE/Priism software package. For each 
reconstructed volume, a denoising procedure to discern and interpret the structural features 
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was applied. Denoised volumes were segmented using AMIRA (TGS Europe, Merignac, France) 
with semiautomatic masking generation tools. For the visualization of the three-dimensional 
volumes, both AMIRA and Chimera 24 softwares were used.    
Cryo soft X-ray microscopy 
Native surfactant complexes and material secreted by ATII-LCs differentiated under SC 
conditons were loaded on glow discharged bare copper grids for 1 min at room temperature. 
Fast freezing was performed in the same conditions as described above for cryo-ET.
Full-field transmission X-ray microscopy was performed at the undulator beamline U41 at 
the BESSY II synchrotron (Berlin, Germany). Briefly, synchrotron radiation is the electromagnetic 
radiation emitted when charged particles (i.e.: electrons) are radially accelerated in an electron 
ring through magnetic fields to high speeds in several stages, generating a final energy in the GeV 
range (Elder, Gurewitsch et al. 1947) (Figure 22) . A synchrotron light source typically begins with 
an electron gun, containing a man-made material, to which an electrical and thermal current 
is applied (Fig. 22B). This results in electrons “lifting off” and beginning their journey by being 
propelled down a linear accelerator (linac). Then, electrons enter a circular-shaped booster ring, 
where they are accelerated to relativistic speeds. Finally, they enter into another ring, often 
called a “storage ring”, where they circulate for hours. The electron travel in a straight line, so at 
points around the ring, special bending magnets help them maintain their circular path. When 
electrons are manipulated by bending magnets to change their direction, they emit a fan of 
radiation (synchrotron light). This radiation branches off the storage ring and enters laboratories 
or beamlines. Here it is refined with devices such as monochromators and mirrors, before it is 
shone on the sample. There is a unique spectral region termed the “water window”, bounded by 
the carbon and oxygen k-absorption edges at 284 and 540 eV, respectively, where soft X-rays are 
strongly absorbed by carbon-rich structures (protein, lipid, membranes) whereas attenuation 
by surrounding oxygen-dominated material (ice) is minimal. Thus, biological specimens can be 
imaged at around 500 eV without the need of additional contrast agents (Carzaniga, Domart et 
al. 2014). 
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Similarly to other microscopes, the X-ray microscope requires a source and a means of 
delivering the beam to the sample (condenser), collecting the beam once it has passed through 
the sample (objective) and detecting the resulting image (Fig. 22C). In the experiments presented 
as part of this Thesis, the source is originated from synchrotron radiation and the desired X-ray 
energy is selected by a monochromator, which is then focused onto the sample using a capillary 
condenser. Then, X-rays are collected using a diffractive, focusing optical element termed a zone 
plate. Zone plates are made from concentric rings of material, in such a way that the smaller the 
width of the outermost zone the higher governs the maximum resolution achievable. 
Figure 22. Cryo soft X-ray microscopy. A. Bird’s eye view of a synchrotron facility (ALBA synchrotron, Bar-
celona, Spain). Note the considerable size of this kind of facilities. Taken from http://www.cells.es/. B. A 
synchrotron is typically constituted by the following components: injection system (1), booster (2), storage 
ring (3), beamlines (4), front ends (5), optics hutch (6), experimental hutch (7), control cabin (8), and ra-
diofrequency cavity (9). Adapted from http://www.diamond.ac.uk/. C. Basic schematic representation of a 
transmission X-ray microscope. A condenser glass capillary focus the light onto the sample which is rotated 
to collect the tilt angle projections. The zone plate forms the image of the sample onto the CCD camera 
detector. Adapted from https://confluence.aps.anl.gov. 
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Finally, X-rays are detected by a CCD detector, whose active chip remains inside the vacuum 
space of the microscope. Soft X-ray tomography follows a similar protocol to electron tomography 
as the projection images are collected by rotating the specimen over an angular range that 
depends on the sample stage set-up and with an angular step that can be varied depending on 
sample needs, usually 1° step (Pereiro and Chichón 2014). 
In our experimental conditions, tilt series of ±65° at 2.43 nm wavelength (photon energy E= 
510 eV) were recorded as previously reported (Carrascosa, Chichón et al. 2009). A complete 
tomographic data set using a constant 1° tilt increment yielded 131 projections in 35 min. The 
condenser was a single-bounce ellipsoidal glass capillary (XRADIA) with a working distance of 
about 5 mm and focal spot size of about 1 µm FWHM. The sample stage was constituted by an 
FEI compustage modified for X-ray synchrotron beam geometry and a Gatan model 630 cryo-
holder. Images were formed by Fresnel objective zone plates (Helmholtz Zentrum, Berlin). Two 
different zone plate objectives were used: one high resolution objective with 900 zones, focal 
length of 0.925 nm (E = 510 eV) and outermost zone width of drN = 25 nm, and another medium 
resolution objective for larger depth of field with 560 zones, focal length of 1.5 mm (E = 510 
eV) and outermost zone width of drN = 40 nm. The monochromatized photon flux impinging 
on the sample was on the order of 109 photons/ (µm2s). The enlarged projections formed by 
the zone plate objective were recorded by a Peltier-cooled, back thinned, direct illuminated 
1340x1300 pixel soft X-ray CCD camera (Roper Scientific PI-SX 1300) with a pixel size of 20 µm. 
Image processing was performed as previously described for cryo-ET.
Atomic force microscopy 
Atomic force microscopy (AFM) is a technique that permits the acquisition of high resolution 
images in real time by measuring different physical properties of a sample at nanometric scale. 
AFM is particularly valuable since it allows observation of samples in their native environment 
without fixing and in a non-invasive manner, providing topographical and mechanical information 
about biological structures (Fotiadis, Scheuring et al. 2002; Gaczynska and Osmulski 2008). An 
atomic force microscope basically contains the following components: 1) A fine probe consisting 
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of a cantilevered beam attached to a sharp probe which scans near the surface; 2) A piezoelectric 
translation system controlling the tip/surface separation and translations in the same plane; 3) A 
feedback system which holds the tip near the surface adjusting the vertical separation between 
tip and surface (Cohen and Bitler 2008) (Figure 23). To prevent the detachment of the sample 
from the support, the object has to be strongly immobilized on an atomically flat surface in 
the range of micrometers. For this purpose, mica moscovita is the most used substrate for 
electrostatic attachment of bioparticles, since this mineral can be easily peeled off exposing a 
clean and flat surface.
There are three major modes of operation in AFM: contact, oscillating (tapping) and force. In 
the contact mode, both tip and sample are in direct contact leading to the cantilever deflection 
whereas in tapping, the tip touches the sample very briefly and with a low force in a more 
non-invasive conditions. In tapping mode, the probe vibrates vertically while scanning and 
the proximity of the atoms of the scanned sample provokes variations in the amplitude of 
oscillations of the probe due to van der Waals and electrostatic forces. Modifications in the 
Figure 23. Atomic Force Microscopy (AFM). Schematic representation of the principal components of an 
atomic force microscope, including piezoelectric scanner, tip, laser, photodiode and an electronic control 
system. Scale bar in the picture represents 10 µm.
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amplitude are translated into a topography image offering a 3D map of the outer surface of the 
object. When changes in the phase of the vibrating cantilever instead of amplitude are recorded, 
“phase images” are generated containing height information and offering a 3D-like appearance. 
Moreover, contact and tapping modes can be fusioned, where the tip oscillates while keeping 
constant contact with the sample (Tinazli, Piehler et al. 2007). Finally, in the force mode (also 
called force spectroscopy), cartesian coordinates of the surface sample are not provided but 
the strength of the interaction between the tip and the sample is determined in the order of 
picoNewtons (Radmacher, Cleveland et al. 1994), usually modifying the tip with a receptor-
specific ligand. Force and tapping modes can be also combined giving rise to the jumping mode 
or pulsed force microscopy, providing at the same time data about topography and adhesion 
force (Moreno-Herrero, Colchero et al. 2004).  
Suspensions of secreted LBPs were directly deposited on top of a freshly exfoliated mica 
substrate to be adsorpted, incubating the samples until solvent evaporation. The AFM images 
were obtained with a Multimode Nanoscope IIIA equipped with a type E scanner (Veeco 
Instruments, Santa Barbara, CA), operated in tapping mode. Tips used were RTESP phosphorus 
(n) doped silicon probes with a typical radius of less than 10 nm, nominal spring constant of 40 
mN/m and resonance frequency between 266 and 309 KHz. Topography and phase images were 
recorded from each sample with 256 scan lines and a frame rate of 0.5 Hz.
FUNCTIONAL ASSAYS
Real-time exocytosis monitoring assay
DMSCs and ATII-LCs differentiated for 5 days under SC conditions were grown on 8-well 
chamber slides (Ibidi, Instrumentación y componentes, Zaragoza, Spain)  and incubated with 50 
nM LysoTracker Green DND-26 (LTG) (Invitrogen, Fisher Scientific, Madrid, Spain) for 20 min in 
DMEM and then washed with buffered solution. Cells were next mounted into a heated chamber 
(37° C) for live imaging. Exocytosis was stimulated with ATP and PMA and secreted surfactant 
was stained in the continuous presence of 4 μM FM 1-43 (Invitrogen, Fisher Scientific, Madrid, 
Spain) as previously described (Haller, Ortmayr et al. 1998). Images were collected on a LSM 510 
98
Materials and methods
Meta Confocal Microscope (Zeiss, Carl Zeiss AG, Jena, Germany) mounted on a Zeiss Axiovert 
200M inverted microscope using 1 to 5 % Argon laser power (488 nm) and a Kalman filter to 
average both scans. Emitted light was collected by a META detector set to 497-508 and 604-754 
nm for LTG and FM 1-43 emissions, respectively. Single plane (4 μm) and z-stack images (4 μm, 
z-step=2 μm) of multiple focal planes (from 6 to 8) were obtained using a 63x oil-immersion 
objective. Images were acquired at 1.024 x 1.024 or 2.048 x 2.048 pixel resolution (1 pixel = 140 
or 70 nm, respectively). For image handling and z-stack projections we used the public domain 
software ImageJ v.1.32j (Wayne Rasband, National Institute of Health).
Adsorption kinetics assay 
Surfactant adsorption kinetics into air-liquid interfaces were evaluated with a high-throughput 
screening method based on fluorescence microplate readers. Surfactant materials were stained 
with a trace of BodipyPC (Invitrogen, Fisher Scientific, Madrid, Spain), upon preincubation with 
the probe at 45 °C for 1 h (probe/surfactant = 1 mol/mol %). Accumulation of surfactant at the 
interface was evaluated in 96-well micro-titer plates as described by Ravasio et al. (Ravasio, Cruz 
et al. 2008) in a FLUORSTAR Optima Microplate Reader (BMG Labtech, Offenburg, Germany). 
Briefly, wells were filled with a solution containing 5 mg/ml of the strongly light-absorbing agent 
Brilliant Black (BB) and labeled-surfactant samples (0.5 μg/well) were injected at the bottom of 
the wells. After orbital shaking, fluorescence coming from surface-adsorbed material (as well 
as the material accumulated up to 100 nm in the subphase) was measured by the instrument, 
whereas fluorescence coming from non-adsorbed complexes was quenched by BB (Figure 
24). To evaluate the inhibitory effect of plasma proteins and cholesterol on the adsorption 
of the surfactant materials, experiments were also performed in the presence of increasing 
concentrations of human serum or meconium, respectively. Data in these experiments are 
presented in relative fluorescence units corrected by subtraction of the measured background 
(RFU-bg).
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Captive Bubble Surfactometer (CBS)
The biophysical behaviour of the different subfractions purified from NS samples was 
assessed using a fully computer-controlled CBS evolved from the original setup developed by Dr. 
Samuel Schurch and co-workers in the 80’s at Calgary University (Canada) (Schurch, Bachofen et 
al. 1989). The CBS allows to monitor the surface activity of surfactant samples once adsorpted 
into the air-liquid interface of an air bubble confined in a chamber under physiologically relevant 
conditions (see Figure 25). Surface tension, area and volume are calculated from bubble height 
and diameter, using automated video capture hardware and software (Schoel, Schurch et al. 
1994).  
The chamber basically consists of a glass cylinder with a metallic base perforated by a 
little hole (2 mm) through which a bubble of approximately 0.035-0.040 cm3 can be created, 
permitting the air to enter into the chamber and through which a capillary is inserted for 
sample injection. Once the bubble is created, it floats against a hydrophilic roof consisting of an 
agarose cap (1 % w/v), by buoyancy. The cap is adjusted to a piston in such a way that bubble 
volume can be controlled by varying the hydrostatic pressure in the chamber as a result of the 
compression or expansion of the space between the cap and the metallic base, which is sealed. 
As bubble volume is decreased, the surface area is subsequently reduced and surface tension 
of the surfactant film falls (Figure 26). The chamber is filled with a buffered solution containing 
Figure 24. Interfacial adsorption microplate assay. The quenching agent Brilliant Black (BB) is added to 
a well from a microtiter plate previously containing an aqueous solution (1). An aliquot of fluorescently-
labelled surfactant is injected at the bottom of the well but its fluorescence is quenched by BB (2). Upon 
orbital shaking, the sample adsorbs into the air-liquid interface resulting in that the fluorescence is no 
longer blocked and can be detected from the top of the plate to monitor the adsorption kinetics (3). 
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5 mM Tris, 150 mM NaCl pH 7.4 
as well as 10 % sucrose, in order 
to increase the density of the 
solution, leading the surfactant 
material to float directly against 
the bubble avoiding a dilution 
effect in the hypophase. The 
inclusion of sucrose has been 
previously demonstrated to 
have no effects in surfactant 
performance (Gunasekara, 
Schurch et al. 2005). Temperature 
is controlled by enclosing the 
chamber in a metallic jacket 
containing a water bath which 
permits a homogeneous 
distribution of the heat provided 
by an external source. The 
chamber is thermostated at 37 °C 
by a feedback system monitored 
with a thermocouple in contact 
with the water and connected to 
the computer. 
Despite the fact that surfactant 
preparations are routinely 
assayed at optimal concentrations 
of 25 mg/mL, we tested samples 
at concentrations on the limit of 
activity (12 mg/mL) in order to 
Figure 25. Captive Bubble Surfactometer (CBS) system.     
A. Overview of the principal components of the CBS: 
1) Captive bubble apparatus, 2) Air Heater, 3) Camera, 
4) Electronics, 5) Computer, 6) Tilt adjustment screws. 
B. Detail of the CBS apparatus: 7) Adjustment knob for 
settling bubble volume, 8) Temperature probe, 9) Infrared 
illuminator, 10) Water bath container. C. Magnification of 
the bubble chamber: 11) Piston, 12) Agarose plug, 13) Air 
bubble. D. Videocamera with base: 14) Camera lens, 15) 
Camera lens extension tube, 16) CCD videocamera, 17) 
Linear adjustments for X, Y and Z.   
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detect subtle differences among the different fractions. Experimentally, the evaluation of the 
surfactant performance of the samples was carried out as follows:
•	 Degasification: before sample application, the bubble was expanded in the sealed 
chamber for 10 min, allowing the liberation of the dissolved air in the aqueous 
subphase as little bubbles that join the expanded one, due to the pressure inside the 
chamber.
•	 Measurement of the initial adsorption kinetics: it simulates the accumulation of 
surfactant complexes at the air-liquid interface present in lung alveoli forming a 
film that reduces surface tension to equilibrium. In this first stage, around 200 nL 
of sample are injected into the chamber through a capillary connected to a 10 µL-
Hamilton syringe directly touching the bubble surface and so applying the surfactant 
into the interface. Then, variations in surface tension are registered as changes in 
bubble shape (from a rounded to a flattened contour) during 5 min after sample 
application. An active surfactant reduces the normal surface tension of the aqueous 
subphase (70 mN/m) to the equilibrium surface tension of surfactant (20-23 mN/m) 
in a few seconds. 
•	 Measurement of post-expansion kinetics: in this stage, the chamber is sealed and the 
bubble is rapidly expanded to a maximum volume of 0.15 cm3. Surface tension is then 
monitored for 5 additional min while the reorganization, transfer and spreading of 
Figure 26. Changes in bubble shape as a consequence of surface tension variations. An 
initial bubble is created (A) and this gets flatter as the surface tension is reduced after 
injection of a surfactant sample down to equilibrium surface tension (B). Upon compression, 
an active surfactant leads to a decrease in surface tension to values close to 0 mN/m (C).  
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the surfactant is taking place. 
•	 Quasi-static compression-expansion cycling: it consists of 4 successive compression-
expansion cycles at low speed, taking as initial volume the one the bubble reached 
during post-expansion. First, the bubble is compressed in a series of compression-
relaxation steps, each reducing 20 % its previous volume, until reaching the minimum 
bubble size just before the interfacial film collapses. Bubble collapse can be detected 
by the operator when there is a decrease of the width of the bubble whilst there is no 
more flattening and subsequently no change in surface tension. Once the bubble has 
reached the minimum volume it is subjected again to expansion-relaxation cycles until 
acquiring the initial volume. To make data analysis easier, surface tension is plotted 
against the relative area of the bubble (with respect to the initial area), permitting 
the calculation of the compression rate. In principle, this quasi-static analysis does 
not have physiological significance since animal lungs does not perform respiratory 
cycles at such low speed. However, it is appropriate to describe the intrinsic kinetic 
properties of the sample since its biophysical behaviour is not hampered by putative 
kinetic effects imposed by a compression-expansion speed that might be quicker than 
the reorganization processes of the material. 
•	 Compression-expansion dynamic cycling: finally and after finishing quasi-static 
cycling, the bubble is subjected to fast compression-expansion cycles at a rate of 20 
cycles/min, mimicking the physiological performance. The compression range of the 
bubble is defined in the previous stage and so avoiding bubble collapse. Typically, only 
the cycles 1, 10 and 20 are represented against relative area.
•	 Stability after mechanical perturbations: additionally, after physiological dynamic 
cycling, the stability of the interfacial film can be assessed in terms of maintenance 
of a low surface tension during moderately long periods of time under mechanical 
perturbations (in physiological terms, sudden movements, external impact, coughing, 
etc.). For this purpose, films are compressed to the minimum surface tension possible 
without collapsing them, and then perturbed by a pendulum hammer consisting of 
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a steel rod attached to a rectangular 
metal block, whose small face acts 
as the striking surface. This block is 
released from a position of 90° to the 
vertical where it strikes the chamber 
(Figure 27). Experimentally, 10 
perturbations are carried out in 
succession and surface tension is 
measured after each hit.
Bioelectrical measurements
Transepithelial electrical resistance (TEER) is a universally stablished biophysical parameter 
that provides information about the tightness of a cell monolayer and monitors the growth of 
epithelial tissue in vitro. TEER measures the capacity of the monolayer to oppose the flow of 
the current passing through it when a voltage is applied.  Sharp increases in TEER values are 
correlated with highly confluent and tight cell monolayers (Benson, Cramer et al. 2013). TEER 
was measured using an epithelial Volt-Ohm-Meter (EVOM) (World Precision Instruments Inc., 
Sarasota, FL, USA) connected with planar chopstick electrodes (Figure 28).  TEER measurements 
were performed submerging one of the probing electrodes in the apical compartment and 
the other one in the basolateral part (see Figure 28B). The difference of voltage across both 
electrodes was taken every 24 h from 0 to 6 days of time in culture. For cells differentiated at 
the ALI, prewarmed medium was added in the apical compartment and cells were then allowed 
to equilibrate for 15 min before TEER measurement. Values were corrected for the background 
value contributed by growth support and medium.
Figure 27. Experimental setup for the 
evaluation of mechanical stability of 
surfactant films. Once the bubble is led 
to maximum compression, a pendulum 
hammer is used to introduce repetitive 
mechanical perturbations whilst 
surface tension is monitored.
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Transport studies
     Transport experiments with the paracellular fluorescent marker sodium fluorescein were 
carried out in freshly prepared Krebs-Ringer buffer (KRB) pH 7.4, containing 15 mM HEPES, 116.4 
mM NaCl, 5.4 mM KCl, 0.78 mM NaH
2
PO
4
, 25 mM NaHCO
3
, 1.8 mM CaCl
2
, 0.81 mM MgSO
4
 and 
5.55 mM glucose, as adapted from a previous published protocol (Salomon, Muchitsch et al. 
2014). DMSCs were differentiated under SC and ALI conditions on Transwell Clear supports. TEER 
values were determined after 4-5 days of differentiation and prior to the transport experiment in 
order to control the state of the monolayer. Initially, both compartments of the Transwell system 
were washed with prewarmed KRB, followed by 30 min of equilibration with KRB at 37°C. Then, the 
incubation buffer was substituted by a solution of sodium fluorescein 50 µM in KRB in the apical 
compartment (520 µL) and blank KRB was added to the basolateral compartment (1.5 mL). The 
initial donor concentration was quantified by taking 20 µL from the apical compartment directly 
Figure 28. Measurement of transepithelial resistance (TEER) in cell 
monolayers. A. Experimental setup to determine TEER consituted by 
an Epithelial Volt-Ohm-meter (EVOM) (taken from “www.wpiinc.com”) 
(left) and chopstick electrodes (taken from “www.pharmaceutical-int.
com”) (right). B.Schematic drawing representing the measurement of 
TEER in cells grown in Transwell systems.                                
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after the addition of the donor fluids. Differentiated cells were maintained at 37°C throughout 
the experiment, and 200 µL -samples were collected from the basolateral compartment at 20, 
40, 60, 90 and 120 min. The collected volumes were replaced by adding 200 µL of KRB to the 
receiver compartment to keep a constant volume. At the end of the experiment, 20 µL from the 
donor compartment was taken to calculate the final concentration. The fluorescence of samples 
was evaluated in 96-well plates in an automated plate reader (Tecan Deutschland GmbH, 
Crailsheim, Germany) at excitation and emission wavelengths of 485 and 520 nm, respectively. 
A calibration curve was prepared in triplicate with sodium fluorescein in KRB with the following 
concentrations: 10, 8, 6, 4, 2, 1, 0.5 and 0 µg/mL. At the end of the experiment, TEER values were 
measured again to verify the cell layer integrity. 
To assess the estimated membrane permeability (cm/s), the apparent permeability coefficient 
of the monolayers for sodium fluorescein was determined using the following equation: 
Papp=(dQ/dt)×A
-1×c
0
-1, being dQ/dt, flux of the substrate (µg/s); A, area of the membrane (cm2); 
and c
0
, initial concentration in the donor compartment (µg/ml).
After plotting the transported amount of sodium fluorescein against the time, a regression 
line was applied for the linear part of the curve. The slope of the regression line corresponded 
to the flux across the monolayer.
Cell viability assay
The cytotoxic effect of nanoparticles was assessed using the MTT assay, a widespread simple 
and accurate method to evaluate cell viability based on the activity of living cells via mitochondrial 
dehydrogenases (Mosmann 1983; Denizot and Lang 1986). MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl tetrazolium bromide) displays a yellowish colour and mitochondrial dehydrogenases of 
viable cells are able to cleave the tetrazolium ring, yielding insoluble purple formazan crystals. 
Formazan can be solubilized in DMSO resulting in a purple solution spectrophotometrically 
measurable. Any variation in the number of cells results in a change in the amount of formazan 
yielded, indicating the degree of cytoxicity caused by the test compound.  Differentiated ATII-
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LCs under SC conditions grown in 96 well-plates were incubated with anionic or cationic PLGA 
or silver NPs at concentrations of 1, 2.5, 5, 10, 50 and 100 µg/mL in KRB for 24 h . Cells grown 
in culture medium alone were considered as a high viability control (100 % viability) and others 
incubated with Triton X-100 (1 % v/v) were used as a low viability control (0 % viability). A549 
cells were also used as a control of robustness and tolerance to the exposure to anionic PLGA 
and silver NPs. After 24 h of incubation, the medium containing NPs was removed and cells 
were washed with KRB. Then, fresh buffer containing 10 % (v/v) of MTT reagent (5 mg/mL) was 
added and cells were incubated for 4 h at 37 °C with shaking and protected from light.  At this 
point, the buffer was removed and DMSO was added to the microwells to dissolve the formazan 
crystals formed inside the cells. Absorbance at 550 nm was measured in a multiwell plate reader 
(Tecan Deutschland GmbH, Crailsheim, Germany). Cell viability was calculated by the following 
equation:  % cell viability=  (Abs
exp
- Abslow control)/(Abshigh control- Abslow control).
 Aerosolization of non ionic PLGA nanoparticles
Air-Liquid interface cell exposure system (ALICE)
The ALICE is a validated device for dose-controlled delivery of NPs or other substances in 
liquids or solutions to cells cultured under air-liquid interface conditions (Lenz, Karg et al. 2009) 
(Figure 29). Its operation principle is based on a method of cloud settling combined with single 
particle sedimentation. The term “cloud settling” refers to the situation in which the droplet 
concentration is high enough to provide a sufficient flow resistance to provoke the air to go 
around, instead of through, the cloud of droplets. 
The ALICE system consists of the following principal components:
- A nebulizer or droplet generator, in charge of providing the dense cloud of droplets 
(80-130 g/m3). The liquid sample to be tested is nebulized by a perforated, piezoelectrically-
driven vibrating membrane. When the membrane vibrates (at a frequency of 117 kHz), 
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it generates acoustic pressure waves, which press small amounts of fluid through the 
tapered holes. 
- The exposure chamber, a polycarbonate 12 liter-box where the droplets are deposited 
onto the cells placed at the bottom of the chamber, is designed to hold up to twelve 
transwell inserts. Its transparent nature permits an easy visualization of the bulk motion 
of the cloud.
- The flow system wich is operated with a closed loop flow system generated by an air 
pump and a flow meter yielding rates of 5 L/min. The flow rate is standardized to this 
value to assure that the cloud is transported to the central part of the chamber to provide 
with a uniform spatial distribution of the aerosolized substance. 
Cell exposure to FA-PLGA nanoparticles
Differentiated ATII-LCs under ALI conditions in Transwell systems were exposed to FA-PLGA 
NPs using the air-liquid interface cell exposure system (ALICE) (Vitrocell® Cloud 12/12, Vitrocell 
Systems GMbH)  as previously described (Lenz, Karg et al. 2009; Brandenberger, Rothen-
Rutishauser et al. 2010; Herzog, Clift et al. 2013). The base module was filled with prewarmed 
culture medium prior to the insertion of the supports covered by cells. 100 µL of FA-PLGA 
nanoparticles at concentrations of 10 µg/mL and 25 µg/mL in PBS were nebulized forming a 
cloud which was settled for 5 min. These concentrations were chosen taking into account the 
results provided by the cytotoxicity experiments to avoid a deleterious effect in the cells as well 
as the efficiency in the aerosolization procedure (around 70 %). The nebulizer gradually filled 
the chamber with the droplet cloud and as soon as the nebulizer was empty, the air flow was 
stopped and the droplets settled to the ground onto the cells. Then, the inserts with cells were 
taken out and placed back in the incubator maintaining ALI conditions for post-incubation and 
analytical processing. 
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Cellular uptake of PLGA nanoparticles
Cells were incubated for 3 h and 24 h after the exposure to FA-PLGA NPs with the ALICE system 
and cells were immunostained at room temperature as follows. Cells were washed with PBS 
twice and fixed with 3 % paraformaldehyde in PBS for 30 min. After fixation, blocking was carried 
out by incubation with 50 mM NH
4
Cl/PBS for 15 min. Next, cells were permeabilized with 0.05 % 
saponin/1 % BSA/PBS and incubated for 20 min. Afterwards, actin was stained with AlexaFluor 
680-phalloidin (Invitrogen) in a dilution of 1:500 for 30 min. After washing with PBS, nuclear 
staining was performed by incubation with DAPI (1:5000) for 20 min. Samples were washed and 
inserts were cut with a scalpel and mounted with a coverslip in a slide with mounting medium 
(Dako) and stored at 4 °C in darkness. Cells not exposed to NPs were also used as a negative 
control to exclude any side effects.
Slides were visualized by confocal electron microscopy under a LSM 710, Axio Obsever 
microscope (Zeiss). Single plane (4 µm) and z-stack images (14 µm, z-step= 0.4 µm) of multiple 
focal planes were obtained using a LD C-Apochromat 40x/1.1 W Korr M27 objective. Excitation 
wavelengths for Alexa Fluor 680, DAPI and fluoresceinamine from NPs were 633, 405 and 
488 nm, respectively. Image visualization and processing was performed using ZEN software 
(Zeiss).
Figure 29. Air Liquid Cell Exposure (ALICE) system. Images of the ALICE Vitrocell® Cloud 12/12 device, 
constituted by a nebulizer for aerosolization of liquid formulations and a exposure chamber with controlled 
flow allowing deposition of aerosolized liquids onto cells in cultivation.    
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DATA REPRODUCIBILITY AND STATISTICS
When possible, figures represent the mean ± standard deviation after averaging data from at 
least three independent experiments. In other cases, like cycling isotherms, illustrative curves are 
shown after at least three repetitions. Comparisons among the experimental groups were made 
using the Student’s t-test  or an analysis of variance (ANOVA) using the Holm-Sidak method, with 
significance level p= 0.05.
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Part of the experiments included in the present chapter were performed at the Department 
of Medical Physics (Inssbruck University, Austria), with the assisstance and supervision of Prof. 
Dr. Thomas Haller and at the Department of Chemistry of Imperial College London (United 
Kingdom), in collaboration with Dr. Nicholas Brooks.
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INTRODUCTION
Phospholipids, neutral lipids and the associated proteins essentially constituting the 
pulmonary surfactant system (Goerke 1998; Blanco and Pérez-Gil 2007; Pérez-Gil and Weaver 
2010), are produced in alveolar type II (ATII) cells located in the distal airways of the lung. The 
protein components are synthesized in the endoplasmic reticulum, processed in the Golgi 
apparatus and late endosomes/multivesicular bodies and partly assembled in the intracellular 
storage organelles known as lamellar bodies (LBs), whereas surfactant lipids may traffic directly 
from the ER to the LBs (Wright and Clements 1987; Pérez-Gil and Weaver 2010; Vanhecke, 
Herrmann et al. 2010). 
A typical ATII cell can have 100-150 LBs with various sizes but typically of 1 µm in diameter. 
LBs are lysosome-related vesicles with an acidic pH of about 6 (Chander, Johnson et al. 1986). 
Proteomic profiling of LBs reveals a highly dynamic organelle containing proteins corresponding 
to different functional categories,  mainly associated with lipid-related functions and involved in 
the biosynthetic, secretory and endocytic pathways of lung surfactant (Wang, Chintagari et al. 
2008; Ridsdale, Na et al. 2011). Interestingly, the lipid importer ABCA3 has been proposed to play a 
key rol in surfactant biogenesis incorporating phosphatidylcholine (PC) and phosphatidylglycerol 
(PG) through the limiting membrane and into the LB (Ban, Matsumura et al. 2007; Ridsdale, Na 
et al. 2011). Deficiencies in this transporter are associated with some respiratory syndromes of 
variable severity (Fitzgerald, Xavier et al. 2007). By transmission electron microscopy, LBs appear 
as osmiophilic vesicles with tightly packed, relatively periodic arranged lamellae, surrounded 
by an outer limiting membrane (Vanhecke, Herrmann et al. 2010). Interestingly, morphological 
differences in LBs can be discerned among species. Human LBs are constituted by concentric 
arranged lamellae revealing a dense projection core enriched in SP-B, whereas LBs from rodents 
do not contain this specific protein accumulation and their lamellae are organized in parallel (Ochs 
2010), probably due to a different spatial distribution of the surfactant proteins, particularly SP-B 
(Brasch, Johnen et al. 2004; Pérez-Gil 2008). 
Exocytosis of LBs is a constitutive and regulated process, which can be stimulated by certain 
chemical or physical factors implicated in the delay between stimulus and fusion of the surfactant 
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secretory vesicles, the expansion of the fusion pore, the release of vesicle content, and, finally, 
its extracellular dispersion (Chander and Fisher 1990; Mason and Voelker 1998; Dietl, Haller et 
al. 2001; Dietl and Haller 2005). Upon secretion, LBs are released as dense particulate entities 
(lamellar body-like particles, LBPs) which remain in a compact state until reaching the alveolar 
air-liquid interface (Haller, Dietl et al. 2004). At this point, LBPs disintegrate leading to an 
instantaneous spreading of material onto the interface and formation of an active surface film. 
It has been recently reported how the adsorptive capacity of LBPs into an air-liquid interface is 
affected by some physicochemical parameters, such as pH and temperature (Hobi, Siber et al. 
2014). A particular dramatic impact on interfacial adsorption was seen by proteolytic treatment of 
LBPs, suggesting the importance of surfactant protein for adsorption and surface film formation. 
It had been previously established that the films formed by adsorbed LBPs exhibit a lateral 
structural heterogeneity manifested by a lipid phase coexistence displaying segregated ordered 
and disordered regions (Ravasio, Olmeda et al. 2010). In addition, progressive adsorption of LBPs 
leads to the appearance of large protruded 3-dimensional (3-D) complex structures as well as a 
stiffening and solidification of the ensuing surface films. Interestingly, the solid-like character and 
the 3-D structures are not observed upon adsorption of surfactant purified from bronchoalveolar 
lavage (BAL). These findings suggested that surfactant derived from BAL, which is typically used 
as a standard material and a reference for optimal surfactant function, could only partially 
represent the properties of the film existing in the alveolar spaces, perhaps preventing a proper 
interpretation of the structure and behavior of surfactant in the native situation.            
In the present chapter and to further investigate the genuine structural organization of LBPs, 
we have assessed the packing and hydration properties of native lung surfactant membranes 
isolated from porcine bronchoalveolar lavage in comparison with surfactant stored in the 
form of intracellular LBs as well as in LBPs secreted by primary cultures of rat AT II cells. We 
have also analyzed the nanostructural features of adsorbed LBPs as well as their response to 
inhibitory agents in terms of surface activity and stability. Our findings corroborate the existence 
of significant structural differences between both types of surfactant organizations and their 
correlation with functional efficiency at the air-liquid interface.
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RESULTS
Membrane thermotropic properties
To evaluate the packing and hydration properties of the native surfactant forms we took 
advantage of the spectroscopic features of the probe Laurdan, which is sensitive to the hydration 
level of the lipid headgroup region and allows to detect changes in membrane phase properties. 
We started our investigations in intact rat ATII cells, the source of pulmonary surfactant, where 
we found that staining of intracellular LBs by Laurdan was extremely time- and T-dependent 
(Figure 1.1). At 37 °C and after 1 h of incubation, most of the probe was accumulated close to 
the limiting membrane of LBs (Fig.1.1B) whereas diffusion of the probe into deeper layers of LBs 
occurred at prolonged incubation times (3 h). As obvious from this figure, LBs were the main site 
of Laurdan accumulation and individual LBs showed a consistent spectral emission of Laurdan 
with only small differences in the distribution between lipid ordered (blue) and lipid disordered 
(green) states. 
Figure 1.1. Laurdan fluorescence in living rat ATII cell cultures. A. One single ATII cell displaying 
its characteristic cytoplasm full of storing lamellar bodies under brightfield microscopy. B. Laurdan 
fluorescence from labeled lamellar bodies suggesting a progressive labelling of the membranes from 
outer to inner locations. C. GPF representation in one ATII cell evidencing the sensitivity to temperature-
dependent structural changes in LB membranes. D. Plot of the thermotropic profile of GPF in intracellular 
LB membranes. Scale bars represent 5 µm.
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In some LBs, a sort of opening lacking of fluorescence signal could be discerned (Fig.1.1B, 
arrow). The thermotropic phase behaviour was tested by applying a T-ramp (15 to 50 °C) to 
the stained cells (Fig. 1.1C, D), demonstrating a relatively high dehydrated and packed state 
below and even above physiological temperatures. At 25 °C, LB membranes showed GPF 
values of around 0.4, similarly to what has been previously reported for condensed pure DPPC 
monolayers but significantly higher than those obtained from expanded fully hydrated POPC 
bilayer and monolayer structures, which display values around -0.2 at the same temperature 
(Picardi, Cruz et al. 2011). However, at 45 °C GPF in intracellular surfactant membranes still 
remained in positive values of around 0.20 (dehydrated, condensed packing) compared to the 
fairly expanded and hydrated character of DPPC, POPC or DPPC/PG bilayers, which exhibit values 
below 0 at equivalent temperatures (Picardi, Cruz et al. 2011). 
To gain additional insight into structural features of the lipid assemblies present in LBs, we 
examined living ATII cells by incident polarized light microscopy (Figure 1.2). Birrefringent signal 
coming from intracellular lamellar bodies (Fig. 1.2A) as wells as secreted LBPs (Fig. 1.2A insert) 
appeared as bright crosses, suggesting the presence of crystal-like highly ordered structures. The 
relationship between signal intensity and temperature was shown to be inverse, as polarization 
decreased when temperature was increased (Fig. 1.2A right panel and 1.2C). At high temperature, 
the signal seemed to disappear but returned again after cooling.             
DPPC vesicles were also examined and similarly to LBs, they were found to display optical 
signs of birrefringence at temperatures below Tm. However, in this case, the intensity of the 
polarization signal was not significantly declined when temperature was increased (Fig. 1.2B). 
In summary, the thermotropic profiles obtained from polarization microscopy and Laurdan 
fluorescence were similar, and even showed a linear correlation (Fig. 1.2D).
Laurdan fluorescence, but not polarization, could be applied to test for differences between 
released LBPs, native surfactant membranes and membranes reconstituted from its organic 
extracts (Figure 1.3). Whereas NS and OE exhibited a typical broaden phase transition, from 
an ordered (blue emission) to a disordered state (green emission), ending slightly above 37 °C 
(Fig. 1.3A and 1.3C), released LBPs showed a significantly less pronounced GP change upon the 
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same thermal treatment by maintaining a blue emission throughout the entire T-range up to non 
physiological high temperatures (Fig. 1.3B and 1.3C), similar to that obtained with intracellular 
LBs. Thus, LBs as well as LBPs exhibited an apparently more limited phase transition, which is 
different from that of NS or OE. Nevertheless, when compared intracellular and freshly released 
LBs at high temperatures such as 50 °C, the second ones exhibited even upper GPF values 
(0.11 vs 0.32, respectively), demonstrating a striking condensed and dehydrated character.  
Figure 1.2. Polarized light microscopy of intracellular and secreted lamellar bodies. Birrefringent cross 
polarization signal coming from intracellular LB membranes (A)  and DPPC vesicles (B), at 30 °C (left) 
and 45 °C  (right) and exocyted LBPs (A, insert) at 30 °C. C. Plot showing the inverse relation between 
polarization signal and temperature. D. Plot presenting the significative correlation between Laurdan and 
polarization signals.
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ATR-FTIR spectra also evidenced differences in the thermotropic behaviour and structural 
organization of lipid phases in LBPs (Figure 1.4). LBPs displayed a particular thermotropic profile 
shifted to substantially higher wavenumbers, and their Tm was increased in comparison with that 
of NS or OE membranes (Fig 1.4A). The increase of wavenumber in the CH
2
 stretching bands upon 
heating above Tm is attributed to the presence of gauche conformers along the acyl chains. The 
frequency of the LBPs band was shifted to higher wavenumbers than observed in NS, indicating 
more intrinsically disordered acyl chains in LBPs (Fig. 1.4C). CH
2
 bending bands are sensitive to 
hexagonally packed hydrocarbon chains.  LBPs showed displaced bands with relation to NS or its 
OE, suggesting the potential presence in LBPs of non-lamellar lipid phases (Fig. 1.4B). 
Figure 1.3. Laurdan fluorescence in surfactant preparations in cuvette experiments. Fluorescence spectra 
of Laurdan in suspensions of native surfactant (NS) membranes purified from BAL (A) or suspensions of 
secreted LBPs from rat ATII cells (B) recorded at 10 °C (), 15 °C (), 20 °C (), 25 °C (), 30 °C (), 
35 °C (), 37 °C (), 40 °C () , 42 °C (), 45 °C (), 50 °C(), 55 °C() and 60 °C(). Fluorescence 
spectra of the probe in reconstituted membranes from the organic extract of NS were almost identical to 
the spectra of NS and they are not shown. C. Thermotropic profiles of Generalized Polarization Function 
of the fluorescence in NS membranes (), membranes reconstituted from organic extract of NS () and 
LBPs (). 
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Lateral organization of membranes derived from LBPs 
GUVs formed from material 
of LBPs were generated to 
determine their lateral phase 
structure. Images of single GUVs 
composed of LBPs doped with 
the fluorescent probes Bodipy-
PC and DiIC18 can be observed 
in Figure 1.5. The particular 
round shape of the domains as 
well as the partition properties 
of the different fluorescent 
probes suggested that the 
lateral organization of the 
vesicles corresponded to a fluid ordered/fluid disordered-like phase coexistence (Fig 1.5A). 
In Fig. 1.5B, one vesicle adsorbed onto the glass support can be observed. Once the vesicle 
spread, a different structural organization took place and the previous type of coexistence 
Figure 1.4. ATR-FTIR spectroscopy of surfactant preparations. Thermotropic behaviour of native surfactant 
membranes () or membranes reconstituted from its organic extract () and secreted LBPs () according 
to the CH
2
 stretching bands wavelength (A). ATR-FTIR spectra of NS, OE and LBPs corresponding to the CH
2
 
bending band (B) or to the CH
2
 stretching band (C). Numbers inside the plots indicate the peak values for 
NS (orange line) and LBPs (yellow dotted line) in the corresponding absorption band.
Figure 1.5. Giant Unilamellar Vesicles (GUVs) prepared from 
LBPs. Images prior to adsorption (A) and after spontaneous 
spreading of the sample (B). The giant vesicles are labeled 
with the lipophilic fluorescence probes Bodipy-PC (green, 
left panel) and DiIC 18 (red, central panel). Merge of the 
channels is displayed in right panel. Rounded red areas in the 
images correspond to fluid ordered regions, and the green 
background corresponds to fluid disordered phase.  The scale 
bars correspond to 5 µm in A and 10 µm in B.
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seemed to disappear revealing a core region surrounded by an area of more disordered material. 
Nanostructure of adsorbed LBPs  
To further explore the lateral structure of the membranes constituting LBPs at submicrometer 
and nanometric scales we examined their organization by AFM. Figure 1.6 shows AFM images 
obtained from the structures that LBPs spontaneously form upon adsorption and direct spreading 
onto the mica support. In Fig. 1.6A homogeneous membranous patches with round protruding 
boundaries and containing a central core displaying a particular pattern composed of structures 
of different heights can be discerned.  Topological analysis showed that the distribution of heights 
observed in the central core is more heterogeneous than the height distribution observed in the 
surrounding area. The central area is magnified in Fig. 1.6B, revealing numerous well-defined 
sub-micron sized structures with similar diameters (around 0.1 µm) and a height of around 7-8 nm 
with respect to the general lipid patch and distributed with certain regularity (distanced 0.1 µm 
with respect to each other). Although with a minor proportion, other structural organizations 
were observed as seen in Fig. 1.6C, which shows a membrane patch with similar morphology but 
without the presence of a distinguishable central area and displaying various nano-sized areas 
with at least four different levels of height.  
Adsorption properties and resistance to inhibition 
To investigate the interfacial adsorption properties of LBPs in the presence of inhibitory agents, 
we used a method that allows evaluation of the amount of surfactant material accumulating at 
the interface and the resistance of the formed surface films and associated structures against 
mechanical agitation. The deleterious effect of  serum proteins and meconium has been previously 
shown to cause a significant impairment of the surface properties of surfactant, associated with 
severe respiratory disorders such as acute respiratory distress syndrome or meconium aspiration 
syndrome, respectively (López-Rodríguez, Echaide et al. 2011; López-Rodríguez, Ospina et al. 
2012). 
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In Figure. 1.7, adsorption kinetics in the presence of increasing amounts of serum (Fig. 1.7A) 
or meconium (Fig. 1.7C) of comparable quantities of suspensions of native surfactant (left panel), 
its reconstituted organic extract (middle panel) or LBPs (right panel) are displayed. The results 
show how all the materials were able to reach the interface quickly and stably remain associated 
with it, while their exposure to increasing concentrations of either of the two inhibitory agents, 
produced a progressive reduction in the amount of interfacial surfactant. However, LBPs showed 
a marked resistance to inhibition, displaying significantly better adsorption kinetics than native 
Figure 1.6. AFM scanning images from adsorbed LBPs. Images under phase contrast mode, topology 
images, tridimensional projections and topological profiles (corresponding to the blue lines marked in 
topology images) of suspensions of LBPs upon adsorption onto mica supports at different magnifications. 
Image B corresponds to a magnification of the area highlighted in A. Lateral distances are 5 µm in A and 
C and 1 µm in B.
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surfactant membranes in the presence of equivalent concentrations of inhibitory agents (Fig. 
1.7B,D).   
Figure 1.7. Resistance to inhibition in terms of interfacial adsorption properties of surfactant preparations. 
Dose-dependent inhibitory effect of human serum proteins (A) or meconium (C) on the adsorption kinetics 
of native surfactant (NS, left panel) membranes reconstituted from its organic extract (OE, central panel) 
and secreted LBPs from rat ATII cells (right panel)  Serum protein concentrations were 0 (), 1 (), 5 () 10 
(), 25 () 100 () and 200 () µg/ml and cholesterol concentrations  in meconium were 0 (), 0.25(), 
0.5 (), 1 (), 1.5 () and 2()µg/ml. Fluorescence values taken after 60 min of adsorption of NS (), OE 
() and LBPs () as a function of serum protein concentration (B) or meconium (D). Adsorption efficacy in 
terms of amount of adsorbed material into the surface was significantly (*p<0.05 and ** p<0.01) higher in 
the case of LBPs than in NS and its OE at elevated concentrations of inhibitory agents. (RFU – bg = Relative 
fluorescence units – background).
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DISCUSSION
The assembly of lung surfactant membranes in the lamellar bodies (LBs) of alveolar type II cells 
requires ABCA3 transporters as well as the energy provided by ATP hydrolysis. Considering these 
requirements, an hypothesis can be raised that the energy expenditure during LB biogenesis 
confers to surfactant complexes an “energy-loaded state”, which later might sustain the 
remarkable efficiency by which released LBPs avidly transform into an interfacial film (Ravasio, 
Olmeda et al. 2010). In contrast, native surfactant (NS) complexes purified from bronchoalveolar 
lavages have been usually considered as the most representative surfactant material, a sort of 
“gold standard”, for defining structure-function determinants and optimal surfactant functions. 
However, taking into account that the isolation procedure consists of collecting material from 
very different regions of the respiratory tract and that this material may contain the product 
of different states of metabolic and physical conversions (i.e. already exposed to an air-liquid 
interface or even recycled), the resultant samples may consist only partially the functional active 
fraction secreted to the lung alveoli. In fact, previous studies provided evidence that interfacial 
films formed by freshly secreted LBPs have significantly different structures and properties than 
films formed by whole natural surfactant purified from animal lungs (Ravasio, Olmeda et al. 
2010), which could also contain already “spent“ or partly inactivated surfactant.
To gain more insight into the real behaviour of freshly assembled and secreted surfactant 
within the alveolar spaces we investigated the specific organization of lipids and proteins in 
surfactant membranes directly obtained from alveolar type II cells and compared these data with 
surfactant purified from animal lungs. On the one hand, we assessed the thermotropic behaviour 
of surfactant membranes in terms of packing and hydration by monitoring the fluorescent probe 
Laurdan. This probe is sensitive to the polarity of the environment and is also known to partition 
into both ordered and disordered regions providing a general overview of lipid organization. 
The results show that membranes constituting freshly secreted LBPs posses a highly dehydrated 
and packed state in comparison with NS and membranes reconstituted from its organic extract 
(OE). This is astonishing because in NS, a highly dehydrated and packed state can only be seen by 
applying a lateral compression. This observation is also consistent with previous morphological 
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descriptions in which released LBPs appear as dense particulate entities which retain a highly 
packed character until contacting the air-liquid interface (Haller, Dietl et al. 2004). In addition, it 
also reflects consistence with the observation that the efficiency in surfactant performance at 
the interface is related to the propensity of surfactant layers to reach highly dehydrated states 
(Picardi, Cruz et al. 2011).
On the other hand, we also took advantage of the spectral properties of Laurdan to obtain 
qualitative and quantitative information of the packing state of surfactant stored within the cells. 
Labeling of primary cultures of ATII cells with the probe resulted in its preferred accumulation in 
LBs. However, accumulation was not uniform as fluorescence intensity was maximal in regions 
close to the vesicle’s periphery. This could reflect the time-dependent diffusion of the probe into 
deeper surfactant layers or the existence of more compact layers constituting a diffusion barrier 
near the central core. Also, labeling differs among individual LBs within the same cell, which 
could reflect the coexistence of different stages in biogenesis and maturation of these organelles. 
Interestingly, a defined site of the packed structure exhibits a sort of opening in many of the LBs, 
lacking fluorescence signal. It is tempting to speculate with the possibility that the “opening” 
could be the location of a putative protein-based “machinery” in charge of controlling the 
opening and spreading of pre-packed membranes once contacted with the air-liquid interface, 
although further investigation will be needed to confirm this hypothesis. Importantly, Laurdan 
reveals a highly dehydrated state of the surfactant lipids in LBs and a thermotropic profile that is 
similar to that of LBPs. 
The thermotropic profile as revealed by Laurdan spectroscopy reveals a striking similarity 
to the changes obtained by polarization microscopy. Although the former method is most 
likely reporting about changes in lipid packing and hydration and the latter most likely about 
periodical molecular organization, it can be assumed that both inform essentially about the same 
phenomenon connected with the transition from ordered into disordered states. Polarization, 
however, is non-invasive and thus serves as an acceptable positive control for the use of Laurdan 
as an invasive lipophilic probe. It is known that anisotropic lipids forming crystal-like structures 
are able to produce birrefringence patterns under polarized light (Butovich, Lu et al. 2014). 
Considering this, we interpret that the optical anisotropy of LBs is probably the result of the 
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radial-symmetric orientation of the phospholipid acyl chains and that the strong birrefringent 
signal suggests that LBs exist in a liquid-crystal arrangement at physiological temperatures. We 
further speculate that the polarization intensity may be determined by either the amount of 
bilayers per unit of volume and/or the degree of molecular alignment of the acyl chains with 
respect to the orientation of the polarized light wave front. As a matter of fact, the preponderance 
of anisotropy reflected in these cross-signals has been observed in other lipid preparations 
being also associated to smectic liquid-crystalline states (Katz, Shipley et al. 1976). The fact that 
the polarization signal diminished at heating towards an optically isotropic state but increased 
again after cooling could be consistent with a reversible kind of structural reorganization such 
a phase transition. Indeed, the observation of isotropic phases in other lipid samples at high 
temperature has been related to organizations in such a way  that one of the three-dimensional 
crystallographic cubic space groups is satisfied (Shipley, Avecilla et al. 1974) resulting in a cubic 
symmetry with finite-length rods of lipids linked and interwoven (Luzzati, Gulik-Krzywicki et al. 
1968). Interestingly, preparations containing exclusively DPPC molecules, which are known to be 
arranged in pure lamellar phases, did not seem to experiment this type of transition maintaining 
a birrefingent signal after heating.   
By Attenuated Total Reflectance-Fourier Transformed Infrared Spectroscopy (ATR-FTIR) we 
also acquired thermotropic profiles that revealed temperature-dependent changes in packing and 
lipid order, without the necessity of introducing extrinsic probes. The results again demonstrate 
that the IR thermotropic profile of LBPs is significantly different from those of NS membranes 
or membranes reconstituted from its OE. The intensity of the CH
2
 asymmetric stretching IR 
absorption band, which is sensitive to conformation, increases upon heating above Tm, which is 
attributed to the presence of gauche conformers along the acyl chains (Casal and Mantsch 1984; 
Lotta, Virtanen et al. 1988; Lewis and McElhaney 2013). In LBPs, the frequency of the band is 
shifted to significantly higher wavenumbers than observed in NS, indicating more intrinsically 
disordered acyl chains. This higher disordered state of the acyl chains in LBPs as determined 
by ATR-FTIR is apparently in conflict with the results obtained by the Laurdan measurements, 
which demonstrated a higher packing and lower hydration. However, these inconsistencies 
could be conciliated considering the possible presence of non-lamellar phases (Lewis and 
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McElhaney 2013). We examined the IR spectra at the CH
2
 bending absorption band, which is 
dependent on acyl chain packing and conformation and so sensitive to the presence of non-
lamellar phases (Wallach, Verma et al. 1979; Casal and Mantsch 1984). This band also reflects 
important differences between LBP membranes and both NS and its OE, which are known to 
be organized constituting two lamellar phases with different thicknesses, as observed by Small 
Angle X-ray Scattering (SAXS) analysis (Bernardino de la Serna, Vargas et al. 2013). Recently, it 
has been proposed that non-lamellar phases might indeed exist in surfactant lipid complexes 
and that these phases could be involved in the interconnection of the active surface film with 
multilayered structures acting as a surfactant reservoir at the aqueous subphase (Chavarha, 
Khoojinian et al. 2010). By using lipid model systems, it has also been shown that surfactant 
proteins SP-B and SP-C promote the formation of cubic phases (Chavarha, Khoojinian et al. 2010; 
Chavarha, Loney et al. 2012). Furthermore, surface-active lipids have been shown to facilitate 
the formation of hexagonal HII phases (Perkins, Dause et al. 1996), highlighting the importance 
of lipid polymorphism in surfactant function. Unfortunately though, ATR-FTIR does not provide 
sufficient structural information to definitely prove or disprove the presence of particular 
lipid phases as could be the case for a number of other methods. These methods, however, in 
particular  X-ray diffraction or P31 NMR, could not be applied to study LBP samples due to the 
extremely limited amount of LBPs that can be collected from isolated cells.
Considering the complex composition of lipids and proteins in lung surfactant, the role of 
phase coexistence has already been suggested as a key feature in functional terms (Bernardino 
de la Serna, Pérez-Gil et al. 2004; Casals and Cañadas 2012). Our results obtained upon 
examination of the lateral phase structure of intact GUVs prepared from LBP membranes are 
consistent with previous reports from Ravasio and collaborators (Ravasio, Olmeda et al. 2010) 
who demonstrated that the films formed by adsorbed LBPs spontaneously segregate into both 
ordered and disordered phases. We have also observed that adsorption of LBP-derived GUVs on 
solid supports results in the formation of structures with a particular organization, dominated 
by disordered regions, which could be interpreted as an intermediary stage in the adsorption 
process. 
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Examination by AFM revealed that once adsorbed onto the mica support, LBPs generate 
structures with two different areas including a central core exhibiting well-defined domains 
distanced with certain regularity surrounded by flat patches of membranes. The prominent 
domains could be interpreted as the result of the formation of large protruded 3-dimensional 
structures typically observed from LBPs adsorbed on air-liquid interfaces (Ravasio, Olmeda et 
al. 2010). The periodical distribution of the domains present in the core resemble a lattice-
like structure and could suggest the presence of membrane-associated scaffolds of proteins, 
imposing these distances.  Moreover, the complexity observed in the nanostructure of adsorbed 
LBPs displays marked differences with respect to the organization of NS membranes visualized 
under AFM (Blanco, Cruz et al. 2012).
Finally, we evaluated the adsorptive properties of LBPs in the presence of two 
pathophysiologically relevant inhibitors, serum proteins and meconium. Both agents are well 
known to significantly disturb and impair surfactant function (Taeusch, Bernardino de la Serna et 
al. 2005; Gunasekara, Schoel et al. 2008; López-Rodríguez, Echaide et al. 2011; López-Rodríguez 
and Pérez-Gil 2014). The higher adsorptive capacity of LBPs in comparison with whole NS 
membranes has already been demonstrated (Ravasio, Cruz et al. 2008). Consistent with previous 
biophysical studies (López-Rodríguez, Ospina et al. 2012; Hobi, Siber et al. 2014), we also observed 
that these inhibitors lead to a dramatic reduction in the accumulation of surfactant material into 
the air-liquid interface and so reduce its adsorptive capability. Here, we have shown that freshly 
secreted LBPs display a significantly higher resistance to both serum proteins and cholesterol 
than whole NS and complexes reconstituted from its OE. These findings suggest that LBPs are 
endowed with adsorptive mechanisms that are clearly different from those of NS or its OE. 
Although the nature and molecular identity of these mechanisms is still enigmatic, the present 
study is putting forward the idea that either a peculiar phase organization in the membranes 
of LBPs, or the presence of a protein scaffold on the outermost LBP membrane constitutes a 
mechanism by which an efficient adsorption can occur, even in the presence of strong inhibitory 
substances. The elucidation of these mechanisms would be of high relevance for the design of 
novel therapeutic materials with less susceptibility to inhibition and a higher efficiency for the 
treatment of respiratory pathologies such as ARDS or interstitial lung diseases.
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In summary, our results show that the surfactant membranes as they are assembled and 
freshly released by the ATII cells display very distinctive features. They are in a highly packed and 
dehydrated state with an optimized adsorptive performance towards an air-liquid interface, and 
with a high resistance to inactivation. These features are very different from those of natural 
surfactant typically isolated from animal lungs and classically used in surfactant research, and 
could arise from the fact that LBPs are a primordial form in which surfactant is released, still 
containing the whole complement of lipids and proteins in a possibly unaltered structural 
configuration. Future investigations will be necessary to unveil this configuration at a molecular 
level and to apply this knowledge to the design and production of new optimized therapeutic 
surfactants.

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
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INTRODUCTION
Pulmonary surfactant is a membrane-based non-homogeneous material and it has been 
shown to exist in a variety of discrete subtypes with different features, which are generated 
during normal lung function (Guthmann, Haupt et al. 1995; Putman, Creuwels et al. 1996), 
namely a lamellar body-like form, a tubular myelin form and a small vesicular form (Wright and 
Clements 1987; Gross, Kellam et al. 2000). The widely accepted model of alveolar surfactant 
metabolism implies that freshly secreted lamellar bodies convert to tubular myelin, which is 
thought to represent the reservoir of material for the surface film at the alveolar interface. Then, 
the processes of compression/expansion cycling of the interface occurring during breathing 
result in the generation of small and low sedimentable forms with poor activity and are probably 
assigned for their removal from the airspaces (Magoon, Wright et al. 1983; Gross and Narine 
1989; Guthmann, Haupt et al. 1995). The proportions of these subtypes change in the perinatal 
period (Spain, Silbajoris et al. 1987), as a result of physiological events (i.e. deep breathing or 
exercise) (Nicholas, Power et al. 1982) or in response to certain drugs (Miles, Bowman et al. 
1986). The existence of different surfactant-related structures in the same or different pulmonary 
compartments and their connection with processes involved in secretion, reorganization, 
recycling or adaptation of the surfactant system to different physiopathological contexts, is still 
a fully open question.                    
Although a number of methods have been described in the literature to separate surfactant 
subtypes, these have not been standardized and have varied among studies, preventing a proper 
interpretation of the results and leading to discrepancies among investigators. It was in 1979 
when the group of Thet described the heterogeneity of pulmonary surfactant with respect to its 
sedimentation properties (Thet, Clerch et al. 1979). Over the last three decades, researchers have 
utilized different centrifugation schemes to obtain purified fractions of pulmonary surfactant. In 
general, two alternative types of separation methods from bronchoalveolar lavage fluid (BAL) 
have been established: differential centrifugation and equilibrium buoyant density gradient 
centrifugation (Gross, Kellam et al. 2000). 
132
Chapter 2
Differential centrifugation has been traditionally used to fractionate BAL from animal lungs 
into large aggregates (LA), large membrane-based structures with relatively high density and 
surface active, and small aggregates (SA), of light density and worse surface activity (Pérez-Gil 
2008). LA have been associated to the maintenance of alveolar stability through the reduction 
of surface tension at the alveoli (Brackenbury, Malloy et al. 2002). In vivo, during respiration, LA 
are converted into SA, which are either recycled back into the pneumocyte or cleared from the 
air-spaces (Gross and Narine 1989). Interestingly, the conversion of large into small surfactant 
aggregates in vivo can be reproduced and studied in vitro by a technique known as “surface-area 
cycling” (Gross and Narine 1989; Veldhuizen, Hearn et al. 1994). Moreover, alterations in the 
ratio of SA to LA are associated  to some pathological situations, being abnormally increased, 
for instance, in N-nitroso-N-methylurethane-induced lung injury in rabbits (Higuchi, Lewis 
et al. 1992) or decreased in BAL obtained upon radiation pneumonitis (Gross 1991). From an 
experimental point of view, the protocol to separate the two fractions is easy to perform and 
it is based on a single step ultracentrifugation at 40000 x g for 15 min, resulting in a pelleted 
fraction (LA, around 25 %) and a supernatant (SA, around 75 %) (Veldhuizen, Inchley et al. 1993; 
Veldhuizen, Hearn et al. 1994). Additionally, surfactant subfractions can be also separated by 
sequential centrifugation, obtaining the different forms as pelleted fractions; i.e.: centrifugation 
at 1000 x g for 20 min, 60000 x g for 60 min and 100000 x g for 16 h (Magoon, Wright et al. 1983). 
On the other hand, by using density gradient centrifugation, pulmonary surfactant can be 
separated into three peaks termed light, heavy and ultraheavy fractions (Gross and Narine 1989). 
The “light” subtype has little surface activity and it is mainly comprised by small unilamellar 
vesicles. The “heavy” fraction consists of small amounts of tubular myelin and empty vesicles 
whereas the “ultraheavy” portion contains aggregates of tubular myelin as well as lamellar body-
like structures. In terms of metabolic correspondence and similarly to the case of LA and SA, 
the ultraheavy form is thought to be generated upon secretion into the alveolar compartments, 
giving rise to the heavy and light forms and this conversion can be also mimicked in vitro by “area 
cycling” (Gross and Narine 1989). This approach to obtain the different surfactant fractions is 
more laborious than the first method and it is normally based on continuous or discontinuous 
sucrose gradients and longer centrifugations, i.e.: 196000 x g at 8 °C for 16 h. In this case, yields 
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are normally around 45 % (ultraheavy and heavy forms) and 55 % (light form) (Gross, Kellam et 
al. 2000). 
In Chapter 1, we gained insight into some distinctive structural features of freshly secreted 
surfactant in the form of lamellar body-like particles (LBPs) released from primary cultures of rat 
alveolar type II cells. However, the limited yield of material achieved at a “cell culture scale” (few 
micrograms) prevents the utilization of a number of techniques extremely useful to elucidate 
some features of LBPs which still remain unclear. In the search of additional sources of this 
relevant material, but also to identify other defined surfactant structures playing specific roles 
in the airways, we have subjected the whole native pulmonary surfactant, to further purification 
by using an adapted method originally conceived for the isolation of lamellar bodies from lung 
tissue. By discontinuous sucrose density gradient, we have fractioned these native surfactant 
complexes from porcine BAL as described in the previous chapter, into five additional discrete 
subforms. In chapter 2, we have aimed to analyze the different native surfactant subfractions 
correlating surface activity with morphology and biochemical composition. Our results suggest 
that the “gold standard” of an efficient surfactant, which has been traditionally considered as a 
simple compartment of homogeneous material, is constituted by multiple types of structures, 
some of them probably not directly related with surface-active properties but with surfactant 
homeostasis.   
RESULTS
Ultrastructural analysis of surfactant subfractions
Morphological differences could be identified in the various subfractions isolated from NS 
complexes, as revealed by transmission electron microscopy (Figures 2.1 and 2.2). N2 contained 
large aggregates of spherical corpuscles with a fairly uniform size distribution of about 1-2 
µm, composed by a high number of parallel membranes consistent with the morphology of 
typical lamellar body-like particles (LBPs) as illustrated in Fig. 2.1A,B and 2.2A-G. Although the 
multillamelated character was characteristic in this subfraction,  a variable density of packaging of 
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lamellae could be discerned, 
observing intact LBPs (Fig. 
2.1A,B) but also partially 
dilated corpuscles (Fig. 
2.2A-G), with broken 
limiting membranes in 
some places probably 
due to lipid extraction 
as a consequence of the 
chemical fixation performed 
for the inclusions into resin. 
Occasionally, areas with 
multiple paralel membranes 
of ~ 8 nm in thickness 
reflecting a noticeable 
periodicity with apparently 
imposed repetitive distances 
(around 20 nm between 
neighbouring membranes) 
were visualized (Fig. 2.2D), 
partially resembling incipient 
features of the organization 
of tubular myelin figures. 
Interestingly, tubules 
forming tubular myelin have 
been described to be also of 
8 nm in thickness (Williams 1977), although the canonical lattice-like appearance of this structure 
was not detected. Nevertheless, one should not be discard the possibility that these images 
represent longitudinal sections of tubes instead of cross sections (squares). On the other hand, 
Figure 2.1. Morphological analysis of surfactant subtypes 
by negative staining. Micrographs corresponding to different 
subfractions purified from native surfactant stained with uranyl 
acetate and visualized under transmission electron microscopy. A, 
B. N2, scale bar = 0.5 µm. C, D. N3, scale bar = 1 µm. E, F. N4, scale 
bars = 1 µm and 0.2 µm, respectively. G, H. N5, scale bars = 0.5 and 
2 µm, respectively.      
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the spacing between the layers (~ 20 nm) does not correspond with that reported for tubular 
myelin (~ 50 nm) but it coincides with descriptions of transitions from regular square lattice 
structures to parallel systems of smaller repeat period (less than 23 nm) previously observed in 
isolated surfactant fractions (Gil and Reiss 1973). 
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N3 (Fig. 2.1C,D)  comprised a more heterogeneous material in terms of size, with less 
compact lamellar body-like structures as well as small vesicles of less than 500 nm of diameter. 
N4 (Fig. 2.1E,F) included disorganized and seemingly less complex material in the form of vesicles 
and membranous sheets. The pellet, N5 (Fig. 2.1G,H and 2.2H-K) mainly contained clusters 
of nano-sized oligomellar and unilamellar vesicles as well as completely unfolded membrane 
patches and amorphous material. Most vesicles appeared as highly osmiophylic and they seemed 
to have an internal relatively formless content.    
Figure 2.2. Ultrastructural features of subfractions N2 and N5. Micrographs of resin-embedded sections 
of material from the isolated subfractions N2 (A-G) and N5 (H-K) stained with osmium tetroxide and 
visualized under transmission electron microscopy. Scale bars = 1 µm in A, B, H and K; 0.5 µm in D, E and 
I; 0.2 µm in F, G and J.
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Biochemical composition of surfactant subfractions
Content in phospholipids, proteins and cholesterol was measured in the different NS fractions, 
determining the total amounts as well as their relative proportions with respect to the whole NS 
complexes (Figure 2.3A). A marked tendency of decreasing in the content of phospholipid was 
observed from the lightest to the heaviest subfractions. Indeed, more than 50 % of phospholipid 
was located in N2, whereas  N5 accounted only for around 3 % with respect to the total. However, 
the total amount of protein presented an opposite trend and light fractions appeared to contain 
relatively less protein than heavy fractions. 18 % of protein was found in N2, considerably less 
than in N4 (30 %) although the pellet contained a lower proportion (22 %) compared to N4.  As a 
consequence of these results, lipid/protein ratios (Fig. 2.3B) exhibited a overall decline from the 
less dense fraction N2 (36, lipid/protein, w/w) to the denser fractions N4 and N5 (less than 3). 
Figure 2.3. Lipid and protein content of surfactant subfractions. A. Table showing the mean amount (mg) 
of total phospholipid, protein and cholesterol present in each band (N2-N5) upon subfractionation of 500 
µL of whole NS. Also shown is the proportion (%) of each fraction with respect to the total NS.  B. Plots 
indicating the ratios lipid/protein (left) and lipid/cholesterol (right) among the isolated subfractions and 
complete native surfactant complexes. 
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On the other hand, the amount of cholesterol was found to increase from the lightest fraction 
(21 % in N2), to the heaviest subtype (around 33 % in the pelleted fraction N5). Similarly to the 
lipid/protein ratio, the proportion between phospholipid and cholesterol (Fig. 2.3B) drastically 
diminished from the less dense fraction (more than 100) to the densest fractions (around 3.5 in 
N5). 
In addition, the distribution of individual lipid species among the individual subfractions in 
comparison with the pattern present in whole NS was also determined (Figure 2.4). From a 
qualitative point of view, the composition of lipid species in the surfactant subtypes showed little 
difference if any, containing mainly PC, PG and PE (Fig. 2.4A). Another lipid band below the one 
corresponding to PC can be observed in all the samples, although its identification is hampered 
due to an insufficient resolution. In the lane corresponding to whole NS (NS) an additonal diffuse 
band with a low chromatographic mobility can be visualized. Although it seems to be apparently 
absent into the different isolated subfractions, a weak signal can be discerned, particularly in the 
case of N5. The band corresponded to cholesterol can be also hardly distinguished, due to the 
fact that the development with iodine vapors is not optimimal for its visualization.   
Finally, in order to analyze from a quantitative point of view the apparent differences of 
content in the most significant surfactant species of the different subfractions, the corresponding 
bands of PC and PG were scratched and subjected to quantitation by phosphorus mineralization 
and molar percentages with respect to total phospholipids were calculated (Fig. 2.4B). With 
respect to the content in PC species and in accordance with the results observed by TLC, the 
lighter subfractions  N2 (55 % molar) and particularly N3 (around 75 % molar) were the ones 
with higher enrichment, being the major recipients of PC from whole NS (aproximately 70 % 
molar, the average between N2 and N3). In the case of the denser subtypes, the proportion was 
markedly reduced to 20-30 % molar in both N4 and N5. In reference to the content in PG, N2, N3 
and N4 displayed a similar molar percentage (around 3-4 % molar), while was slightly reduced 
in the pellet N5 (around 2.5 % molar). Unlike PC, the total amount of PG species seemed to be 
equally distributed among all the NS subtypes.   
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Surfactant proteins in subfractions
The determination of content in surfactant proteins A, B and C revealed a distinctive 
compositional pattern among the different surfactant subfractions, as illustrated in Figure 2.5.
 A gradual increment in the amount of SP-A from the light to the heavy subfractions was found. 
In the top panel,  a weak band in N2 with mobility corresponding to 38 kDa (likely SP-A monomer) 
could be discerned whereas the more dense fraction N5 seemed to be most enriched in SP-A, 
with several bands of different molecular weight. Of note, a band above the one corresponding 
to the monomeric form could be perceived in all individual fractions except in N2. This could be 
explained as result of a partial reduction of disulfide bonds (which affected particularly to whole 
NS, where the monomer expression seems negligible) and it could be attributed to a dimeric 
Figure 2.4. Compositional analysis of the lipid fraction of surfactant subtypes. Lipid composition 
of the isolated subfractions and complete native surfactant as analyzed by thin-layer-
chromatography (A). Quantitative compositional profile of PC and PG classes as determined by 
phosphorus quantitation of each of the TLC bands in the regions defined in the chromatogram (B).
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state. On the other hand, at least 3 bands of low molecular weight were detected predominantly 
in N5, possibly representing non glycosilated 
forms or a partial proteolytic degradation of 
SP-A. 
The distribution of both hidrophobic 
proteins SP-B and SP-C in the different 
subfractions differed considerably compared 
to SP-A .  As seen in the middle panel, the 
monomeric form of SP-B (around 8.7 kDa) 
was found to be more abundant in the less 
dense subfractions N2 and N3 whilst it was 
patently reduced in the heaviest subtypes N4 
and particularly in N5.  
In the case of SP-C (bottom panel), 
although it was present in all the subfractions, 
a different profile of forms with a clearly 
diverse oligomerization degree was observed. 
This can be attributed to an inefficient action 
of β-mercaptoethanol or due to the 
original state of the samples. Furthermore, 
distorsion of bands as a result of the high 
lipid concentration in the samples has to be 
taken into account as possible explanation 
for the different sizes observed in the blot, 
difficulting an accurate interpretation. The 
monomer (around 3.7 kDa) could be only 
clearly distinguished in whole NS and N3, 
whereas  polimeric forms, between 10-15 
Figure 2.5. Content of surfactant associated 
proteins of surfactant subfractions. 
Representative western blots of surfactant 
proteins A, B and C in isolated subfractions 
and complete native surfactant complexes. For 
comparison, total protein corresponding to 
100 µg of lipid, was loaded into each lane of a 
10 % (SP-A) and 16 % (SP-B, SP-C) acrylamide 
gel. Gels were run in reducing conditons 
upond incubation of the samples with 
β-mercaptoethanol.
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kDa, were present in all the samples. The most conspicuous SP-C signal was observed in N2, 
which was found to be the most enriched in SP-C.  Noticeably, a high amount of aggregates of 
high molecular weight appeared “trapped” in the concentrating part of the gel, predominantly 
in the lane corresponding to N5. 
Surface activity evaluation of surfactant subfractions
Functional assessment of the different surfactant fractions was performed by captive bubble 
surfactometry revealing a different activity among the isolated subfractions isolated from 
whole NS complexes (Figures 2.6, 2.7 and Table 2.1). Firstly, after sample injection, adsorption 
of surfactant material and subsequent drop in surface tension to equilibrium values (around 
20-25 mN/m) was found to take place in all samples at some point (Figure 2.6, left panels). 
However, N2 was shown to be the most active fraction in  film formation, provoking an almost 
instanteneous (5 s) decline to values near to 20 mN/m. N3 displayed a similar rate compared 
to N2 reaching the equilibrium after 5 s being slightly more efficient than complete NS. The 
heaviest fractions were much less competent and the equilibrium was further delayed, being 
reached later, after 20 s (N4) or 60 s (N5).
Five minutes after the initial surface film formation, bubbles were rapidly expanded, measuring 
the tension reduction corresponding to the incorporation of remaining material present in the 
aqueous hypohase (Figure 2.6, right panels). The evaluation of this stage is particularly adventageous 
in comparison with the initial adsorption since this is not subjected to possible experimental artifacts 
(i.e. proximity of the capillary to the bubble) and it is closer to the real situation in which surfactant 
adsorpts to an expanding surface already occupied by surfactant  (Schurch, Green et al. 1998; Schurch, 
Ospina et al. 2010). All films, except that formed by N5, were similarly active as evidenced by the 
drops in surface tension after expansion to equilibrium values close to 22 mN/m. In correspondence 
with the initial adsoprtion, N2 and N3 were the most efficient fractions to re-stablish surface films 
during interfacial expansion, reaching the equilibrium very quickly (5 s), even faster than whole NS 
(20 s). N4 was comparable in activity to the complete NS attaining equilibrium values within 20 s. In 
contrast, N5 showed a slower kinetics, reaching a surface tension of ~ 24 mN/m after 300 s. 
142
Chapter 2
Figure 2.6. Interfacial adsorption of isolated surfactant subfractions. Initial 
(left panels) and post-expansion (right panels) adsorption kinetics of purified 
surfactant subtypes and complete native surfactant assemblies.
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Afterwards, the surface behaviour of the different films was evaluated under slow quasistatic 
compression/expansion cycling, permiting the films to relax for several seconds between 
compression steps. Figure 2.7 (left panels) summarizes compression-expansion isotherms 
reveling important differences between samples. The first quasi-static cycle (brown circles) 
showed clearly greater hysteresis than the subsequent cycles in the case of N3 and N4 in a similar 
way to the cycles exhibited by complete NS complexes.  Of note, this well characterized behaviour 
was not detected in the subfraction N2 and particularly in N5, where all the isotherms seemed to 
exhibit a comparable range of hysteresis. Indeed, films formed by N2 showed behaviour distinct 
from those of other samples, with relative area changes lower than 40 %  in contrast to N3, N4 
and N5 (~ 60 %) or to whole NS ( ~ 50 %). Maximum surface tensions did not exceed 30 mN/m 
in any of the samples. Minimum values close to 0 mN/m were reached in all samples except for 
N5, which did not attain values lower than 20 mN/m, revealing a poor surface activity. Finally, at 
the fourth quasi-static cycle (green circles) smaller area changes  and less hysteresis indicative of 
a changed film configuration and/or structure (Schurch, Ospina et al. 2010) were observed in all 
samples with the exception of N5 which displayed a long plateau in all cycles. 
Figure 2.7 (right panels) illustrates the dynamic compression/expansion isotherms centered 
on the 1st, 10th and 20th cycles of films formed by the different fractions. Again, patent differences 
among the samples could be discerned. Films formed by N2, N3 or whole NS were completely 
functional and behaved similarly, exhibiting dynamic cycles almost identical with pratically no 
hysteresis and slightly higher maximum tensions than that at the end of the fourth quasi-static 
cycle. A slightly less inclined slope could be noticed in N2 isotherms, which needed less than 
15 % of area reduction to reach the lowest surface tension, in comparison to N3 (~ 20 %) and 
particularly to complete NS (> 20%). N4 worked similarly to N3, except for the first dynamic cycle 
that exhibited some hysteresis. Films formed by N5 were again poorly active, exhibiting very high 
maximal tension values (close to 50 mN/m), whereas the minimal values were not lower than 7 
mN/m. In addition, films formed from N5 required much larger area reductions (> 40 % to reach 
the lowest tensions) and more hysteresis than films formed by the other fractions. 
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Figure 2.7. Compression-expansion isotherms of surfactant subfraction 
films. Quasi-static (left panels) and dynamic (right panels) compression/
expansion isotherms from films formed from surfactant subfractions and 
complete native surfactant. A representative experiment is shown here 
after repeating three independent experiments with each sample.
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Finally, after the full 
experimental protocol, the 
stability of the different 
films was investigated by 
monitoring changes in surface 
tension after mechanical 
perturbations introduced 
into compressed stages. 
In Figure 2.8, surface tension 
is plotted as a function of 
the number of perturbations 
introduced into the CBS 
chamber by the pendulum 
hammer. Complete NS was 
shown to form the most stable films, following a trend that finished in a plateau of around 4 
mN/m to get a stable surface tension after more than 15 perturbations. Films of subfractions 
N2, N3 and N4 showed an analogous behaviour and plateaued at around 5-6 mN/m, generating 
stable collapsed structures after a higher number of perturbations. Since the heaviest fraction 
N5 was unable to reach comparable minimum values under dynamic cycling, it was not included 
in the evaluation of stability.  
DISCUSSION
The extracellular surfactant structures have various levels of complexity and densities 
depending on the stage of surfactant metabolism and these can be separated into subtypes with 
distinctive morphologies and characteristics but likely maintaining certain metabolic relation 
with each other (Putman, Creuwels et al. 1996). In Chapter 2, we have fractioned the lipid protein 
assemblies purified as porcine NS complexes into several subforms differing in ultrastructural 
appearance, composition and ability to reduce surface tension at air-liquid interfaces during 
Figure 2.8. Film stability against mechanical perturbations. 
Plot representing surface tension as a function of the number 
of perturbations introduced in the compressed bubble by the 
pendulum hammer.
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simulated breathing cycling. To accomplish this task we have taken advantage of a separation 
protocol based on a density gradient centrifugation similar to that originally designed by Gross 
and Narine to achieve the separation of surfactant in light, heavy and ultraheavy subforms 
(Gross and Narine 1989; Gross and Narine 1989). However, the composition and activity of the 
fractions have been only marginally characterized. The modifications we have implemented in 
our experimental 4 step-purification method have resulted in a different subfractioning of NS. 
Indeed, whereas traditional techniques directly layer alveolar lavage fluid onto a continuous 
sucrose gradient without any preliminary “cleaning up” procedure, we have subjected BAL to 
a previous low-speed centrifugation to sediment cells and then to an ultracentrifugation step 
at 100000 x g for 1 h in where we think the pelleted part is mainly constituted by the fraction 
corresponded to the heavy/ultraheavy  forms (or large agreggates) with a negligible contribution 
of light forms (or small agreggates). This conclusion is supported by the fact that for efficiently 
precipitating the small vesicular forms of surfactant, other investigators subject BAL to longer 
ultracentrifugations, around 16 h at 100000 x g  (Magoon, Wright et al. 1983; Oulton, MacDonald 
et al. 1993; Guthmann, Haupt et al. 1995; Knells, Ahmed et al. 1995). On the other hand, after 
applying the product of the first isolation onto the NaBr gradient and later onto the sucrose 
gradient , the lightest assessable layer (N2) contains material consistent with the lamellar body 
fraction. Thus, we think that our method results in a further division of different populations 
included into the ultraheavy fraction (or large aggregates). In this line, the possibility of the 
existence of additional complexity levels beyond small/large or light/heavy subfractioning has 
been previously proposed, suggesting that these portions might be intrinsically heterogeneous 
containing more than one type of structures (Pérez-Gil 2008).   
Of note, we have not observed clear evidences of tubular myelin, which presence has been 
previously shown in both heavy and ultraheavy forms (Gross and Narine 1989). However, it 
has been reported that the morphology of the heaviest fractions is particularly susceptible to 
resuspension and manipulation, resulting in the disintegration of lamellar bodies into membrane 
sheets to configure tubular myelin figures (Putman, Creuwels et al. 1996). Furthermore, the 
formation of tubular myelin has been described to be seriously affected by temperature, pH 
or the ionic environment (Gil and Reiss 1973; Williams 1977). Thus, these discrepances could 
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be attributed to a differential handling of the samples, among other subtle methodological 
variations.  
The electron microscopic observation of the NS subfractions suggests that our isolation 
method results in the separation of presumably two populations of lamellar bodies with different 
density (fractions N2 and N3) in concordance with previous findings reported by Magoon and 
collaborators (Magoon, Wright et al. 1983), which also described two fractions enriched in 
lamellar bodies (called light and dense lamellar bodies) upon surfactant subfractioning with 
sucrose gradients. Although the phospholipid composition and the proportion of PC and PG in 
the two lamellar body fractions were equiparable, the phospholipid to protein ratio, however, 
was higher in the light lamellar bodies, also consistent with Magoon’s results.   In general, the 
lipid composition of the individual subfractions showed only minor differences, althouh N4 and 
N5 contained much less proportion of PC species than N2 and N3, with concomitant functional 
consequences. 
Unlike the lighter fractions, the assignation of N4 and N5 to specific metabolic stages of the 
life cycle of surfactant results more complicated due to the absence of representative structural 
features. We suggest that they might be part of the heterogenity that other authors have 
observed in the densest fractions, describing them as large vesicles and membranous material 
(Magoon, Wright et al. 1983; Gross and Narine 1989; Putman, Creuwels et al. 1996). 
In the light of the results, we consider that differences in parameters, such as the lipid to 
cholesterol ratio or in the distribution of surfactant associated proteins, are of particular 
importance given the clear effect of these components in modulating the surface activity and 
dynamic behaviour of surfactant. Indeed,  the influence of cholesterol in both surfactant structure 
and function has been previously outlined and it has been proposed that its proportion in the 
composition of surfactant membranes is strictly regulated (Orgeig and Daniels 2001; Orgeig, 
Daniels et al. 2003; Bernardino de la Serna, Pérez-Gil et al. 2004). In fact, the modulation of 
cholesterol levels has been shown to be key in the adaptation to diverse specific situations (i.e.: 
strenuous exercise, changing body temperature) (Langman, Orgeig et al. 1996; Orgeig, Bernhard 
et al. 2007). In addition, alterations and particularly exacerbated cholesterol levels in surfactant 
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have been associated to pathological states such as acute respiratory distress syndrome (Markart, 
Ruppert et al. 2007) or idiopathic pulmonary fibrosis (Fireman, Spitzer et al. 1996), among others. 
Our data show that N4 and specially N5 contain the highest proportion of cholesterol with 
respect to the total phospholipid content and this seem to be reflected in their poor perfomance 
at the captive bubble surfactometer, demonstrating an impaired function during compression-
expansion cycling. Abnormally increased levels of cholesterol have been proved to generate 
excessively fluid membranes and subsequently an early collapse of the interfacial films due to 
a disproportionate liquefying of the L
β
 ordered phases of the lipid membranes (Bernardino de 
la Serna, Oradd et al. 2009). Thus, the compromised phase segregation of membrane domains, 
which is essential for the surfactant dynamic properties would explain the dysfunctional 
mechanical plasticity exhibited by N5.    
However and as we stated before, the decreased surfactant activity displayed by the densest 
fractions could be attributed, not only to an excess of cholesterol and a reduced content in PC 
(the most important lipid for surfactant adsorption) but also to the alteration in the pattern of 
surfactant proteins. By immunoblot, we have observed that N4 and predominantly N5 contain 
significantly less amount of functional forms of SP-B and SP-C, compared to the other fractions. 
The consequences of insufficient amount of both hydropobic proteins would explain the slower 
lipid transfer from the subphase to the interfacial film and thus, the possible lack of refinement 
during film compression resulting in an apparent inefficient re-extension of material from the 
reservoir during expansion, and the subsequent increase in the hysteresis of the dynamic cycles 
(Taneva and Keough 1994; Creuwels, Boer et al. 1995; Kramer, Wintergalen et al. 2000; Krol, Ross 
et al. 2000; Baoukina and Tieleman 2011; Olmeda, García-Álvarez et al. 2013). Strikingly, the 
subfraction N5 was shown to comprise a considerable amount of oligomerizated SP-C forming 
aggregates of high molecular weight what could be also related to the high cholesterol content. 
Indeed, a specific interaction between cholesterol and SP-C through the palmitoylated segment 
of the protein  has been previously proposed altough this feature has not been verified so far 
(Baumgart, Ospina et al. 2010; López-Rodríguez and Pérez-Gil 2014). On the other hand, SP-C 
has been described to strongly destabilize bilayers, promoting their disintegration and dispersion 
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(Parra, Moleiro et al. 2011). This could lead us to postulate that fractions N4 and particularly N5, 
might be responsible of sustaining the presence of cholesterol reservoirs in the airways. The 
mobilization of cholesterol, in and out of the most active surfactant structures, as it has been 
described in certain physiological conditions, may include transfer of cholesterol between the 
lighter and the heavier fractions revealed here. Thus, we speculate that N5 exerts an alternative 
function at modulating surfactant homeostasis, governing the transit of cholesterol from the 
membranes present in the active surfactant films to the subphase and/or vice versa, rather 
than participating in surfactant performance at the air-liquid interface. An alternative function 
for the densest fractions is also plausible taking into consideration the high accumulation of 
SP-A. However, the interpretation is complex considering that this protein has additional roles 
(defensive) beyond its potential contribution to optimize the intrinsic biophysical properties of 
pulmonary surfactant (Wright 2003). 
As expected, N2 and N3, as representative of lamellar body-enriched fractions, displayed 
a superior performance at the captive bubble surfactometer in terms of a rapid interfacial 
adsoprtion and efficient compression/expansion dynamics with virtually no hysteresis, in virtue 
of their optimized lipid and protein composition and probably due to their singular structural 
organization (Ravasio, Olmeda et al. 2010; Hobi, Siber et al. 2014). Moreover, taking into 
consideration the considerable resistance to inhibition displayed by freshly secreted LBPs from 
type II cells (see chapter 1), the assessment of the surface activity at the CBS of these fractions 
in the presence of serum or meconium would be particularly relevant to see the potential effect 
of deleterious components in close to physiological conditions. 
Considering our initial attempt of finding alternative sources of lamellar body-like particles, 
we could conclude that the present isolation technique based on the subfractioning of pre-
purified NS complexes from porcine BAL, allow us to obtain signficant amount of material with 
characteristic features highly consistent with LBPs. This method does not require extensive 
animal sacrifice and it is thus, economical and ethical-friendly, since we take advantage of pigs 
already slaughtered. We think that, in conjuction with the perceptible improved yield, it will allow 
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us to get access to new experimental methodologies that will shed light on the structural and 
functional aspects of freshly secreted surfactant which remain still obscure. However, we should 
bear in mind the possible differences between recently collected complexes released from cell 
cultures and the material that has been already exposed to the lung environment and has been 
in contact with other molecules with a potential unknown effect. Thus, further experiments will 
be needed to assess to what extent LBPs from NS are analogous to those freshly exocyted from 
type II cells in culture.            
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appendix
The experiments presented in this section were carried out at the National Center of Biotechnology 
(Madrid, Spain) in collaboration with Dr. José María Valpuesta, Dr. Javier Chichón, Dr. Rocío 
Arranz and Javier Conesa. Soft X-ray cryo-electron microscopy studies were accomplished at the 
facilities of the BESSY II synchrotron (Berlin, Germany).
155
Chapter 2: appendix
INTRODUCTION
The results revealed in Chapter 2 indicate that native surfactant purified from animal lungs, 
which has been considered so far as the best surfactant material in terms of physiological-like 
surface behaviour, is not a homogenous material and contains a variety of distinct structures 
with presumably different functions. We have analyzed the morphological features of the 
different constituents of native surfactant complexes using traditional TEM, a widely used 
technique suitable to examine ultrastructural fine details of specimens. Nevertheless, sample 
preparation for TEM is time consuming and requires laborious protocols, including fixation, 
staining, dehydration, resin embedding and sectioning of the samples. Most importantly, the 
samples might suffer structural or chemical alterations as a consequence of their processing (i.e.: 
lipid extraction result of the dehydration process), giving rise to potential artifacts. 
Around 40 years ago, the group of Glaeser pioneered cryo-electron microscopy, the imaging 
of frozen hydrated samples at low temperature, in their natural aqueous habitat (Glaeser and 
Hobbs 1975; Glaeser and Taylor 1978). Although the first images were obscured by ice crystal 
damage, the subsequent introduction of plunge freezing and cryo-transfer methods permitted 
the vitrification of the samples avoiding the generation of ice crystals (Dubochet, Adrian et al. 
1988). Indeed, cryo-fixation avoids dehydration, staining and physical sectioning allowing sample 
visualization in a closer to native state. In the present work we have visualized native surfactant 
assemblies upon cryo-electron tomography (cryo-ET), a method to image macromolecular 
complexes three-dimensionally in their native settings with the best possible structural 
preservation (Lucic, Forster et al. 2005). Furthermore, the tomographic combination of electron 
microscope images allows the reconstruction of three-dimensional structures at resolutions 
of a few nanometers (Fung, Liu et al. 1996).  However, an important limitation of the cryo-ET 
methodology is derived from the poor penetration due to the multiple scattering of electrons in 
soft materials and as a result, electron tomographic reconstruction is limited to around 0.5 µm 
thick samples (Carrascosa, Chichon et al. 2009). Bearing this in mind, we also took advantage of 
cryo soft X-ray tomography (cryo-SXT), whose penetration power permits to obtain high contrast 
images from several microns thick samples (up to 10 µm thickness) (Schneider, Guttmann et 
al. 2010). Therefore, the combination of X-ray imaging with the preservation of the samples at 
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cryogenic temperatures minimize the effect of radiation damage in biological samples (Schneider 
1998). 
In this appendix of Chapter 2 we have implemented the microscopic techniques stated above 
to analyze the different morphological entities present in native surfactant in a close to native 
state and with further structural detail. This approach has let us to get additional insight into the 
particular arrangements that pulmonary surfactant display in its multiple biological forms.               
RESULTS AND DISCUSSION
We have explored the ultrastructure of cryo-fixed whole pulmonary native surfactant (NS) 
complexes under fully hydrated conditions close to the native situation and avoiding intensive 
sample processing and so precluding the generation of potential artifacts. 
First, cryo-EM allowed us to visualize the relatively simpler material present in NS assemblies 
due to the thickness limitation of this technique. Even then, NS membranes displayed a high 
complexity level, adopting a variety of morphological arrangements (Figures AP1 and AP2). In 
general terms, the structural diversity consisted of unilamellar vesicles (Fig. AP1A), interspersed 
with oligolamellar and multillamelar structures (Fig. AP1B, C), patches with piled membranes 
(Fig. AP1E, F) and apparent fragmented membranes or filaments (Fig. AP1A, D). The unilamellar 
vesicles had variable dimensions (250-400 nm in diameter) and appeared to enclose a dense 
material. Oligolamellar and multillamelar liposomes, occasionally exhibiting aggregation signs, 
were generally larger (350-800 nm in diameter) and similarly to unilamellar vesicles, they also 
seemed to contain an amorphous material in the inner compartments. 
Additionally, areas with regularly spaced stacked membranes of around 8 nm in thickness were 
also observed (Fig. AP1F). Interestingly, separation distances from one layer to its adjacent were 
of around 30 nm, close with those previously reported for natural surfactant structures (Weibel, 
Kistler et al. 1966; Gil and Reiss 1973) and also to those described in DPPC/PG and DPPC/PI + 
SP-A mixtures (Poulain, Akiyama et al. 1999). These data slightly differ with our previous results 
shown in Chapter 2 (Figure 2.2D, page 135), where we described similar structures, although we 
used a different microscopic technique in that case. 
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Figure AP1. Ultrastructure of native pulmonary surfactant membranes as studied by cryo-electron 
microscopy.Representative projections of the morphological variability found in native surfactant 
complexes as examined with cryo-electron microscopy in close-to-native conditions. Distances among 
membrane sheets (red line) in panel F are calculated by means of a histogram. Scale bars represent 200 
nm (A, B, F), 100 nm (E) and 50 nm (C, D). 
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On the other hand, the formation of tightly apposed multilamellated structures like those 
observed in Fig. AP1E has been also experimentally reproduced by combining SP-A, SP-B, and 
DPPC/PG liposomes (Poulain, Allen et al. 1992), suggesting the probable involvement of these 
proteins in the generation of these particular arrangements. In fact, previous results evidence 
that SP-B promotes the creation of highly cohesive multillamelar structures, which might be 
related to the high resistance that pulmonary surfactant exhibits under mechanical perturbations 
(Bernardino de la Serna, Vargas et al. 2013).  Figure AP2A shows large membranous sheets with 
interllamelar swapping, probably due to the SP-B action to establish membrane-membrane 
contacts. 
Figure AP2. Cryo-electron tomography of native surfactant complexes. Tomographic 
slices (left) and volumetric reconstructions (right) from different tomograms (A-C) 
providing with a 3-D view of the structural features characteristic of native surfactant 
assemblies. Scale bars in all images represent 100 nm.
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Moreover, the tomographic reconstructions provide an exceptional insight on additional 
structural features hardly noticeable at the 2-D projections. Figures AP2B and AP2C unveil 
the existence of disk-shaped structures with apparent folded membranes or invaginations, 
occasionally interconnected at some points between them. In this regard, SP-B has been 
previously shown to promote formation of small membrane disks of 50-70 nm from disrupted 
liposomes (Poulain, Allen et al. 1992). The dimensions reported by Poulain and collaborators do 
not coincide with those observed in our samples, although this could be explained considering 
that the lipid composition that they used in their experiments was a simplified version of the 
complex compositional heterogeneity present in native surfactant. Of note, the inner membranes 
present in the disks display marked kinks as well as discernible boundaries, strongly suggesting 
the presence of protein imposing these particular arrangements or the occurrence of lipids with 
capabilities to generate highly curved geometrical constraints. 
As stated before, some structures of higher complexity and size present in the native surfactant 
samples were beyond of the power resolution of cryo-EM. To overcome this restriction, we 
implemented the technique of cryo-soft X-ray tomography at the BESSY synchrotron radiation source 
(Berlin, Germany). To our knowledge, this is the first time that native surfactant complexes have 
been examined by means of this approach. Importantly, we were able to directly image structures 
consistent with lamellar body-like particles (LBPs) in a fully hydrated environment (Figure AP3), 
Figure AP3. Cryo soft X-ray tomography of native surfactant complexes. Representative 
tomographic slices (A, B) of the morphological heterogeneity present in native surfactant complexes 
as documented by cryo soft X-rays microscopy at a synchrotron radiation source. Scale bars represent 
1 µm.
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which maintains the original shape and structure of these membrane assemblies, among other 
membranous organizations including large (around 2 µm) and small (100-700 nm) unilamellar 
vesicles. A small fraction of intact LBPs of 1-2 µm diameter was detected, whereas most of 
these structures appeared partially disrupted or already unravelled. In fact, LBPs were found 
exhibiting a variety of morphological arrangements and packing states, allowing us to sketch 
the different steps of their gradual unravelling process (Figure AP4). Of note, a sort of pore was 
clearly discerned close to the outer layers of LBPs (Fig. AP4AB, C, D), in consistence with our 
previous results shown in Chapter 1 with Laurdan-stained intracellular lamellar-bodies (see page 
115). We have already postulated the presence of a protein-based gate-like machinery present 
in these areas, in charge of controlling the opening and spreading of the surfactant membranes. 
We speculate that this “protein complex” would act as a pressure-sensitive valve, which after 
contacting with the air-water interface, could undergo a conformational change, which could 
permit the opening of the structure (Fig. AP4 B) leading to the ejection of the internal membranes 
at a first moment, as insinuated in Fig. AP4 C and D. In view of this, we presume that membrane 
propelling takes place “from inside to outside” in the LBPs, since the inner layers seem to be first 
expelled, whereas the outer layers appear intact.          
The next steps in the unravelling process would consist on a progressive rupture and unpacking 
of the LBP (Fig. AP4 E), giving rise to lace-shaped forms (Fig. AP4 F) and finally to interconnected 
membrane sheets with lower organization levels (Fig. AP4 G). In the native environment, this 
would derivate either into the formation of the surface film and/or other interrelated structures 
like tubular myelin or the surface-associated multilayered reservoirs.  
On the other hand, the possibility of cryo-soft X ray tomography to build tridimensional 
reconstructions allowed us to get further insight into the LBP structure (Figure AP5). Fig. AP5B, 
C and D show the volumetric representation of the diverse packing areas of a partially 
unravelled LBP, from different perspectives. Indeed, part of the examined LBP was shown 
to be still compact and dense at some areas, whereas in others it seemed to be unpacked 
generating long membranous projections as well as small loops (Fig. AP5E). Interestingly, those 
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internal membranes in contact with the “opening area” of the LBP adopted a remarkable curled 
morphology (Fig. AP5E, red colored in inset) with multiple membrane-membrane contacts, 
which might be promoted by SP-B (Bernardino de la Serna, Vargas et al. 2013). We conjecture 
that this could be effect of a modified state of mechanical tension, once the internal pressure is 
relaxed after the opening of the structure. 
Figure AP4. Unpacking of lamellar body-like particles. Tomographic slices showing different lamellar 
body-like particles throughout their gradual process of unravelling, from a highly packed state to a 
network of disorganized membranes, as examined under cryo soft X-ray microscopy. Scale bars 
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In conclusion, we have examined the morphology of NS complexes as purified from BAL under 
close to native conditions, maximizing their physical preservation and so circumventing potential 
artifacts, by means of cryo-fixation. In spite of the fact that electron tomography has been 
already implemented by other authors to observe A549 cells and to generate 3D visualizations 
of lung multivesicular bodies (Mayhew, Muhlfeld et al. 2009), the higher power penetration of 
soft X-rays is crucial to resolve complex structural organizations, such as those displayed by LBPs. 
Despite being a high-end approach, which requires sophisticated instrumentation and a high 
level of expertise, the potential of this technique has been proven to be enormous, allowing 
us to obtain unprecedented images and 3D renderizations and subsequently qualitative and 
quantitative information useful for the interpretation of the various biological forms in which 
lung surfactant occurs.
Figure AP5. Tridimensional modeling of a partially unravelled lamellar body-like particle. 
 A. 2D soft X-ray cryo projection of a LBP in the process of unravelling. Scale bar represents 500 
nm. B, C. 3D volumetric representation of the tomogram from different spatial orientations. 
D. Tomographic slice and segmentation (inset). Note that the membranes display a distinct 
curled shape (red) in the area close to the opening, by which internal membranes might be 
ejected through. E, F. Tomographic slice (E) and reconstructed volume (F) showing an area 
where the membranous sheets from the LBP exhibit an unpacked and disorganized state.
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Part of the experiments presented in this chapter were performed at the Research 
Institute of 12 de Octubre Hospital and at Medical Innsbrück University (Austria) in 
collaboration with Prof. Dr. Thomas Haller, and published in the following article:
Cerrada A, de la Torre P, Grande J, Haller T, Flores AI, et al. (2014) Human Decidua-
Derived Mesenchymal Stem Cells Differentiate into Functional Alveolar Type II-Like Cells 
that Synthesize and Secrete Pulmonary Surfactant Complexes. PLoS ONE 9(10): e110195.
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INTRODUCTION
Preceding chapters have discussed the singular features presented by lung surfactant when 
is intracellularly stored and subsequently exocyted in the form of lamellar bodies by cultures 
of primary alveolar type II (ATII) cells, as well as the relevance of this process. Indeed, much 
research has been carried out to study pulmonary surfactant biogenesis and secretion in primary 
cultures of isolated ATII cells purified mainly from mammalian lungs. However, this methodology 
is laborious, expensive, animal  demanding and  the yield of cells is low (Jennings, Bertocchi et 
al. 2005).  Therefore, it does not necessarily conform with the 3-R principle of refining, reducing 
and replacing animal testing as defined by the Basler declaration (http://www.basel-declaration.
org/). In addition, isolated primary ATII cells in culture rapidly lose their original phenotypical 
features differentiating into type I-like cells and failing to proliferate, precluding their use for 
long term studies (Dobbs, Williams et al. 1985; Mason, Lewis et al. 2002). On the other hand, 
commercially available cell lines such as the adult rat pulmonary epithelial cell line L2 or the 
adenocarcinomic human alveolar basal epithelial cells A549 are inherently problematic.  Their 
origin and state of differentiation are poorly defined, and no study exists to unambiguously 
demonstrate that these cell lines release functionally active surfactant components after 
physiological stimulations. Alternatively, immortal cells isolated from transgenic mouse models 
(H-2Kb-tsA58) circumvent the problem of short-term culture to a certain extent, but are still 
depending on the use of laboratory animals. In consequence, surfactant-producing pneumocyte-
like cell lines are not well established yet, preventing a proper and exhaustive characterization 
of biosynthetic and trafficking pathways involved in surfactant biogenesis. In this context, it is 
mandatory the search of new strategies to obtain in vitro ATII cells. 
In recent years, stem cells have been extensively investigated as a potential source of alveolar 
epithelial cells (Wong and Rossant 2013). Murine (Siti-Ismail, Samadikuchaksaraei et al. 2012; Ali, 
Edgar et al. 2002; Rippon, Polak et al. 2006; Samadikuchaksaraei and Bishop 2006; Van Vranken, 
Rippon et al. 2007; Winkler, Mauritz et al. 2008; Roszell, Mondrinos et al. 2009; Schmeckebier, 
Mauritz et al. 2013) and human (Samadikuchaksaraei, Cohen et al. 2006; Van Vranken, Rippon 
et al. 2007; Wang, Haviland et al. 2007) embryonic stem cells,  adult bone marrow-derived 
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mesenchymal stem cells (MSCs) from rat (Knoll, Brockmeyer et al. 2013) and human (Wang, 
Bunnell et al. 2005; Ma, Gai et al. 2011), as well as MSCs obtained  from amniotic fluid (Carraro, 
Perin et al. 2008), amnion (Moodley, Ilancheran et al. 2010) or umbilical cord blood (Berger, 
Adams et al. 2006) have been differentiated into cells with phenotypical features consistent with 
ATII cells.  
A population of MSCs isolated from human extraembryonic membranes by the group of Flores 
(Macías, Grande et al. 2010) and termed Decidua-derived Mesenchymal Stem Cells (DMSCs) 
have the capacity to differentiate into cells that have remarkable similarities with alveolar type 
II cells. In fact, human placenta, besides playing a fundamental role during fetal development, 
feto-maternal tolerance and nutrition, it is also an important reservoir of stem cells (Matikainen 
and Laine 2005; Parolini, Alviano et al. 2008).  Placental tissue exhibits certain advantages 
as a source of stem cells including MSCs, such as  easy isolation of cells without any invasive 
procedures, absence of viral infection and  nonexistence of ethical problems (Hemberger, Yang 
et al. 2008; Marcus and Woodbury 2008). The extraembryonic membranes of human placenta 
are composed of fetal (amniotic and chorionic structures) and maternal tissues (decidua) (Pipino, 
Shangaris et al. 2013).  DMSCs belong to the maternal part of the placental membranes, i.e., the 
decidua, and display high plasticity and high differentiation capacity into derivatives of all germ 
layers (Hemberger, Yang et al. 2008; Macías, Grande et al. 2010; Bornstein, Macías et al. 2012). 
Mesodermal (chondrogenic, osteogenic, myogenic and cardiogenic), ectodermal (neurogenic) 
and endodermal (lung epithelial cells) differentiation of DMSCs was demonstrated by evaluation 
of specific markers for each cell lineage. Indeed, this multipotent behaviour is explained by the 
fact that DMSCs express OCT-4 and REX-1, two transcription factors associated to pluripotency 
of embryonic stem cells. In addition, DMSCs express GATA-4, a transcription factor involved 
in organogenesis and in mesodermal and endodermal differentiation during embryogenesis. 
Interestingly, DMSCs have a limited life span and their expansion capacity decrease with time and 
at around a median of 20 passages cells stop dividing, precluding an aptitude for spontaneous 
transformation. This feature has been also confirmed by studying telomerase activity, which 
levels were low compared to a positive control and were undetected beyond passage 10. The 
limited proliferation capacity of DMSCs, the genomic stability after proliferation in culture and 
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the low and limited telomerase activity suggest that DMSCs are safe cells and will not produce 
tumors after transplantation. Additionally, DMSCs can be cryopreserved in liquid nitrogen 
for long periods of time while maintaining their original phenotype, exponential growth and 
differentiation characteristics suggesting that DMSCs could be stored in cell banks as an “off-the-
shelf” treatment based on expanded DMSCs and ready to be used for cell therapies.  
In the present chapter, the differentiation of DMSCs into Alveolar Type II-Like Cells (ATII-LCs) 
has characterized in depth. We evaluated the capability of ATII-LCs to express genes encoding 
lung specific markers and whether those genes are translated into proteins. In addition we 
assessed the ability of ATII-LCs to generate surfactant-like assemblies, to accumulate them 
in specialized storage organelles and to secrete them upon a proper stimulation. Finally, we 
analyzed the biophysical properties of the secreted material and whether this secreted material 
has functional properties as a surface active agent. Our results suggest that the ATII-LCs could be 
a novel and very promising cell model to study intrinsic ATII characteristics and functions.
RESULTS
Morphological features of ATII-LCs
DMSCs are a homogeneous population of fibroblast-like cells with spindle-like shape and 
similar morphological characteristics to bone marrow MSCs (Figure 3.1A). After 1-2 days of 
culture in pulmonary differentiation medium, few differences could be observed although 
some areas started to undergo slight morphological modifications (Fig. 3.1B-C). However, after 
3-4 days in differentiation media, the morphological changes were apparent such as a more 
epithelioid shape (Fig. 3.1D-F) and the presence of light-dense cytoplasmic granules (Fig. 3.1F, 
arrows). The morphology of these dense particles in the cytoplasm of ATII-LCs was examined by 
transmission electron microscopy, revealing ellipsoid and circular membranous structures with 
multiple, variably densely packed concentric lamellae (Figure 3.2). These structures resemble 
the complex internal organization of the phospholipid-rich surfactant stores (lamellar bodies) 
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in ATII cells, and are similar in morphology 
to the lamellar body-like granules obtained 
from bronchoalveolar lavage and observed 
under the same conditions (Ravasio, 
Olmeda et al. 2010). In addition, ATII-LCs 
exhibited at the culture-exposed cell side the 
presence of structures with the appearance 
of incipient microvilli (Fig. 3.2A), suggesting 
that the cells might be initiating a polarized 
morphological differentiation.
The differentiation of DMSCs to ATII-
LCs showed high reproducibility. Several 
different placentas have been used 
and all of them differentiated into ATII-
Figure 3.1. Morphology of DMSCs and ATII-LCs. Phase contrast images visualizing morphological changes 
of DMSCs during differentiation into ATII-LCs. A. Undifferentiated DMSCs showing a smooth and fibroblast-
like morphology. B-C. Differentiated ATII-LCs after 1 (B) or 2 (C) days of incubation in differentiation 
medium, exhibiting scarce morphological changes with respect to the undifferentiated state. D-F. Images 
corresponding to ATII-LCs after 3 (D) or 4 (E, F) differentiation days displaying a more flattened shape and 
a highly granulated cytoplasm. F. Magnified view of 4 days differentiated-ATII-LCs containing groups of 
highly-refractive cytoplasmic particles (arrows). Scale bars in A-E correspond to 100 µm and in F to 50 µm.
Figure 3.2. Ultrastructure of ATII-LCsTransmission 
electron micrographs of differentiated ATII-
LCs. A. Presence of numerous electron-dense 
cytoplasmic organelles and cell surface associated 
structures, probably microvilli. (x20,000; scale bar 
= 200 nm). B. Membranous structures containing 
multiple concentric lamellae (left) and one 
partially unraveled fragmented lamellar body-like 
complex (right), displaying numerous unpacked 
membranes (x 120,000; scale bar = 50 nm) C-E. 
Individual membranous structures with ellipsoid 
(C) or circular (D, E) shapes and a multilamellar 
ultrastructure (x 40000, scale bar = 200 nm). 
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LCs. Examination under the microscope revealed that in all cases near 100 % of cells in the 
tissue culture plate developed the intracellular dense particles associated with lamellar body 
biogenesis, indicating a very high differentiation yield.
Synthesis of surfactant lipids 
We then explored whether the morphological differentiation of DMSCs into ATII-LCs, with the 
assembly of apparently lamellar body-like structures, could be associated with activation of the 
synthesis of genuine surfactant phospholipid species, i.e. with the accumulation of disaturated 
phospholipids, and particularly of dipalmitoylphosphatidylcholine (DPPC). Table 3.1.A 
summarizes the data of the lipidomic analysis obtained by mass spectrometry, of the whole PC 
(phosphatidylcholine) fraction from full membranes obtained from the different pelleted cells. 
For the complet set of data regarding the content in single PC molecular species, see Table 3.1.B. 
Membranes from non-differentiated DMSCs contained 17.6 % of PC disaturated species, and 
only around 10 % of PC was DPPC. However, upon differentiation, ATII-LCs apparently doubled 
their content up to 35 % of disaturated PC species, with more than 25 % being DPPC. Although 
the small number of samples analyzed precludes a proper statistical analysis of differences, these 
results showed that the content in total disaturated PCs and DPPC of differentiated ATII-LCs was 
similar to that determined for a cell population enriched in true type II pneumocytes, as purified 
from lung tissue.
Gene expression of alveolar epithelial markers
We investigated by end-point PCR in ATII-LCs whether the effect of the pulmonary differentiation 
media led to the expression of specific genes indicative of lung development and related to 
pulmonary surfactant (Figure 3.3).  The data shows that ATII-LCs express FOXA1, FOXA2 and TTF1 
mRNAs, which are known to be involved in specification of endoderm. GPR116, which plays an 
essential role in the regulation of lung surfactant homeostasis was also expressed in ATII-LCs, as 
well as CTFR, a gene implicated in epithelial fluid transport in the lung. Aspartyl proteases Napsin 
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Table 3.1. A. Fraction of saturated phosphatidylcholines in undifferentiated (DMSCs) and 
differentiated (ATII-LCs) decidua-derived mesenchimal cells in comparison with primary ATII 
pneumocytes 
  Cell types  
 DMSCs (n=2) ATII-LCs 
(n=3) 
ATII 
% DPPC 10,2 ± 2,8 25,4 ± 9,3 26,4 
% PC disat. 17,6 ± 3,6 35,5 ± 12,3 40,3 
mean values ± s.d. have been calculated with respect to total PC 
B. Total fraction of phosphatidylcholine molecular species in undifferentiated (DMSCs) and 
differentiated (ATII-LCs) decidua-derived mesenchimal cells in comparison with primary ATII 
pneumocytes 
 Cell types 
 PC* 
molecular 
species 
DMSCs  
(n=2) ATII-LCs (n=3) 
               ATII 
              (n=1) 
28:0-PC 0.5 ± 0.01  0.2 ± 0.1 0.5   
30:0-PC 5.0 ± 0.4  6.8 ± 2.7 10.5   
30:1-PC 1.6 ± 0.2  0.5 ± 0.1 1.1   
32:0-PC 10.2 ± 2.8  25.4 ± 9.3 26.4   
32:1-PC 13.7 ± 0.5  10.0 ± 0.9 16.3   
32:2-PC 2.7 ± 0.3  0.8 ± 0.2 2.2   
34:0-PC 1.8 ± 0.4  3.1 ± 0.3 2.8   
34:1-PC 21.8 ± 0.3  23.0 ± 3.1 9.9   
34:2-PC 11.1 ± 1.3  5.6 ± 1.2 8.8   
34:3-PC 1.1 ± 0.1  0.4 ± 0.1 1.5   
34:4-PC 0.1 ± 0.01  - 0.4   
36:0-PC -  - 0.1   
36:1-PC 5.8 ± 0.1  7.0 ± 2.5 0.5   
36:2-PC 16.0 ± 0.4  9.6 ± 3.9 2.3   
36:3-PC -  1.4 ± 0.4 2.0   
36:4-PC 1.1 ± 0.1  0.9 ± 0.2 7.4   
36:5-PC 0.3 ± 0.02  0.2 ± 0.1 0.8   
38:2-PC 1.2 ± 0.1  0.6 ± 0.4 0.1   
38:3-PC 1.8 ± 0.1  1.1 ± 0.8 0.6   
38:4-PC 1.0 ± 0.1  1.0 ± 0.4 2.6   
38:5-PC 1.3 ± 0.1  1.1 ± 0.5 1.0   
38:6-PC 0.6 ± 0.1  0.5 ± 0.1 1.2   
40:5-PC 0.6 ± 0.1  0.4 ± 0.3 0.3   
40:6-PC 0.4 ± 0.1  0.2 ± 0.2 0.1   
40:6-PC 0.2 ± 0.01  0.2 ± 0.1 0.3   
*The different molecular species are identified as n:m-PC, where n is the total number of 
carbons of the sn-1 and sn-2 acyl chains, and m, the total number of double bonds mean 
values ±  s.d. have been calculated as percent fraction with respect to total PC 
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A and Cathepsin H, which participate in the proteolytic processing of surfactant proteins were 
expressed in differentiated cells as well. The expression of genes encoding surfactant proteins A, 
B, C and D and ABCA3 was distinctively found in ATII-LCs, at different time points. Surprisingly, 
all these genes were also detected in undifferentiated DMSCs, although the differentiation 
treatment resulted in an up-regulation of these genes according to the band densities. 
Quantitative time-course of surfactant-related gene expression 
To evaluate whether the expression of surfactant-related genes is regulated throughout 
differentiation, we assessed the presence of specific mRNAs in DMSCs and in ATII-LCs after 
various incubation times in the differentiation medium (24, 48 and 96 h) by real-time PCR 
(Figure 3.4). SP-A mRNA levels were found to be 4-fold significantly increased (p<0.001) with 
respect to the gene expression level of DMSCs, at 96 h of differentiation. Similarly, SP-C mRNA 
Figure 3.3. Gene expression of surfactant and lung development markers in ATII-LCs. Specific markers of 
pulmonary surfactant function and maturation examined by endpoint reverse transcription PCR (RT-PCR). 
Expression of genes encoding surfactant proteins A, B, C and D as well as ABCA3 was analyzed in DMSCs 
and ATII-LCs after 24, 48 or 96 h of differentiation. mRNAs codifying Thyroid transcription factor 1 (TTF1), 
Forkhead box protein A1 and A2 (FOXA1 and FOXA2, respectively), Cathepsin H, Napsin A, G-protein 
coupled receptor 116 (GPR116) and Cystic fibrosis transmembrane conductance regulator (CFTR) were 
evaluated at maximum point of differentiation (96 h). Glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) expression was used as loading control of complementary DNA. Left lane represents the RT 
control (RT-).
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expression showed a marked increase during differentiation, reaching levels of 7-fold induction at 
96 h (p<0.001). However, the maximum increase in the level of gene expression for the proteins 
SP-B (p<0.05) and SP-D (p<0.001) took place at the beginning of differentiation, reaching values 
around 3-fold of induction at 24 h. The expression of these two genes decreased at 48 h and this 
level was maintained until 96 h. 
We also examined the gene expression pattern of the surfactant lipid importer ABCA3, which 
plays a critical role in the biogenesis of surfactant complexes in ATII cells. ABCA3 gene expression 
level was 3-fold (p<0.001) increased from 24h to 96 h of PLC differentiation.  
Expression of surfactant proteins
To determine whether ATII-LCs also synthesize, process and secrete surfactant proteins into 
the extracellular medium, the expression of these proteins was evaluated by western blot in both, 
DMSCs and ATII-LCs after 4-days in differentiation media, as well as in their respective incubation 
media (Figure 3.5). Enhanced levels of surfactant proteins SP-A, SP-B and SP-C were observed 
in ATII-LCs compared to DMSCs. Increased expression of dimeric (≈72 kDa), and particularly 
multimeric forms of SP-A (>150 kDa) can be discerned in ATII-LCs, likely as a consequence of only 
Figure 3.4. Time-course expression of pulmonary surfactant-related genes during ATII-LC differentiation. 
Gene expression of surfactant proteins SP-A to SP-D and the lipid transporter ABCA3 during differentiation 
of DMSCs as determined by quantitative real-time PCR. Values are expressed as means (N=5) of fold 
induction with respect to mRNA levels in DMSCs. Human adult lung was used as a calibration control. The 
results were normalized to TBP values used as a housekeeping gene and represented as mean ± standard 
deviation. * p<0.05), ** p<0.01, *** p<0.001.
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partial reduction of disulfides in the proteins 
embedded into the large secreted lipid-protein 
complexes. Presence of monomeric (≈ 8.7 kDa) 
and dimeric (≈ 17.4 kDa) forms of SP-B as well 
as monomeric (≈ 3.7 kDa) forms of SP-C are also 
more noticeable in the case of differentiated 
cells. Protein bands corresponding to molecular 
weights compatible with the presence of 
precursors of SP-B (proSP-B, ≈ 43 kDa) and 
SP-C (proSP-C, ≈21 kDa) as well as other 
intermediaries can be also distinguishable. 
Expression of SP-D was barely detectable. 
Presence of the mature forms of these proteins 
was also evident in the culture medium of ATII-
LCs compared to DMSCs, suggesting that ATII-
LCs were metabolically active and secreted 
these proteins. Basal expression of all the 
surfactant proteins was noticed in DMSCs, 
particularly in the case of SP-A and SP-C.
Surfactant exocytosis
Since regulated secretion of lung surfactant is 
considered to be the most important functional 
characteristic of ATII cells, we aimed to explore 
the ability of ATII-LCs to exocytose their surfactant-like stores after stimulation. For this purpose, 
we used a method previously described to monitor the exocytotic activity of primary cultures of 
ATII cells, taking advantage of the special properties of the fluorescent probes LTG and FM 1-43. 
LTG permeates through the plasma membrane and accumulates into acidic compartments such 
Figure 3.5. Pulmonary surfactant proteins 
in ATII-LC cultures. Western blots of 
pulmonary surfactant proteins (SP-A to 
SP-D) in DMSCs and ATII-LCs as well as the 
secreted proteins in the respective cell 
culture supernatants. The figure compares 
representative western blots (N=3) after 
loading equivalent amounts of total 
protein, using α-tubulin expression as a 
loading control. (C = control DMSCs; D = 
differentiated ATII-LCs).
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as surfactant-accumulating lamellar bodies and lysosomes. Thus, LTG was visualized as bright 
green fluorescence not only in ATII-LCs but also in DMSCs (Figure 3.6). We stained cells with LTG 
to firstly demonstrate the presence of acidic compartments, secondly to visualize the cells and 
to get the LBs in the focal plane, and lastly to make sure that always approximately the same 
amount of LTG-positive vesicles and cells are in the respective field of measurement. The cells 
were then stimulated with ATP (100 μM) and PMA (100 nM) which are secretagogues in native 
ATII cells. At this point, FM 1-43, a membrane-impermeable dye that has no fluorescence in 
Figure 3.6. Secretion of pulmonary surfactant-like complexes by ATII-LCs. Confocal microscopy of DMSCs 
(A) and ATII-LCs (B, C) during stimulated exocytosis. Images are z-stack projections of multiple focal planes. 
Non stimulated DMSCs or ATII-LCs were preincubated with LTG, showing green fluorescence originating 
from acidic compartments (e.g. lysosomes, late endosomes and Lamellar Bodies). Yellow fluorescence 
denotes FM 1-43 fluorescence, a lipid sensing probe.  FM 1-43 was added to the cultures together with 
the secretagoges ATP and PMA immediately after time 0. Upon fusion of lipid-charged vesicles with 
the plasma membrane, bright yellow fluorescence resulted from FM1-43 incorporation into secreted 
surfactant-like complexes.  (C) Representative images of single confocal sections evidencing a high amount 
of secreted lipid assemblies associated to some ATII-LCs. Images were slightly corrected for a small loss in 
LTG fluorescence due to photobleaching. (Scale bar= 10 μm).
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aqueous solution but exhibits fluorescence once intercalated into lipid membranes, was added 
to the cells. FM 1-43 enters through the fusion pore of the exocytosed vesicles, staining their lipid 
content and thus emitting a conspicuous yellow fluorescence. Stimulation of ATII-LCs cultures 
resulted in a progressive appearance of secreted lipid material visualized as bright yellow spots 
forming clusters at the periphery of the cells. In contrast, DMSCs were practically unresponsive 
to secretagogues. As a negative control, non-stimulated cells incubated in the presence of FM1-
43 but in the absence of secretagogues showed no fluorescent response.
To further investigate the ultrastructural features of the lipid complexes secreted by the ATII-
LCs, exocytosed material harvested from the extracellular medium was examined by transmission 
electron microscopy (TEM) (Figure 3.7). We discerned the presence of partially disorganized 
lamellar particles (Fig. 3.7B and C), as well as apparently unraveled lipid membranes. These 
membranes frequently showed the presence of defined structures, with marked kinks at 
some areas, suggesting the presence of membrane-associated proteins imposing significant 
perturbations (Fig.  3.7A, D and E). In the case of DMSCs, the scarce amount of secreted material 
harvested upon stimulation made impossible its structural examination.
Additionally, secreted material by ATII-LCs was studied in a close-to-native state taking 
advantage of cryo-electron microscopy (Figure 3.8). The polymorphic appearance of this material 
was also confirmed with this technique, with a variety of winding membranous structures with 
manifest twists (Fig. 3.8A, B), multillamelar vesicles with piled membranes (Fig.3. 8C) as well 
as intact and disrupted liposomes with a dense material inside (Fig. 3.8F-H). Interestingly, the 
external part of some vesicles seemed to be covered by proteins stablishing contacts between 
adyacent membranes (Fig. 3.8D, E). Occasionally, rounded liposomes could be discerned 
containing protein-like filaments (Fig.3. 8H), although is most cases, the content of these vesicles 
remained undefined.  
Finally, ultrastructural analysis of the secreted material from ATII-LCs by using cryo-x-ray 
tomography (Figure 3.9) allowed us to visualize diverse unilamellar and multilamellar vesicles 
as well as multivesicular bodies of varied sizes, from one to several microns, enclosing in some 
cases a dense material (Fig. 3.9 A,B,D). Occasionally, the vesicles appeared partially disrupted 
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and the content seemed to be already released (Fig. 3.9B, white arrow). Worth mentioning is 
the fact that a type of sharp opening could be discerned in some liposomes (Fig. 3.9A, B; black 
arrows).
Figure 3.7. Ultrastructure of membrane complexes secreted by ATII-
LCs. Transmission electron micrographs show harvested membranous 
complexes exocytosed by ATII-LCs upon stimulation with secretagoges 
for 6 h at 37°C. A, D. Multiple lipid membranes with numerous kinks 
constituting intricate structures possibly due to the presence of mem-
brane-associated proteins. B, C, E. Membranous assemblies with some 
highly electron-dense areas, resembling the appearance of secreted 
and partially unraveled lamellar body-like particles. (Scale bars corres-
pond to 1.000 nm in A and B, to 500 nm in C and D and 200 nm in E).
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Figure 3.8. Ultrastructural analysis of secreted material from ATII-LCs in a hydrated state. Cryo-electron 
micrographs of the membranous assemblies exocyted by differentiated ATII-LCs processed without 
any chemical fixation. A, B. Heterogeneous lipid membranes adopting twisted morphologies probably 
modulated by protein components. C-E. Multillamelar lipid complexes exhibiting particulate structures in 
the outer layer contacting adjacent membranes. F-H. Intact (F) or partially disrupted (G) liposomes with a 
diffuse electrondense core or enclosing numerous filaments (H). (Scale bars correspond to 100 nm in A, 
E-G and to 50 nm in B-D and H). 
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Figure 3.9. Lipid complexes exocyted by ATII-LCs examined under cryo-x-ray tomography. Cryo-x-ray 
tomographic sections of secreted material by differentiated cells state obtained taking advantage of an 
energy synchrotron source. Polymorphic unilamellar and multilamellar vesicles of various sizes without 
apparent internal content as well as containing a dense material inside or already released (white arrow 
in B) can be distinguished. A spiky opening can be noticed in some liposomes (black arrows in A and B), 
indicative of areas of evagination or disrupture. Occasionally, micron sized-multivesicular bodies (4-5 µm) 
containing internal vesicles were observed (D). (Scale bars represent 1000 nm in A and B and 500 nm in 
C-F).
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Biophysical activity of secreted surfactant-like material 
 One of the most important properties of a functional surfactant is its capability to adsorb 
and accumulate rapidly and efficiently at the air-liquid interface, in order to form surface active 
films. To evaluate the interfacial adsorption properties of the material secreted by ATII-LCs, we 
have used a method developed in our laboratory that measures the kinetics of accumulation 
of surfactant at the interface and the resistance of the formed surface films and associated 
structures against mechanical agitation (Ravasio, Cruz et al. 2008). Surfactant-like complexes 
exocytosed by ATII-LCs displayed a rapid adsorption into the air-water interface. This adsorption 
was even faster than that of natural surfactant purified from bronchoalveolar lavages (BAL), 
which is typically used as standard material and a reference for optimal surfactant function. 
The scarce secreted material from stimulated DMSCs showed almost no adsorption properties, 
displaying a negligible accumulation at the interface (Figure 3.10A). 
Figure 3.10.   Interfacial adsorption properties of pulmonary surfactant-like complexes secreted by ATII-
LCs. A. Comparison of surface adsorption properties of surfactant-like assemblies secreted by stimulated 
ATII-LCs (open circles) or secreted material by DMSCs (closed triangles) with respect to native surfactant 
purified from BAL (closed circles). Formation of a stably surface-associated lipid film is monitored by 
collecting BODIPY-fluorescence from the top of 96-wells during constant orbital shaking as described in 
detail in (38). Values of fluorescence were corrected for background (basal fluorescence prior to injection of 
labeled samples) and plotted as the mean of 5 experiments (N=5) ± standard deviation. B. Dose-dependent 
inhibitory effect of human serum proteins on the adsorption kinetics of Native Surfactant (NS, left panel) 
or material secreted from ATII-LCs (SM, right panel)  Serum protein concentrations were 0 (), 1 (), 5 
() 10 () and 50 ()  µg/ml.  Insert. Fluorescence values taken after 60 min of adsorption of SM from 
ATII-LCs (open circles) or of NS (closed circles) as a function of serum protein concentration. Adsorption 
efficacy in terms of amount of adsorbed material into the surface was significantly (p<0.05) higher in the 
case of SM than in NS at elevated serum concentrations (*). (RFU – bg = Background-substracted relative 
fluorescent units).
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Lung surfactant is, under some circumstances, susceptible to inhibition by substances such us 
serum proteins, for example, leaking from the blood into the airspaces in cases of a breakdown of 
the alveolar-capillary barrier function during e.g. high altitude pulmonary edema formation. We 
have compared the inhibitory effect of serum on the adsorption rate of both natural surfactant 
purified from BAL and material secreted by ATII-LCs (Fig. 3.10B). Surfactant-like material secreted 
by ATII-LCs showed a noticeable resistance to serum inhibition, displaying significantly better 
adsorption kinetics than native surfactant membranes, which was particularly evident in the 
presence of the highest concentrations of serum (p<0.05) (Fig. 3.10B).  
DISCUSSION
The present lack of suitable in vitro models to provide an easier and simplified way to understand 
key biological mechanisms in lung alveolar cells necessarily claims for the development of new 
strategies.  In this context, we have taken advantage of a population of adult mesenchymal 
stem cells isolated from the maternal portion of human extraembryonic membranes (Decidua-
derived Mesenchymal Stem Cells, DMSCs) capable to differentiate into derivatives of all germ 
layers, including ATII-like cells (Macías, Grande et al. 2010). The present work demonstrates that 
placenta-derived Alveolar Type II-Like Cells (ATII-LCs) not only differentiate towards an ATII cell-
like phenotype but develop into truly functional units with the potential of expressing lung and 
surfactant-related genes and proteins, and with the capability of producing, storing and secreting 
highly surface-active, lipid-based assemblies into the extracellular fluid, thereby mimicking the 
exocytotic behavior of native ATII cells (Pérez-Gil and Weaver 2010). 
Examination of ATII-LCs by light and transmission electron microscopy reveals that the cell 
morphology is consistent with the ATII cell phenotype, including characteristic lamellar body-
like structures analogous to those observed in material obtained from bronchoalveolar lavage 
(Ravasio, Olmeda et al. 2010), and a cell shape suggesting incipient formation of microvilli in 
contact with the aqueous phase. 
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On the other hand, ATII-LCs overexpress mRNAs encoding surfactant proteins A-D and ABCA3 
in response to the differentiation signals. Noticeably, mRNA levels of SP-B and SP-D, were 
upregulated at the onset of the differentiation process, (early expression genes) whereas mRNA 
levels of the late expression genes SP-A and SP-C were increased later (late expression genes). 
The biological relevance of this distinct expression pattern is unclear but will be explored in future 
studies. Previous studies reported an earlier expression in human fetuses of the SP-B and SP-C 
genes preceding the expression of SP-A, suggesting that during lung development, hydrophobic 
surfactant proteins SP-B and SP-C are independently regulated of the hydrophilic protein SP-A 
(Mendelson and Boggaram 1990; Mendelson and Boggaram 1991; Pryhuber, Hull et al. 1991). 
It has been reported that the expression of mRNAs encoding surfactant proteins and ABCA3 is 
collectively regulated by a number of transcription factors like the thyroid transcription factor-1 
(TTF-1) and the Forkhead ortholog a1 and a2 (FOXA1 and FOXA2) (Bohinski, Di Lauro et al. 1994; 
Wan, Xu et al. 2004). Importantly, we found expression of the genes encoding these characteristic 
markers for endodermal development, the germ layer which gives rise to alveolar epithelium. 
TTF-1 has been described to be expressed in the respiratory epithelium of the rat, appearing 
not only in fetal lung buds of the embryonic rat lung being essential for lung development and 
differentiation (Ikeda, Clark et al. 1995; Boggaram 2009), but also in adult ATII cells (Hosgor, 
Ijzendoorn et al. 2002). Interestingly, TTF-1 has been previously reported as an ATII cell marker 
in other lung differentiations from mesenchymal stem cells (Gu, Yan et al. 2014).  In combination 
with TTF-1, FOX A factors, detected during the stem cell differentiation into endoderm (Levinson-
Dushnik and Benvenisty 1997),  have been reported to regulate the expression of SP-B (Zhou, Lim 
et al. 1996). Therefore, surfactant protein gene expression in the lung is regulated by complex 
mechanisms and combinatorial actions of multiple transcription factors (Boggaram 2003, Kalin, 
Wang et al. 2008). The particular signaling pathways involved in the differentiation of DMSCs into 
the lung phenotype under our culture conditions remains as an open question that will need 
further investigation but that was not the purpose of the present work.  
As stated before, we also found expression of these genes in non-differentiated DMSCs. 
Without excluding the possibility that they might have a specific function in the placental 
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environment, the semi-quantitative nature of end-point PCR prevents an accurate determination 
hampering the visualization of subtle differences in the expression of these genes.  
Our results indicate an initial differentiation towards a surfactant producing ATII-LC phenotype. 
However, we should not discard the fact that patterns of protein expression at longer times under 
differentiation conditions could be related with further differentiation into other phenotypes 
such as those of type I pneumocytes. Differentiation of ATII cells of pulmonary origin into ATI 
cells is widely documented both in vitro and in vivo (Fuchs, Hollins et al. 2003; Steimer, Laue et 
al. 2006). 
Our findings showed that the onset for enhanced expression of all these mRNAs correlated 
with the appearance of lamellar body-like intracellular particles suggesting an evident signal 
of lung maturation (Stahlman, Gray et al. 1992; Zhou, Lim et al. 1996; Stahlman, Besnard et al. 
2007). Surprisingly, DMSCs were shown to already express basal levels of surfactant proteins. 
This could be related to their placental origin.  Presence of SP-A and SP-D has been previously 
reported in human amniotic epithelium and chorio-decidual layers (Miyamura, Malhotra et al. 
1994; Sun, Brockman et al. 2006). As a matter of fact, SP-A has been proposed to participate as 
an inductor of parturition (Sun, Brockman et al. 2006).  In addition, SP-A and SP-D lectin domains 
have been described to display an active role in the recognition and clearance of pathogens 
from amniotic fluid (Miyamura, Malhotra et al. 1994). Presence of SP-B and SP-C has also been 
demonstrated in placenta and other fetal environments (Newman, Phizackerley et al. 1991; Sati, 
Seval-Celik et al. 2007). Although their role is still under debate, it has been suggested that SP-C 
might participate in modulating inflammatory responses in the extraembryonic environment 
(Newman, Phizackerley et al. 1991). Our results demonstrate that differentiated ATII-LCs have the 
capability to properly process surfactant proteins from their precursors into the mature forms, 
a process that has been specifically linked with the ATII phenotype, but that should likely be 
extended to other epithelia layers related with the fetal/environment interface. This complete 
processing is consistent with the enhanced expression in ATII-LCs of the genes encoding the 
aspartyl proteases Napsin A and Cathepsin H, which are known to be expressed in fetal lung and 
adult ATII cells and being involved in the maturation of SP-B and SP-C (Ueno, Linder et al. 2004). 
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Interestingly, the amount of surfactant proteins found in the extracellular fluid of ATII-LC 
cultures was also higher than that in the medium of DMSCs, which is suggestive of a functional 
and metabolically active state of ATII-LCs. This statement would be additionally supported by the 
increased expression of the gene encoding the G-protein couple receptor GPR116. Indeed, this 
receptor plays a critical role in lung surfactant homeostasis, controlling surfactant composition 
as well as its accumulation in the alveolar spaces and uptake by ATII cells, sustaining normal 
surfactant levels (Bridges, Ludwig et al. 2013; Yang, Hilton et al. 2013). With respect to the 
maintenance of the proper lung volumes, ATII-LCs were also able to express mRNA codifying the 
cystic fibrosis transmembrane conductance receptor (CFTR), which has been also described in 
the developing lung as well as in freshly isolated ATII cells (Brochiero, Dagenais et al. 2004). CTFR 
is an important regulator of Cl- and liquid transport in the lung alveolus and mutations in its gene 
are known to cause cystic fibrosis (Fang, Song et al. 2006).
The major function of ATII cells is the production and secretion of surfactant. The fact 
that ATII-LCs are able to synthetize and accumulate disaturated phospholipid species and to 
secrete functional membranous lipid complexes upon stimulation with secretagogues further 
supports the differentiated state of ATII-LCs and their pneumocyte-like functionality. We have 
implemented a method in ATII-LCs to real-time visualizing single events of surfactant release, 
previously described and validated for native ATII cell primary cultures (Miklavc, Mair et al. 2011; 
Haller, Ortmayr et al. 1998; Frick, Eschertzhuber et al. 2001; Frick, Bertocchi et al. 2004; Haller, 
Dietl et al. 2004). Despite the fact that LTG staining was not specifically limited to LBs due to the 
great amount of lysosome-related small vesicles also present in DMSCs, ATII-LCs displayed much 
more acidic compartments (probably LBs) than DMSCs and only ATII-LCs were clearly responsive 
to the addition of secretagogues. Upon incubating with ATP and PMA, ATII-LCs exocytosed an 
appreciable number of lipid vesicles stained with FM1-43 as discrete spherical fluorescent spots. 
These observations indicate that the secreted material remains in an aggregated state and does 
not readily disperse into the buffer solution as it has been also described for material secreted by 
ATII cell primary cultures (Haller, Ortmayr et al. 1998).  Interestingly, the time course of exocytosis 
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in ATII-LCs displayed a slow rate mimicking the secretory behavior well documented in rat ATII 
cell primary cultures (Haller, Ortmayr et al. 1998; Frick, Bertocchi et al. 2004).  
As revealed by ultrastructural analysis, surfactant-like material secreted from ATII-LCs 
contained a mixture of different structures, mainly partially unpacked osmiophilic entities and 
multiple lipid membrane patches with particular morphologies, probably residual features from 
a previous more complex organization as well as relatively simpler unillamelar and multillamelar 
vesicles loaded in some cases with a dense material inside. In general terms, the structures 
observed resemble the lipoprotein complexes exocytosed upon stimulation by native ATII 
cells (Ravasio, Olmeda et al. 2010), and had similar efficient interfacial adsorption capabilities. 
Previous work had demonstrated that surfactant complexes freshly secreted by primary cultures 
of type II pneumocytes adsorb to the interface at higher rates than surfactant complexes isolated 
from bronchoalveolar lavage (Ravasio, Cruz et al. 2008). These results  have been interpreted 
considering that material obtained from airspaces could actually contain not only freshly 
secreted surfactant but also surfactant complexes that may have been already consumed, partly 
inactivated due to oxidation, or to insertion of spurious components. The fact that material 
secreted by ATII-LCs shows superior interfacial adsorption than surfactant purified from lungs 
argues in favour of their true functional pneumocyte-like phenotype. Pulmonary surfactant-like 
assemblies secreted by ATII-LCs even displayed a higher resistance to inhibition by serum than 
whole native surfactant purified from BAL. The limited amounts of material available up to now 
has prevented us to assess whether the interfacial films formed by the material produced by ATII-
LCs are also competent to reach and sustain very low tensions under compression-expansion 
dynamics. Future optimization and scaling-up of conditions for cell culture, differentiation 
and secreted surfactant harvesting will allow to evaluate not only the full performance of this 
surfactant but the potential of this strategy to approach the biotechnological production, at 
large scale, of humanized clinical surfactants for therapeutic applications.
Under the differentiation conditions used in this work, the cultures appear as highly 
enriched in ATII-LCs, exhibiting remarkable yields of differentiation as previously assessed 
in immunocytochemical stainings for proSP-C (Macías, Grande et al. 2010). ATII-LCs display a 
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dynamic phenotype throughout the differentiation process from initial immature phases to 
mature functional stages, and once differentiated, ATII-LCs cannot be expanded further in culture. 
In contrast to other placenta-derived MSCs from fetal membranes (amnion and chorion) and 
chorionic villi (Portmann-Lanz, Schoeberlein et al. 2006; Okamoto, Miyoshi et al. 2007; Soncini, 
Vertua et al. 2007), DMSCs exhibit a notably high life span and subsequently, large amount 
of cells can be obtained  as an important source to generate great amounts of ATII-LCs. Our 
differentiation procedure has shown to be highly effective, simple and quick, but we presume 
that ATII-LCs are still in a less differentiated state than true ATII cells as  compared to cells in the 
lung epithelium in situ or in freshly isolated primary cultures of ATII cells. We speculate that 
the pneumocyte-like phenotype of ATII-LCs could progress further to full differentiation upon 
immersion into a context more similar to the native lung environment, either by transplantation 
into the tissue in vivo or by the use of cell culture models that incorporate features like the 
presence of an air-liquid interface. In this sense, Transwell devices have been reported as 
successful for lung differentiation by other groups (Wang, Bunnell et al. 2005; Knoll, Brockmeyer 
et al. 2013), and it could provide additional signaling and cell-to-cell contacts that would improve 
full differentiation of ATII-LCs. 
The multipotent adult DMSCs used here display important advantages over other sources 
of adult stem cells, such as a high accessibility, since placental tissue is an unrestricted material 
that is discarded after the birth, its use does not evoke any ethical concerns, and the cells are 
easily isolated with a high yield. DMSCs can be cultured and expanded for long periods of time, 
and this could be a novel source to harvest freshly secreted surfactant complexes for further 
investigations.
Clinically, administration of MSCs from different origins into animal models of lung injury 
has been demonstrated by a number of authors to be a valuable therapeutic tool (Spitalieri, 
Quitadamo et al. 2012; Duchesneau, Wong et al. 2010; Wang, Bunnell et al. 2005; Wong, Dutly 
et al. 2007; Cargnoni, Gibelli et al. 2009; Wong, Keating et al. 2009; Knoll, Brockmeyer et al. 
2013; Wang, Li et al. 2013). It has been recently reported that DMSCs could be useful for future 
clinical applications (Bornstein, Macías et al. 2012; Vegh, Grau et al. 2013). DMSCs subjected to 
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hepatic differentiation conditions have shown remarkable functional capabilities, suitable to be 
used as models for studying liver physiology as well as liver diseases with a potential application 
in hepatic regeneration (Bornstein, Macías et al. 2012). On the other hand, the migration and 
engraftment of DMSCs into mammary tumors and the inhibitory effect of the cells on the 
growth of primary tumors and in the development of new tumors has been demonstrated 
(Vegh, Grau et al. 2013). DMSCs do not express the major histocompatibility complex class II 
and the T cell costimulatory molecules, conferring them an intrinsically hypoimmunogenic and 
immunomodulating  properties (Macías, Grande et al. 2010). DMSCs or ATII-LCs could therefore 
open new strategies as a potential therapeutic agent for the treatment of lung injury.
 In conclusion, the results reported in this work support the idea that ATII-LCs could be 
considered as appropriate cell models mimicking ex vivo ATII. This model could be used to 
introduce genetic modifications to study surfactant biogenesis, in particular, protein and lipid 
synthesis, maturation, and trafficking, as well as the packing and storage of surfactant lipid-
protein complexes into LBs.







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The experiments presented in this chapter were carried out at the Helmholtz Institute for 
Pharmaceutical Research/ Saarland University (Saarbrucken, Germany) under the supervision of 
Prof. Dr. Claus-Michael Lehr and Dr. Cristiane Carvahlo.
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INTRODUCTION
In the previous chapter we have described a new cell model based on derived 
placental stem cells, with phenotypical features consistent with alveolar type II (ATII) 
cells able to synthesize, store and secrete active lipid protein complexes with conspicuous 
surface properties. The culture method we have described to obtain alveolar type II-like 
cells (ATII-LCs) was shown to be simple, reliable and highly reproducible. However, as 
previously stated, we postulate that the differentiated alveolar-like cells are not fully 
mature as compared to native pneumocytes. It is well known that the physiological 
microenvironment directly impacts the ATII cell morphology, proliferation, differentiation, 
secretion, movement, signal transduction, and gene expression pathways (Dobbs, Pian 
et al. 1997; Grek, Newton et al. 2009). Therefore, we speculate that our experimental 
differentiation method, based on conventional submerged cultures in plastic plates, 
might not properly mimic the in vivo alveolar situation, likely crucial for the normal gene 
expression and cellular function of ATII cells. For this reason, our research in this chapter has 
been focused on the optimization of cultures trying to further approach the native conditions.
Classically, primary ATII cells have been grown in submerged cultures and not exposed 
to air (Dobbs 1990; Kalina, Riklis et al. 1993; Sugihara, Toda et al. 1993). To closely resemble 
the in vivo situation, air-liquid interface (ALI) cultures have been implemented. In ALI 
cultures the medium is added only into the basolateral surface of cells and the apical 
part is exposed to the air-phase. Early versions of modern ALI cell culture techniques 
were introduced in the 1970s,  where alveolar macrophages were seeding on porous 
membrane filters attached to surfaces of reservoirs filled with nutritive medium and 
maintained alive in direct contact with the atmosphere (Voisin, Aerts et al. 1975; Voisin, 
Aerts et al. 1977; Paur, Cassee et al. 2011). The distinctive effect of the ALI cell culture 
system has been reported to be important for the morphological differentiation and 
development of cilia in tracheal and bronchial epithelial cells (Whitcutt, Adler et al. 1988; 
Yamaya, Finkbeiner et al. 1992; Kaartinen, Nettesheim et al. 1993; Grainger, Greenwell 
et al. 2006; Sakagami 2006; Berube, Prytherch et al. 2010), as well as for the promotion 
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of the expression and maintenance of a differentiated type II phenotype of isolated ATII 
cells in contrast to submerged cultivation (Kohsa, Yamada et al. 1996; Alcorn, Smith et 
al. 1997; Dobbs, Pian et al. 1997; Ito, Ahmad et al. 2011). Interestingly, the usefulness 
of interfaced cultures has been also described  to be crucial for the differentiation of 
stem cells into lung cell derivatives (Wang, Bunnell et al. 2005; Van Haute, De Block et 
al. 2009; Knoll, Brockmeyer et al. 2013; Ghaedi, Méndez et al. 2014). The distinctive 
effect on the differentiation of bone marrow-isolated human mesenchymal stem cells 
cultured into the ALI has been well characterized and compared to submerged cultures 
(Wang, Bunnell et al. 2005). In fact, the differentiation of human embryonic stem cells 
under interfaced conditions has demonstrated the capacity of these cells to derive into 
the main cells of the lung epithelial tissue (Van Haute, De Block et al. 2009). Recently, 
the initial differentiation of human induced pluripotent stem cells into ATII cells and 
subsequently into alveolar type I cells has been also demonstrated, generating an air-
liquid condition in a rolling bioreactor (Ghaedi, Méndez et al. 2014). 
In spite that the significance of ALI cultures has been now well-accepted, an interest 
in discerning the mechanisms involved in the improvement in cell differentiation 
has increased in the last few years.  Indeed, some investigators have evidenced the 
importance of the oxygen tension in culture medium. In fact, isolated primary rat ATII 
cells seem to generate oxygen gradients in the air-liquid cultivation due to the high 
number of active mitochondria (Mamchaoui and Saumon 2000). On the other hand, it 
has been described that hypoxia plays an important role on the expression of surfactant 
proteins and induces the down-regulation of SP-B and SP-C in murine lung epithelial 
cells (Grek, Newton et al. 2009). In addition, levels of hypoxia inducible factor (HIF) have 
been investigated in cultures of rat ATII cells under submerged and air-liquid conditions. 
These studies have revealed that the presence of HIF increased in liquid covered cultures 
with respect to ALI conditions and this rise is correlated with a decline in the expression 
of surfactant proteins, which can be restored upon supplementation with oxygen (Ito, 
Ahmad et al. 2011). Thus, HIF signaling and oxygen tension at the surface of cells appears 
to be important factors that influence the phenotype of ATII cells. 
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Additionally, the extracellular matrix (ECM) is also well known to be a critical 
element in the cellular microenvironment. In physiological conditions, alveolar cells 
are supported by a unique fibrillar ECM that contains principally collagen, fibronectin, 
and laminin (Rannels and Rannels 1989; Dunsmore 2008; Cortiella, Niles et al. 2010). 
Other constituents, such as proteoglycans and in  particular, perlecan (heparan sulfate 
proteoglycan 2) and nidogen, were also found connecting the networks formed by other 
components of the ECM and participating in cell-extracellular matrix interactions (Koval, 
Ward et al. 2010; Eisenberg, Safi et al. 2011). ECM is secreted and constantly modified 
by cells as they grow and develop in vivo and it is one of the main factors influencing 
cell mammary specific metabolism and cell behaviour in vitro (Emerman, Burwen et 
al. 1979; Delabarre, Claudon et al. 1997; Hopkinson, DeBiase et al. 2008). In fact, cell-
ECM interactions play crucial roles in maintaining a proper adhesion, cell motility and 
differentiation (Eisenberg, Safi et al. 2011). 
The effect of the different components of the ECM in the maintenance and 
development of the differentiated phenotypes of primary lung alveolar cells in culture 
has been examined by several groups  (Lwebuga-Mukasa, Thulin et al. 1984; Adamson, 
King et al. 1989; Sannes 1991, Elbert, Schafer et al. 1999; Fuchs, Hollins et al. 2003). 
Moreover, approaches including ECM as a part of the culture systems have been also 
effectively implemented for the derivation into lung epithelial cells of murine embryonic 
stem cells (Cortiella, Niles et al. 2010), as well as human induced pluripotent stem cells 
(Ghaedi, Mendez et al. 2014; Huang, Islam et al. 2014).
On the other hand, it is well known that the lung distal airways offer advantageous 
features such as their large absorptive area, extensive vasculature and relatively low 
extracellular and intracellular enzymatic activity, making them a privileged route for drug 
delivery (Liu, Shao et al. 1993; Foster, Oster et al. 1998). In addition, interest in pulmonary 
administration of therapeutic drugs is currently  increasing  due to many other factors, 
i.e., the increasing number of new therapeutic peptide and protein pharmaceuticals 
with associated difficulties in their delivery by other routes or the continued interest 
192
Chapter 4
in direct targeting of therapeutic agents for respiratory disorders or in the systemic 
delivery of drugs by inhalation (Forbes and Ehrhardt 2005; Patton and Byron 2007; Sung, 
Pulliam et al. 2007).  As a result, different methods to assess and predict the biological 
effects of new compounds in an early stage of their development are currently highly 
demanded. Taking into consideration the principle of the 3R (Replacement, Reduction 
and Replacement, already discussed in the prior chapter), the increasing efforts to 
reduce the number of animals used routinely for toxicological tests, make necessary the 
design of new in vitro methods to accomplish that task. Compared to in vivo approaches, 
in vitro systems offer the simplicity, robustness and a better control of the experiments 
and their data interpretation, besides the benefits of reducing operational costs and the 
use of animals (Sakagami 2006).  In the alveolar field there are not suitable cell lines 
available and the isolation and culture of primary ATII cells is the preferred election in 
most cases (Elbert, Schafer et al. 1999; Forbes and Ehrhardt 2005). However, despite 
the fact that primary cultures may represent a closer option for simulating the in vivo 
situation, they present several disadvantages, such a high heterogeneity and low 
reproducibility, besides the difficulties in terms of resources and time to obtain them 
(de Souza Carvalho, Daum et al. 2014).  
Taking into consideration all the facts previously mentioned, we were interested in 
validating our novel cell model of ATII-LCs as a suitable tool for toxicological studies, 
competent to assess the biocompatibility and safety of new nanoscale materials of utility 
for lung biopharmaceutics. 
The relevance of nanotechnology has increased considerably in the development 
of new drug delivery systems. Nanoparticles (NPs) are defined by the European 
Commission as particles smaller than 100 nm in at least one dimension (Commission 
2011). A high number of methods and raw materials for the preparation of polymeric 
nanocarriers is currently available and these must be chosen according to the final 
application. In particular, polylactic-co-glycolic acid (PLGA) polymers have been reported 
as a convenient material for NP preparations, due to its favorable properties such as 
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biodegradability, biocompatibility and low or absent cytotoxicity (Kitchell and Wise 
1985; Johansen, Men et al. 2000; Grayson, Voskerician et al. 2004; Wu 2004). In vivo, the 
degradation of PLGA NPs takes place by simple hydrolysis that generates carbon dioxide 
and water, which are easily eliminated from the body. However, their degradation 
yields acidic monomers leading to a lower pH inside the NP, which can result with the 
undesirable degradation of the cargo molecule (Fu, Pack et al. 2000).  To overcome 
this inconvenience, supplementary excipients such as poly-vinyl alcohol (PVA) or poly-
ethylene-glycol (PEG) have been incorporated into the NP matrix and are currently 
widely employed as coadjutants improving colloidal stability (Owens and Peppas 2006; 
Santander-Ortega, Bastos-González et al. 2007).  Additionally, PLGA NPs can be modified 
during their synthesis to modify their properties of degradation, offering an excellent 
pharmacokinetic control of drug delivery. Moreover, PLGA NPs are appropriate for the 
encapsulation and delivery of a variety of therapeutic agents, including, but not limited 
to, low molecular weight compounds (Panyam and Labhasetwar 2004; Faraji and Wipf 
2009). Importantly, NPs based on PLGA have been approved by the US Food and Drug 
Administration (FDA) for human use. 
In the last years, extensive research has been carried out in the use of inorganic 
materials, i.e., the development of metallic nanoparticles with multiple applications. 
In particular, silver NPs (AgNPs) are the most commonly used engineered NPs in 
commercialized products due to their antimicrobial properties (Greulich, Kittler et al. 
2009; Hackenberg, Scherzed et al. 2011; Herzog, Clift et al. 2013; Gliga, Skoglund et al. 
2014; Kim, Shin da et al. 2014). However, the use of silver as an antimicrobial agent is not 
a novel concept, as it has been used since the 17th century as a medicinal product (Klasen 
2000; Herzog, Clift et al. 2013). Nowadays, AgNPs are used in a variety of products such as 
cosmetics, clothing, electric home appliances, room sprays and even in the food industry 
(Greulich, Kittler et al. 2009). Considering their well-known antiseptic activities, distinct 
silver compounds are clinically used to reduce skin infections in the treatment of burns, 
and as coatings of various surfaces, such as catheters and implants in order to reduce 
infections (Roe, Karandikar et al. 2008). Additionally, AgNPs have gained attention for 
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medical imaging and biosensing purposes. Despite the widespread application of AgNPs, 
there is a serious lack of information concerning their biological effects on human cells, 
and therefore, their potential cytotoxicity need to be assessed. In particular, an exposure 
route via inhalation is of primary concern for humans in an occupational setting as the 
respiratory system is one of the major entrance sites for nanomaterials. In this context, 
much research has been performed using in vitro cultures of lung cells to examine the 
possible deleterious effect of AgNPs on the human lung (Herzog, Clift et al. 2013; Suliman, 
Ali et al. 2013; Gliga, Skoglund et al. 2014; Kim, Shin da et al. 2014). 
In this chapter, we have explored the influence of different factors in the differentiation 
of mesenchymal stem cells into ATII-LCs under conditions mimicking the alveolar 
microenvironment. For this purpose, we have differentiated the cells exposing them 
to air-liquid interfaces. We have then assessed the potential effect of this particular 
environment in terms of morphology, barrier properties and expression of surfactant and 
transporter proteins, in comparison with conventional submerged cultures. Moreover, 
we have also evaluated the result of differentiating the cells seeded over components 
present in the lung extracellular matrix. 
On the other hand, we have investigated the potential adverse effects of PLGA and 
silver NPs in terms of cell viability of alveolar epithelial cells, taking advantage of the novel 
in vitro cell model of ATII-LCs.  Additionally, we have exposed ATII-LCs differentiated in 
ALI cultures to aerosolized fluorescent PLGA NPs and examined their subsequent cellular 
uptake using a specific air-liquid cell exposure system.
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RESULTS
Morphological features of ATII-LCs grown at the air-liquid interface
The effects of ALI culture conditions on cell morphology were examined by optical 
light microscopy and compared to SC conditions. After 4-5 days of differentiation in 
Transwell systems, ATII-LCs could be discerned as shortened cells with respect to the 
undifferentiated state, undergoing a more rounded shape and showing no substantial 
differences in comparison to differentiated cells under SC conditions (Figure. 4.1). In 
general, the longevity of the culture (around 7 days) in terms of maintenance of cell 
atachment did not reveal any significant variations due to the influence of the air-liquid 
interface  when  compared to SC conditions either. However, more gaps without cells 
covering the porous membranes were observed in air-interfaced cultures probably due 
to cellular stress  because of consecutive washing.
Figure 4.1. Morphological assessment by optical microscopy of ATII-LCS differentiated in transwell 
inserts under submerged culture (SC) and air-liquid interface (ALI) culture conditions. A. Decidua-derived 
mesenchymal stem cells (DMSCs) visually confluent prior to differentiation. B. ATII-LCs after 4 and 6 days 
of differentiation under SC conditions.  C. ATII-LCs after 4 and 6 days of differentiation under ALI culture 
conditions. Note: Sample imaging is hampered due to a partial defocus imposed by the excessive distance 
between sample and objective. Scale bars = 5 µm.
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The influence of the cell culture substrate on the cell differentiation was also tested 
after covering the permeable inserts with a mixture of collagen and fibronectin (Figure. 
4.2). Differences in cell morphology could not be detected in any of the culture conditions. 
However, differentiated ATII-LCs cultured in both, SC and ALI conditions, were able to 
maintain their attachment to the substrate for longer times, about 2 more days, when 
compared to  cells cultured in membrane inserts without any coating.
The morphology of the differentiated ATII-LCs was further investigated by scanning 
electron microscopy and compared  to primary human ATII cells and A549 cells, both type 
of cells also seeded on filter membranes (Figure 4.3). Primary ATII cells were observed 
as cuboidal in shape, being its cytosolic area limited to a zone near to the nucleus. The 
apical surface of the cells was seen to be covered by multiple protrusions and structures 
consistent with microvilli. Furthermore, numerous filopodia were visualized extended 
from lateral borders contacting and attaching the cells to the surface of the filter 
(Fig 4.3A left panel). In addition, some ATI cells could be also discerned, with a larger 
size, typical flattened morphology and absence of distinctive structures on the surface 
(Fig 4.3A right panel). Undifferentiated DMSCs appeared with an elongated and  flat 
spindle-like  morphology typical of a fibroblast and with a relatively smooth external 
surface (Fig 4.3C). After 5 days of differentiation under  ALI conditions, ATII-LCs suffered 
remarkable morfological changes exhibiting a cuboidal epitheliod form with abundant 
invaginations and protuberations on the cell surface  that resemble microvilli (Fig. 4.3D). 
The cells displayed a cellular surface that presents notable similarities with the primary 
human ATII cells. The resemblance of ATII-LCs differentiated under ALI conditions was 
not so evident  when compared to the A549 line (Fig 4.3B).  ATII-LCs differentiated under 
SC conditions (Fig. 4.3E), did not exhibit significant morphological differences in terms of 
shape and surface topography, with respect to the differentiated cells at the ALI in terms 
of shape and surface topography. 
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Figure 4.2. Morphological examination of ATII-LCs seeded on transwell inserts coated with 
fibronectin and collagen throughout the differentiation process. A. Differentiated ATII-LCs under SC 
conditions. B. Differentiated ATII-LCs under ALI culture conditions.
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Figure 4.3. Morphological analysis by scanning electron microscopy. A. Freshly isolated alveolar 
epithelial cells (scale bars = 2 and 5 µm) B. A549 cells (scale bars = 5 µm). C. Undifferentiated 
DMSCs (scale bars = 30 and 10 µm) . D. Differentiated ATII-LCS under ALI culture conditions (scale 
bars = 5 µm). E. Differentiated ATII-LC under SC condtions (scale bars = 2 and 5 µm).
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Barrier properties
Transepithelial electrical 
resistance (TEER) values 
of ATII-LCs differentiated 
at the ALI were slightly 
higher compared to cells 
treated under SC conditions 
throughout the days of 
culture, although this 
variation was not found to be 
statistically significant (Figure. 
4.4). In both differentiation 
conditions, TEER values were increased at the beginning of the treatment, reaching 
peak values of 75 Ωcm2 and then remained unchanged during the whole treatment, 
displaying a relative plateau with values ranging from 50 to 60 Ωcm2. A decline in TEER 
was recorded at the end of the lifetime of the culture that coincides with the general 
loss of cell attachment. According to these TEER values, ATII-LCs cannot be considered 
to form a electrically confluent monolayer, since their TEER levels are lower than the 
standards levels reported for conventional cell monolayers of other epithelial cell types 
(> 300 Ωcm2).
The capacity to configure a tight monolayer was also investigated when the cells were 
differentiated under SC and ALI conditions in the Transwell systems coated with collagen 
and fibronectin (Figure 4.5). Consistently with the previous result, cells showed a gradual 
increase in TEER values at the beginning of the differentiation and a decline in the last 
days of the process. Differentiated cells exposed to the ALI displayed higher TEER values 
than cells treated under SC conditions, but the difference was not statistically significant. 
In both cases, the conditions did not lead to the formation of a tight monolayer and the 
TEER values remained low throughout the differentiation and similar to those found 
Figure 4.4. Measurement of transepithelial electrical 
resistance (TEER) in ATII-LC cultures. TEER values of ATII-LCs 
differentiated under SC conditions (light blue) and under ALI 
culture conditions (dark blue) throughout the differentiation 
process.
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with the uncoated Transwells. 
On the other hand, 
passive fluxes and cumulative 
transport of the paracellular 
marker sodium fluorescein 
across monolayers of 
differentiated cells was also 
assessed (Fig. 4.6). Apparent 
permeabiliy coefficients (Papp) 
were calculated to be 0.29 
± 2.85 x 10-5 cm/s and 0.31 
± 2.01 x 10-5 cm/s in cells exposed to ALI and SC conditions, respectively (Fig. 4.6A). 
According to the preceding findings, these data reveal no differences in the tightness of 
cell monolayers. The differences in the restriction of passive fluxes of sodium fluorescein 
across monolayers were not statistically different when comparing  both culture 
conditions. 
Figure 4.5. Measurement of transepithelial electrical 
resistance (TEER) in ATII-LCs differentiated in transwell 
inserts coated with fibronecting and collagen. TEER values 
of ATII-LCs differentiated under SC conditions (light blue) 
and under ALI culture conditions (dark blue) throughout the 
differentiation process. 
Figure 4.6. Transport of 
sodium fluorescein across 
ATII-LC monolayers.     
A. Time-course of the 
paracellular marker sodium 
fluorescein in the apical-
to-basolateral direction 
across monolayers of ATII-
LCs differentiated under 
SC conditions (light blue) 
and ALI culture conditions 
(dark blue).              
B. Apparent permeability 
coefficients calculated for 
sodium fluorescein in both 
culture conditions.
201
Chapter 4
Protein expression
The impact of the differentiation 
of DMSCs under the ALI in the 
expression of the surfactant proteins 
SP-B and SP-C, as well as in the 
organic cation transport 1 (OCT-1) 
was investigated by immunoblotting 
(Figure 4.7).  Consistently with 
our previous results, incubation 
in the differentiation media 
SAGM revealed an increase in the 
expression of SP-B, not only of its 
precursor form (~ 40 kDa) but also 
of its mature form (~ 8.7 kDa). 
However, no clear differences 
between cells differentiated in SC 
and ALI conditions could be noticed. 
Interestingly, SP-B content in ATII-
LCs was found to be higher than 
in  A549 cells, both the precursors 
and the mature forms. In the case 
of primary human ATII cells, the 
amount of SP-B was observed to 
be notably higher than in ATII-LCs 
differentiated under both culture 
conditions. However, the distortions 
found in the protein bands due to the presence of high amount of lipids associated to 
the proteins prevent a proper quantitative analysis of the data. 
Figure 4.7. Protein expression by western blot. 
Content in surfactant proteins B (SP-B) and C (SP-C) and 
organic cation transporter 1 (OCT-1) was evaluated in 
undifferentiated DMSCs (lane 1), differentiated ATII-
LCs under SC conditions and ALI culture conditions 
(lanes 2 and 3, respectively), A549 cells (lane 4) 
and human primary ATII cells (lane 5). Bars indicate 
molecular weights of the corresponding bands. ß-actin 
was used as a loading control. 
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In relation with SP-C, the band corresponding with the mature form in ATII-LCs (~3.7 
kDa) showed similar intensity independently of the differentiation conditions, but the 
intensity was higher when compared to undifferentiated DMSCs or to the A549 cell line. 
In contrast and similarly to the results found for SP-B, human primary ATII cells contained 
higher amounts of SP-C, as intepreted by the negative staining due to a saturation effect 
observed in the blot. However, due to the uncertain information provided by the protein 
loading control (β-actin), differences in expression of SP-C might not be definitively 
stated, and these results should be currently considered as preliminary results.  
On the other hand, cell differentiation in SAGM provoked an  increase  of the expression 
of OCT-1 close to the levels of human primary cells. However, the ALI  conditions 
produced a  slightly  increase on OCT-1 expression when compared to SC conditions, 
equivalent to the expression in A549 cells. The bands of around 65 kDa corresponded to 
the dimeric form of the protein could be attributed to an incomplete disulfide reduction 
with β-mercaptoethanol. 
Characterization of nanoparticles 
As detailed in the materials and methods section, two different kinds of PLGA 
nanoparticles were prepared according to emulsion-diffusion-evaporation and self-
assembly techniques, using various stabilizers that allow to  modify the surface charge. 
Anionic and cationic chitosan- coated PLGA NPs exhibited mean diameters of 140.6 nm 
and 120.6 nm, respectively. Both formulations had a narrow size distribution with a 
poly-dispersity index in the 0.01-0.2 range. Zeta-potential measurements defined the 
influence of  stabilizers on surface charge: PVA-PLGA NPs displayed a negative zeta-
potential (ζ=-21.5 mV), whereas chitosan-coated PLGA CS-PLGA were positively charged 
(ζ=16.5 mV) (Fig. 4.8) Commercially available silver nanoparticles (AgNPs) consisted of 
particles of about 15 nm size with a narrow size distribution with > 99 % number of 
particles with a size below 20 nm according to manufacturer.
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Effect of nanoparticles on cell viability
In order to explore the toxic effect of the different types of NPs on cultures of ATII-
LCs differentiated under SC conditions as well as on A549 cells, cellular damage after 
exposure to NPs was evaluated in terms of mitochondrial function by the MTT assay. 
Treatments with exposure for 24 h to anionic PLGA NPs revealed certain cytotoxic effect 
in ATII-LCs at relative low concentrations (Figure 4.9A). Although concentrations of NPs 
of 1 and 2.5 µg/mL were shown to be tolerable for cells, exhibiting viability percentages 
around 95-90 %,  higher concentrations, (i.e: 50 and 100  µg/mL) triggered a decrease 
in viability to levels lower than 60 %. A549 cells exhibited a somewhat higher sensitivity 
than ATII-LCS in the range of low  concentrations, but the difference was not statistically 
significant. The toxicity of high concentrations of PLGA NPs was similar in both, A549 
cells and ATII-LCs. 
On the other hand, the cationic CS-PLGA NPs produced minor cytotoxic effects on 
ATII-LCs at elevated concentrations of particles, reaching values of viabilitity around 
Figure 4.8. Nanoparticle characterization by scanning electron microscopy (SEM) and dinamic light 
scattering. A. SEM pictures documenting morphology of fluoreseinamine (FA) PLGA NPs. Scale bars = 500 
nm. B. Particle size, polidispersity index (PdI) and zeta potential of FA-PLGA and chitosan-PLGA (CS-PLGA) 
nanoparticles by analysis with ZetaSizer Nano ZS. 
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90 %  at 50 µg/mL and 80 % 
at 100 µg/mL (Figure. 4.9B). 
Interestingly, CS-NPs charged 
with  clarythromycin  did not 
shown any particular harmful 
influence in cell survival 
since mitochondrial function 
displayed a similar behaviour 
when compared to unloaded 
CS-NPs. Compared to anionic 
PLGA NPs, cationic NPs were 
more tolerable by the ATII-
LCs, particularly when used at 
elevated concentrations, i.e.; 
80 % vs 60 % of cell viability at 
100 µg/ml.   
AgNPs seem to have a  similar 
effect in cell citotoxicity than 
anionic PLGA NPs with a rapid 
decay at low concentrations. 
Again, when compared to 
cationic PLGA NPs, AgNPs had a 
more citotoxic effect at all the 
dillutions tested. It is remarkable 
that AgNPs triggered a significant 
dose-response toxicity in 
ATII-LC cultures, reaching the 
significantly low rates of 30 % 
of cell viability at the highest 
A
B
Figure 4.9. Evaluation of citotoxicity by MTT assay after 
incubation with the different types of nanoparticles.  Cell 
viability after 24 h of exposure to different concentrations 
of anionic PLGA NPs (A), cationic chitosan modified PLGA 
NPs (B) and silver NPs (C) of differentiated ATII-LCs and 
A549 cells (in A, C).  
C
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concentrations evaluated of 100 µg/ml (Fig. 4.9C). On the other hand, A549 cells  seem 
to be more resistant at higher concentrations of AgNPs than ATII-LCs, with a cell viability 
of around 70 % at both, 50 and 100 µg/ml. 
Cellular uptake of fluorescent PLGA nanoparticles
Internalization of fluorescent-labeled FA-PLGA NPs by ATII-LCs grown on Transwell 
supports and differentiated under ALI conditions was assessed by confocal electron 
microscopy after deposition using the ALICE system. Relatively low amounts of 
NPs could be discerned  in the citoplasm of the ATII-LCs 3 h after the exposure 
(Figure 4.10A). However, a remarkable increase in the number of NPs visualized as 
individual or agreggated green fluorescent spots were observed in the citoplasm of the 
cells at 24 h of incubation. Additionally, the uptake of NPs was confirmed by z-stacks 
represented in an orthogonal view, revealing particles penetrating into the cells in a dose-
response dependent manner or already internalized and located at the same planes than 
nuclei and/or actin filaments of the citoplasm (Figure 4.10.B).  ATII-LCs not exposed to 
NPs were shown to have a general morphology and nuclear aspect similar to untreated 
cells suggesting that neither the deposition technique nor the exposure to particles had 
any particular adverse effect in the differentiated cells under ALI conditions.  
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Figure 4.10. Cellular uptake of fluorescent PLGA nanoparticles. A. Images showing two 
different concentrations of fluoresceinamine PLGA NPs (green fluorescence) deposited 
using ALICE device onto ATII-LCs incubated for 3 and 24 h. Negative control without NPs 
is shown. B. Images corresponding to fluorescent PLGA NPs after 24 h of incubation 
incorporating an orthogonal view (x,y plane) created from confocal microscopy sections 
allowing observation of the sample in depth. Nuclei and actin filaments are stained in blue 
and red, respectively. Scale bars = 20 µm.
208
Chapter 4
DISCUSSION
The integrity of the alveolar epithelium of the distal lung is crucial for an efficient 
gas exchange and, at the same time, to define an effective pulmonary delivery of drugs. 
Although ATII cells represent only approximately 5 % of its surface (Crapo, Barry et al. 
1982), they become essential due to their important physiological functions including 
surfactant production and renewal of ATI cells (Daum, Kuehn et al. 2012). Considering 
its key role in the lung functions, useful in vitro models of ATII cells are strongly needed 
to evaluate the safety of novel inhaled terapeutic drugs in the first stages of their 
development. In the previous chapter, we have reported a new model based on the 
differentiation of human mesenchymal stem cells into lung derived-cells (ATII-LCs) with 
the  ability to accumulate, sinthesize and secrete functionally active surfactant-like 
assemblies. Despite ATII-LCs reach a considerable functional state, we hipothesized that 
the differentiation could be extended to a fully mature  stage modifying the in vitro 
culture conditions. 
For this purpose, we subjected DMSCs to differentiation under air-liquid interface 
(ALI) conditions mimicking the native situation. For this, DMSCs were seeded on top 
of permeable supports and exposed their apical part to the air. We observed that ATII-
LCs derivated under ALI conditions underwent notorious morphological modifications. 
Differentiated cells changed from a flat and elongated fibroblast-like aspect to a more 
cuboidal shape displaying a complex external surface with abundant microstructures 
resembling microvilli, as seen by scanning electron microscopy. In spite of the fact 
that this finding could also be indicative of cell polarization, this feature could not be 
definitely confirmed  at this point since cell polarity is not only based on morphological 
evidences, but also in vectorial processes such as fluid transport or exocytosis, among 
others. Significantly, the structural features of ATII-LCs showed high similarity with 
those of native primary ATII cells isolated from human lung. Furthermore, the  images 
acquired by optical microscopy to verify the reorganization of the cell monolayers of 
differentiated cells under ALI conditions are also quite similar to those of primary alveolar 
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cells as reported by other authors (Kohsa, Yamada et al. 1996; Delabarre, Claudon et al. 
1997). However, we hardly discerned significant differences in air-exposed ATII-LCs with 
respect to ATII-LCs  differentiated in subermerged cultures. The absence of substantial 
differences in terms of cytoarchitecture when comparing both culture conditions has 
been also previously observed for native ATII cells (Kohsa, Yamada et al. 1996).  
Afterwards, we proceed to quantify the barrier integrity of the cell monolayers by 
measuring transepithelial electrical resistance (TEER), an independent and non invasive 
technique (Benson, Cramer et al. 2013). In both, air-liquid and submerged conditions, 
we determined that after an initial peek at the beginning of the differentiation, TEER 
levels remained constant throughout the whole differentiation process, coinciding with 
the stationary growth phase. This tendency has been also reported in other studies with 
epithelial cells (Rothen-Rutishauser, Kramer et al. 1998; Braun, Hammerle et al. 2000). 
On the other hand, TEER  levels never reached the 300 Ωcm2, the  normal TEER values 
commonly reported for tightly packed monolayers (Cheek, Evans et al. 1989; Elbert, 
Schafer et al. 1999; Salomon, Muchitsch et al. 2014). Indeed, other respiratoy cells 
known to have strong barrier properties, show elevated resistance values. For example, 
TEER values obatained for Calu-3 (cell model for the bronchial epithelium) monolayers 
have been shown to plateau with values reaching around 470 Ωcm2 when grown under 
the ALI condition (Haghi, Young et al. 2010), although these values can be significantly 
increased when cultured in submerged conditions (Stentebjerg-Andersen, Notlevsen 
et al. 2011). Another bronchial cell line, the 16HBE14o- cells reach TEER values of 
aproximately 330 Ωcm2 (Wan, Winton et al. 2000). NCI-H441 cells, which are presumably 
of Clara-cell origin, are able to reach peak values of 1010 Ωcm2 under submerged culture 
conditions, although under air-liquid conditions TEER values are lower than 300 Ωcm2 
(Salomon, Muchitsch et al. 2014). Surprisingly, as seen in various studies, submerged 
cultures lead to better barrier properties in lung cells but the mechanisms involved still 
remain unclear. In general, electrically packed monolayers are strongly correlated with 
the presence of tight junctions, which are located at cell-cell contact sites.  The tight 
junctions consist of several different classes of transmembrane and peripheral proteins, 
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such as zonula occludens protein 1, E-cadherin and claudin (de Souza Carvalho, Daum et 
al. 2014).  
Interestingly, freshly isolated primary ATII cells, which still mantain their original 
phenotype in culture also display low TEER levels (Elbert, Schafer et al. 1999; Geys, 
Nemery et al. 2007). Indeed, the low TEER values of pure populations of ATII cells 
suggest the absence of epithelial barrier formation mediated by thight junctions (Mason 
and Williams 1980; Germann, Ueberschar et al. 1993). Nevertheless, when primary ATII 
cells dedifferentiate into ATI-like phenotype they generate tight monolayers, reaching 
significant high TEER values over 2000 Ωcm2 (Elbert, Schafer et al. 1999). This finding 
could support  the hypothesis that our differentiated cultures contain a pure population 
of ATII-LCs and  excluding the potential  of differentiation into ATI cells. However, the 
presence of a minor subpopulation of ATI-like differentiated cells cannot be discarded, 
although it would be insufficient  to stablish a measurable electrically tigh monolayer. 
This  hypothesis should be confirmed by analyzing the presence of characteristic markers 
of ATI cells such as caveolin-1, aquoporin or RAGE, for instance.     
To corroborate the results obtained about barrier properties of ATII-LC cultures, 
transport studies with a fluorescent paracellular marker were performed. Passive fluxes 
of sodium fluorescein across monolayers of ATII-LCs were barely restricted, according to 
the calculated apparent permeability  coefficients. The levels were around 0.3x10-5 cm/s 
in both culture conditions, and these values are significantly higher than those reported 
for tight cell monolayers, such those formed by NCI-H441 with levels of 0.5x10-8 cm/s 
for the same molecule (Salomon, Muchitsch et al. 2014). Thus, TEER values were closely 
related to trans-monolayer permeability of sodium fluorescein  suggesting the absence 
of formation of high-resistance cell monolayers by ATII-LCs in either of the differentiation 
conditions analyzed. 
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On the other hand, the potential impact of components of the extracellular matrix 
(ECM) in the differentiation process towards ATII-LCs has been assessed. For this 
purpose, undifferentiated DMSCs were seeded and differentiated  in cell inserts coated 
with fibronectin and collagen. Both compositional and physical signals provided by ECM 
have been previously reported as crucial for differentiation of stem cells into various cell 
lineages (Levenberg, Huang et al. 2003; Yim and Leong 2005), with lung cells being no 
exception (Cortiella, Niles et al. 2010).  Our results suggest that although coatings did not 
have an appreciable influence in terms of cytoarchitecture or barrier properties, ATII-LCs 
could be maintained for longer periods of time in culture without detachment, until 9 
days compared to the 6-7 days in uncoated filters. We hypothesize that this “retention 
effect” might be due to an improved adherence of cells to the substrate. In fact, it is well 
known that integrins and other receptors present on the cell surface actively interact 
with ECM components (Hopkinson, DeBiase et al. 2008). For example, fibronectin 
contains domains for specific binding to integrins which are essential for the activation 
of fibronectin and subsequently assembled into a network of fibrils at the cell surface. 
Intracellularly, integrins also link fibrils to the actin cytoeskeleton iniciating a series of 
signalling pathways that are involved in a variety of physiological procesess including cell 
adhesion (Wierzbicka-Patynowski and Schwarzbauer 2003). Though, discerning whether 
the improvement in cell adherence is the result of activation of downstream signalling 
cascades,  an effect of a reinforced mechanical attachment, or both mechanims acting 
simultaneously will require further investigation and it  is beyond the focus of the present 
work.     
Despite the fact that the inserts were coated with a mixture of collagen and fibronectin 
already validated for other authors for succesfully growing ATII cells (Elbert, Schafer et 
al. 1999; Daum, Kuehn et al. 2012), it is probably that other important components of 
the ECM should be also taken into account. In this sense, laminin-311 (fomerly known as 
laminin 6) is specifically abundant in the alveolar basement membrane within the lung 
and it has been described to have an important role participating in mechanosignaling 
pathways induced by stretch (Budinger, Urich et al. 2008). Besides the effect of specific 
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compounds, general susbtrate stiffness is known to influence cell adhesion by means of 
organization of focal adhesion structures and the actin cytoeskeleton (Eisenberg, Safi 
et al. 2011). Moreover, recent attempts have been focused on developing advanced 
engineered  culture systems, using whole acellular lung as a matrix  to support the 
generation of lung tissue, allowing differentiation of human stem cells into epithelial 
and endothelial cell lineages (Cortiella, Niles et al. 2010). 
In general, considering the inherent notorious complexity of the alveolar ECM, 
additional elements would have to be taken into account for future improvements in the 
culture substrate. 
Lastly, we also assessed the intracellular content of surfactant proteins SP-B and 
SP-C, as well as the organic cation transporter 1 (OCT-1) in ATII-LCs under both SC and 
ALI differentiation conditions, making a comparison with the A459 cell line and freshly 
isolated human primary ATII cells. 
The results showed that the expression levels of SP-B and SP-C in ATII-LCs did not seem 
to be affected by the influence of the ALI interface when compared to SC conditions. 
Interestingly, ATII-LCs showed to produce higher amounts of surfactant proteins than the 
established A549 cell line, although these levels were lower when compared to those 
found in primary ATII cells. However, unlike the previous results reported in chapter 3, 
we did not check the amount of protein secreted to the culture medium. Bearing in mind 
that SP-B, and particularly SP-C are significantly secreted into the extracellular medium 
by ATII-LCs, potential variances in this secretory behaviour should be also analyzed  in 
differentiated cells exposed to air.   
The presence of OCT-1 protein was also evaluated in ATII-LCs, since its expression has 
been recently described in the primary culture of freshly isolated ATII cells (Salomon, 
Muchitsch et al. 2014), as well as in A549 cells and bronchial cell lines (Salomon, Endter 
et al. 2012). OCT-1 is a member of the human polyspecific organic cation transporter 
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(OCT/N) family, and it is critical for the clearance of many endogenous small organic 
cations, in addition to a variety of drugs and environmental toxins. In fact, OCT-1 has 
been proposed to have therapeutic significance in alveolar epithelial cells because many 
drugs administrated via inhalation are organic cations and thus potential substrates 
for this protein (Salomon and Ehrhardt 2012). We confirmed the capability of ATII-LCs 
to express OCT-1 at similar levels of expression independently of the differentiation 
conditions. Its expression is comparable to that of A549 cells and slightly lower than 
detected in primary cells.  
Previous findings reported  an association between low levels of hypoxia inducible 
factors present at the interfaced cultures of ATII cells and the promotion of the expression 
of surfactant proteins (Ito, Ahmad et al. 2011). According to this findings, an increment 
of these factors was also expected in our differentiated cells. However, we observed that 
in our ALI conditions, a considerable amount of fluid in the apical compartment was 
always present and continually generated even when it was removed daily. This fluid 
in the apical compartment could be a contribution of both, the apical liquid that cells 
normally produce at the ALI (Gueven, Glatthaar et al. 1996),  and liquid coming from the 
basolateral compartment due to the absence of a “sealed” monolayer. The fact that ATII-
LCs do not form a tigh monolayer  would indicate that the cells are not differentiated in 
true ALI conditions. Then, the attenuated effects observed in our experiments, at least in 
terms of protein expression, might be attributed to this effect. 
In summary, we could partially conclude that the differentiation of DMSCs under the 
influence of an interfaced condition does not have a major impact neither in terms of 
cytoarchitecture or barrier formation nor in the expression of ATII cell markers. However, 
these data do not necessarily discard that the ALI could affect other relevant parameters 
that were not analyzed in this work, such as  the lipid biosynthesis or the surfactant 
storing and exocytosis. To our knowledge, in spite that other authors have used the ALI 
for lung differentiation, the potential effect of ALI as an isolated factor with respect to 
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submerged cultures has not been specifically addressed. We have also analyzed the effect 
of two components of the ECM as a culture support under the same culture conditions. 
The results suggest that even the addition of these two coating factors to the ALI and SC 
culture conditions might be still insufficient for the cells to reach a much closer state of 
maturation to that of primary ATII cells, including their capability to generate ATI cells. 
We hypothesize that additional paracrine cell-derived soluble factors could be necessary 
to definitely enhance the complete differentiation towards ATII cells. For instance, it has 
been described that in the developing lung, fibroblasts promote the synthesis of surfactant 
by ATII cells through paracrine activity mediated by neuroregulin-1 (Dammann, Nielsen 
et al. 2003). Taking this into account, the incorporation of co-culture systems could 
be a next step to further optimize our cell model. Indeed, more complex cell models 
for the alveolar epithelium have been previously stablished combining pure cultures 
of ATII cells with microvascular endothelial cells to closer mimic the blood-air barrier 
(Gueven, Glatthaar et al. 1996). Later,  more sophisticated co-cultures constituted by 
monocyte-derived macrophages and dendritic cells, together with epithelial cells using 
either A549 cells (Rothen-Rutishauser, Kiama et al. 2005) or isolated primary human 
ATII cells (Lehmann, Daum et al. 2011) have been documented. Other systems of higher 
complexity have been also reported, like tridimensional cultures incorporating four cell 
types, such as A549 cells, macrophages, mast cells and endothelial cells (Alfaro-Moreno, 
Nawrot et al. 2008). 
Interestingly, cocultures have also been  shown to be valuable for differentiation 
of stem cells into lung cell types. For example, human mesenchymal stem cells from 
bone marrow have been differentiated in the presence of primary alveolar epithelial 
cells grown on transwell filters at the ALI generating a pseudostratified airway epithelia 
(Wang, Bunnell et al. 2005). 
However, when purity in cultures is strictly required or to simplify the model system, co-
cultivation with other cell types might be substituted by the addition of the conditioned 
media obtained from fibroblast or the addition of different isolated factors. In this line, 
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the positive effects of glucocorticoid application in lung maturation during embryonic 
development have been associated to an increase in disaturated phosphatidylcholine 
species or in the expression of surfactant protein mRNAs (Oshika, Liu et al. 1998), 
possibly mediated by keratinocyte growth factor (KGF) (Chelly, Henrion et al. 2001). 
Despite the fact that our differentiation medium already contain hydrocortisone, 
other glucocorticoids could be additionally tested. For instance, dexamethasone and 
betamethasone have been shown to increase SP-B levels in NCI-H441 cells (Ladenburger, 
Seehase et al. 2010). Moreover, specific growth factors prompting surfactant expression 
like the previously mentioned  neuroregulins, KGF or leptin, could be also considered to 
be incorporated in our differentiation cultures.  
Although the exposure of DMSCs to the ALI does not appear to  reach a definitive 
ATII phenotype, the results suggest that ATII-LCs, differentiated either under SC or  ALI 
culture conditions are still a valuable in vitro model of ATII cells. Because of these results, 
we aimed to explore the usefulness of ATII-LCs for pulmonary toxicological studies. We 
assessed the potential harmful effects of nanoparticles that may traverse the lung barrier 
and  presumably interact with local ATII cells. 
The results of this Thesis showed that ATII-LCs presented different sensitivities as 
a function of the kind of nanoparticle tested. Silver nanoparticles (AgNPs) have been 
shown to produce strong  adverse effects over various cultured cell types (AshaRani, 
Low Kah Mun et al. 2009; Greulich, Kittler et al. 2009; Eom and Choi 2010; Hackenberg, 
Scherzed et al. 2011; Pascarelli, Moretti et al. 2013).  Human lung cells are also very 
sensitive to AgNPs (Herzog, Clift et al. 2013; Suliman, Ali et al. 2013; Gliga, Skoglund et al. 
2014; Kim, Shin da et al. 2014). Indeed, we also confirmed that AgNPs are cytotoxic in  a 
concentration dependent manner for ATII-LCs, even at relatively low concentrations (10 
µg/mL). Interestingly, in other studies performed with stem cells, toxic effects of AgNPs 
are also appreciable at concentrations of 5-10 µg/mL,  such as in human mesenchymal 
stem cells (Greulich, Kittler et al. 2009; Hackenberg, Scherzed et al. 2011) and murine 
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embryonic stem cells (Ahamed, Karns et al. 2008). Although A459 cells also resulted to 
be damaged by AgNPs, they were less sensitive than ATII-LCs at the same nanoparticle 
concentrations. The citotoxic effect of AgNPs observed here against A459 is in agreement 
with previous studies, where the authors reported cell viabilities of around 70 % after 
24 h of contact with AgNPs and at a concentrations of 100 µg/mL (Lankoff, Sandberg 
et al. 2012). The relative resistance of A549 cells could be attributed to their inherent 
robustness as reported for fast growing tumor-derived cell lines, and argues against their 
usefulness as cell model to evaluate potential pulmonary cytotoxicity on a routine basis.
In general, the generation of reactive oxygen species and oxidative stress seem to 
play a crucial role in the toxicity induced by AgNPs (Park, Yi et al. 2010), but the analysis 
of the mechanisms behind their cytotoxicity is beyond the present study. Moreover, 
although the range of concentrations used in our experiments was commonly employed 
in previous reports, some researchers recommend to use lower concentrations of NPs 
on in vitro experiments, in order to mimic a more realistic exposure scenario (Gangwal, 
Brown et al. 2011). This would be particularly  relevant when the in vitro results have to 
be extrapolated to real-world situations, i.e.: lung deposition after occupational exposure 
to nanomaterials.
PLGA is the most investigated polymer for the preparation of microspheres for 
pulmonary drug administration because of its beneficial properties of biocompatibility 
and biodegradability (Loira-Pastoriza, Todoroff et al. 2014).  We were then interested 
in checking the safety of nanoparticles composed by PLGA against ATII-LCs. We tested 
three types of self-made PLGA NPs prepared with two different methodologies. Anionic 
PLGA NPs made by a emulsion-evaporation technique were shown to be unexpectedly 
cytotoxic for ATII-LCs, reducing cell viabilitiy rates to around 60-70 % at concentrations 
of 10 µg/mL. This rapid decay of viability affecting 40 % of the cell population was also 
observed in A549 cells. However, cationic PLGA-NPs prepared by a self-assembly method 
and surface-modified with chitosan exerted much lower impairment in ATII-LCs. The cell 
viabilities were near 100 % after treatment with these cationic NPs at concentrations 
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of 10 µg/mL and around 80 % at the highest concentrations analyzed. These results 
are in  concordance with previous studies using chitosan-coated PLGA NPs in lung cells 
(Nafee, Schneider et al. 2009).  Indeed, chitosan is particularly benign compared to 
other cationic polymers and also present some other advantages such as improving the 
binding of negatively charged plasmids and enhancing their cellular uptake (Richardson, 
Kolbe et al. 1999; Nafee, Schneider et al. 2009). On the other hand, cationic NPs loaded 
with clarithromycin did not reveal remarkable deleterious effects over the mitochondrial 
activity of ATII-LCs either. Although our experiments did not provide information about 
the release of the drug, this has been previously described as significantly rapid, taking 
place within a few hours after the exposure of the cells to the NPs (Loira-Pastoriza, 
Todoroff et al. 2014). In this sense, it is probably that after 24 h of contact with the cells, 
most of the drug is already released and  our results would be indicative of the safety 
of the clarithromycin formulation into cationic chitosan NPs. In contrast, AgNPs, as an 
inherently toxic system, provoked a clear citotoxic dose-response in ATII-LCs and in A549 
cells. These results are an important proof of concept that our ATII-LCs model could be 
a relevant in vitro model to evaluate the potential harmful or side effects in the initial 
steps of the development of pulmonary drugs. 
The citotoxicity observed in both cells types, ATII-LCs and A549, when the cells are in 
contact with our home-made anionic NPs suggests that it is not dependent on the cell type 
used. The cytotoxic effect of anionic NPs maybe rather related to the specific preparation 
method used, to the coadyuvants employed or even to the particular preparation itself. 
The emulsion-diffusion-evaporation technique is widely used for NP preparations, 
and PVA is known to be rather biocompatible (Feng, Chen et al. 2013). However, the 
citotoxicity effects of different NPS and its comparison are difficult to interpret  due to the 
variety of parameters that are known to be involved in the toxicity of NPs, such as  size, 
shape, bulk material, surface charge, surface area or the composition of the exposure 
medium (Greulich, Kittler et al. 2009; Brandenberger, Rothen-Rutishauser et al. 2010). 
The examination of anionic PLGA NPs under SEM showed that they were aggregated 
forming much larger particles.  The distinctive biological effect of anionic PLGA NPs could 
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be attributed to a diminished acuracy in the dose-response relationship. However, we 
cannot rule out that this microscopic observation could be a mere artefact of the drying 
preparation process. In order to further  corroborate these controversial results, new 
NPs should be prepared and checked, and stock components (PVA, polimer) should be 
also analyzed independently.  
Moreover, although the MTT assay is widely recognised as a reliable method 
to assess cell viability, other approaches might be also explored in order to obtain 
complementary information on the nature of the cytotoxic effects.  For example, ATP 
quantitation could be also useful to evaluate the functional integrity of living cells 
due to the fact that ATP levels normally decrease as a result of any type of cell injury 
(Nafee, Schneider et al. 2009). The Alamar BLue assay is also used to assess cell viability, 
based on the reduction potential of metabolically active cells (Gliga, Skoglund et al. 2014). 
On the other hand, LDH assays are based on the quantification of lactate dehydrogenase 
(LDH) activity released from the cytosol of dead or plasma membrane-damaged cells into 
the culture supernatant. Apart from cell viability, other related factors are also usually 
analysed in toxicity experiments. Genotoxicity of nanomaterials can be investigated with 
the called “comet assay”, which is based on the microscopic detection of damaged DNA 
fragments of single cells and visualized with a “comet” morphology after cell lysis, DNA 
denaturation and electrophoresis (Gliga, Skoglund et al. 2014).  Determination of reactive 
oxygen species in relation to potential damaging oxidative stress processes (Eom and 
Choi 2010) or evaluation of released proinflammatory cytokines (Greulich, Kittler et al. 
2009) can be also a valuable choice for a complete assessment of NP toxicology.       
On the other hand, all the in vitro citotoxicity experiments performed in this work 
were carried out under SC culture conditions. Although this type of methods are 
simple and convenient for soluble molecular toxins, other alternatives have to be taken 
into account when analyzing airborn particles. Indeed, SC constitute just a partially 
realistic way of exposure for aerosols, since in vivo exposure to airborn particles takes 
place at the ALI and not under complete SC conditions (Paur, Cassee et al. 2011). 
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Moreover, adsorption of other molecules present in the culture medium or particle 
agglomeration generating larger assemblies should be considered to possibly alter the 
biological effect of NPs (Limbach, Li et al. 2005). 
Several systems have been developed to facilitate modelling of NP exposure of cells 
cultured under the ALI conditions. In this context, we took advantage of a sophisticated 
device called Air Liquid Interface Cell Exposure (ALICE) system to directly deposit 
fluorescent PLGA-NPS on ATII-LCs differentiated in interfaced cultures in order to mimic 
a more realistic situation. Indeed, the ALICE system displays ideal characteristics to study 
particle-cell interactions. In addition, this system also mimics particle deposition in the 
respiratory tract following inhalation, as opposed to submerged exposure conditions 
where the particles have to penetrate a thick layer of cell culture media. After exposing 
ATII-LCs to PLGA-NPs for 3 or 24 h, we could not detect any change in cell morphology 
after examination by confocal microscopy. We also obtained optical sections to generate 
an orthogonal view that allow observation of the translocation of NPs inside of the cells 
and thus confirming internalization. Different mechanisms of cellular internalization of 
NPs have been proposed (i.e.: actin-based phagocytosis, clathrin-mediated endocytosis, 
etc.), being critical the influence of NP surface properties in all processes (Paur, Cassee 
et al. 2011). However, the experiments presented here do not provide information about 
the specific uptake mechanism and subsequent intracellular route. Additionally, although 
these preliminary results suggest that ATII-LCs are able to suscessfully uptake NPs, this 
approach does not completely exclude that, in some particular cases, the particles 
could be located between the lateral part of adyacent cells and not truly internalized. 
In this sense, the examination of the cells after NPs exposure by transmision electron 
microscopy could aid to confirm the actual uptake of NPs by ATII-LCs, and also to reveal 
the intracellular location and cellular fate of the NPs. Interestingly, the ability of ATII-LCs 
to intenalize NPs is atractive not only from the point of view of toxicology studies, but also 
to optimize potential gene delivery strategies. In fact, PLGA NPs have been formulated as 
DNA carriers achieving high cellular association and making gene editing possible (Ravi 
Kumar, Bakowsky et al. 2004; Fields, Quijano et al. 2014). 
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In  summary, in this Chapter 4 we have shown some preliminary experiments focused 
on the optimization of the ATII-LC culture model by introducing advanced elements in 
order to mimic the in vivo conditions. We conclude that, despite the fact that air interfaced 
cultures and modified substrates are likely to be key aspects to develop a relevant model 
of alveolar epithelial cells, considering the complexity of the native microenvironment, 
further supporting signalling have to be taken into account to optimize the differentiation 
process. Still, the current ATII-LC model is a promising sensor to assess the safety and 
cytoxicity of nanoscaled materials permiting a rapid assessment of the safety of new 
compounds, drug candidates or formulations. The exposure of ATII-LCs to nanomaterials 
in a more realistic air interfaced situations will also permit to gain reliable insights in the 
elucidation of cellular uptake mechanisms and the metabolism of xenobiotics delivered 
to the lung. 







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It was not until 1929 when the Swiss physician Kurt von Neegaard questioned the prevailing 
hypothesis that breathing consisted exclusively of an alternative balance between the force of 
the respiratory muscles and the elastic coil of the chest wall and lung tissue (von Neegaard 1929). 
Indeed, he concluded that the alveoli may have a wet lining and that besides their elastic recoil, 
the force of surface tension should be also taken into account. Firstly, it was suggested that the 
airspaces were lined by an insoluble protein layer with the capacity of reducing the tension 
of the alveolar surface (Pattle 1955). Years later, this partial misconception was subsequently 
corrected, unveiling pulmonary surfactant (PS) as a membrane-like, lipid-protein complex (Klaus, 
Clements et al. 1961; Pattle and Thomas 1961), whose lack was potentially correlated with lung 
pathology (Avery and Mead 1959). From its origins, the expansion of the surfactant field has 
been the result of the convergence of multiple disciplines including biochemistry, molecular 
biology, physics, or therapeutics, among others. 
The present PhD Thesis has also taken advantage of multidisciplinary approaches, from 
membrane biophysics to alveolar and stem cell biology, contributing with innovative looks at 
surfactant research. 
During the last years and so far, PS complexes, as isolated from animal bronchoalveolar lavage 
(BAL), have been considered the standard material for the investigation of structure-function 
determinants and a reference of optimal function in surfactant research. This has been possible 
since the source of material permits to obtain virtually unlimited amounts of surfactant, what 
allows the fulfillment of a variety of experiments. On the other hand, this material is particularly 
useful because a major part of the lipid-protein complexes present in these preparation are the 
most active structures of surfactant, as we confirmed in Chapter 2. However, we have observed 
that there is a considerable morphological and functional heterogeneity in NS. Whereas the most 
active structures are consistent with LBPs, the less functional material might be already spent, 
or deactivated, or participating in not surface-related roles (i.e.: surfactant homeostasis and/or 
refinement). Additionally, some surfactant structures could be originally located in conductive 
locations or in upper airways, being involved in other processes, such as innate defense actions 
or in the clearance of pathogens via the mucociliary escalator (Haagsman, Herias et al. 2003; 
Wright 2005). Taking this into account, we propose that the study of the structure and functional 
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properties of freshly secreted surfactant illustrates in a more reliable way the real behaviour of 
surfactant at the alveolar spaces. This approach has supposed a technological challenge due to 
the necessity to optimize analytical methods to study and evaluate the structure and surface 
behaviour of very small samples, such as those available from cell cultures. 
Firstly, we have demonstrated that PS is intracellularly assembled in lamellar bodies (LBs) 
as highly packed/dehydrated states, which are considerably resistant to temperature-driven 
structural changes. Interestingly, when surfactant is secreted in the form of lamellar body-like 
particles (LBPs), it maintains this particular structural arrangement, in the absence of external 
compression and even at high temperatures. Indeed, the efficiency of PS to show appropriated 
functional properties and to stabilize the respiratory surface depends critically on the capacity 
of PS to form highly packed films at the air-liquid interface at the very demanding physiological 
conditions (Picardi, Cruz et al. 2011). 
Additionally, LBPs demonstrate a superior interfacial activity and a remarkable resistance 
to inhibition, compared to films formed by whole NS. Thus, the elaborated architecture in 
LBPs may have been evolutionarily optimized for this purpose and highly packed LBPs could 
be less susceptible to inactivation by binding deleterious components than the more exposed 
membranes of NS or those of clinical surfactants (Taeusch, Bernardino de la Serna et al. 2005; 
Pérez-Gil 2008). In fact, previous results suggest that LBPs conserve this stable packed state until 
the precise moment when the interface requires to be replenished, being the transfer of material 
from LBPs into the interface prompted by surface tension (Bertocchi, Ravasio et al. 2005). Thus, 
surface tension would be the force that drives LBPs disintegration. In this regard, the present 
PhD thesis provides strong evidences that point to the existence of a protein-based mechanism 
at the limiting membrane of LBs/LBPs, that might be controlling the cooperative opening of the 
whole corpuscle (Chapter 1 and Chapter 2: appendix). Interestingly, the presence of a projection 
core enriched in SP-B has been previously shown in micrographs of LBPs (Ochs 2010). This fact 
leads us to speculate that the protein machinery at the openings could be SP-B based, which 
would be acting as a pressure-sensitive “staple” holding all the interconnected LBP membranes. 
After reaching the air-liquid interface, surface tension would trigger a conformational change 
in the presumed SP-B complexes, potentially leading to the opening of the structure and the 
225
General discussion
release of the inner pressure generated during LB biogenesis and the subsequent rapid ejection 
of the internal membranes. In addition to the fraction of LBPs that adsorbs immediately, another 
fraction remains packed and surface-associated or it is reorganized into other functional units, 
although the intriguing mechanisms underlying these transformations are still obscure.
On the other hand and paradoxically, we found that the high packing/dehydration of the 
LBP membranes at the head group level was not accompanied with an ordered state of the 
acyl chains, but with acyl chains undergoing a high number of trans-gauche isomerizations. In 
addition to other evidences and as we have stated in Chapter 1, our results point to the potential 
occurrence of non-lamellar phases in PS, a possibility that has been also suggested by other 
researchers (Perkins, Dause et al. 1996; Chavarha, Khoojinian et al. 2010; Chavarha, Loney et al. 
2012). Indeed, current models propose that the lipid multilayers present in the alveolar subphase 
are interconnected with interfacial phospholipids through surfactant proteins, by means of 
porous structures (Keating, Zuo et al. 2012) or non-lamellar phases (Chavarha, Khoojinian et al. 
2010). In this line, it has been proposed that the existence of interconnected poring structures 
organized as bicontinuous assemblies might play an important role favoring the transport of 
molecules and oxygen diffusion (Pérez-Gil 2008; Olmeda, Villén et al. 2010). 
Moreover, lipid-protein structures reminiscent of nonbilayer lipids, such as tubular myelin, 
have been shown to be crucial in the rapid transfer of lipids from LBPs to the air-water interface 
(Perkins, Dause et al. 1996). In this regard, it is tempting to think that the structure of tubular 
myelin could be somehow “pre-loaded” inside LBPs and it would be responsible for the non-
lamellar signals, although this hypothesis remains to be fully explored. In fact, although it is 
generally accepted that lipid polymorphic phase behaviour may be key in the effective functioning 
of PS, direct evidences of the existence of stable non-bilayer lipid structures in natural materials, 
beyond transient intermediates in membrane fusion mainly deduced from the analysis of 
artificial model systems, are still lacking. In the current research, the extremely limited amount 
of material available from primary cell cultures of rat alveolar type II (ATII) cells (in the order 
of micrograms and sub micrograms of phospholipid) prevented a deeper structural analysis to 
confirm the existence of non-lamellar phases. Our attempts to circumvent this limitation led us 
to explore alternative sources to obtain freshly secreted surfactant. 
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On the one hand, we found that surfactant material purified from BAL was shown to contain 
to some extent structures consistent with LBPs, which permitted us to gain additional insight into 
the peculiar organization of these structures. By means of cutting-edge techniques such as cryo-
electron tomography and soft x-ray tomography (Chapter 2: appendix), we could discern how 
the membranes are assembled into these structure as well as to postulate the manner in which 
they are progressively unraveled, as discussed above. Indeed, this material could be considered 
as a potential candidate for examination under X-ray diffraction or P31 NMR in order to address 
the question of the lipid polymorphism in PS. However, we have to take into account that in the 
LBP-rich fractions isolated from NS, intact structures coexist with others with a variable extent 
of unpacking, which could interfere with the presumably non-lamellar signal coming from the 
intact ones. 
On the other hand, bearing in mind the handicaps of primary ATII cells, i.e. the intensive 
use of animals to collect small amounts of secreted surfactant, we considered the possibility of 
implementing immortal cell lines. Despite the fact that cell lines are often used as models for 
primary cells since they are easier to culture and have a high proliferation rate, the phenotype 
they express may not be consistent with the true phenotype of their primary counterparts. In 
view of the lack of reliable established surfactant-producing alveolar cell lines, we explored 
the possibility of deriving stem cells into cells with phenotypic features of type II cells. We 
characterized the pulmonary-primed differentiation of a population of mesenchymal stem 
cells isolated from human placenta into alveolar type II-like cells (ATII-LCs) (Chapter 3). ATII-LCs 
synthesize and properly process surfactant proteins, accumulate phospholipids in membranous 
forms in organelles that remind LBs and secrete this membranous material upon exposure to 
secretagoges. Strikingly, the material exocyted by ATII-LCs display remarkable interfacial activity 
and it is also less prone to inactivation, mimicking the properties of that secreted by “true” ATII 
cells isolated from lung tissue. Since mesenchymal stem cells can be cultured and multiplied 
at some scale, their differentiation and eventual use as biofactories could be a promising way 
to access to freshly secreted surfactant. The scaling-up of the cultures could promote their 
utilization as surfactant-producers for restorative therapies with exogenous clinical materials. 
Furthermore, crucial questions about surfactant biosynthesis and trafficking pathways that are 
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still not answered could be addressed thanks to this new cell model. In this regard, either the 
introduction of modified genes or the silencing of genes encoding surfactant proteins might be 
a powerful approach to shed light on the structure-function determinants in PS by analyzing the 
isolated or combined influence of proteins in surfactant biogenesis. 
Besides the utilization of ATII-LCs for the investigation of cell processes, we also show in this 
Thesis that they are valuable as a drug screening tool. Nowadays, drug administration via the lung 
is considered as a favorable non-invasive route for local and systemic delivery, considering the 
large area of the respiratory surface, among other factors (Hidalgo, Cruz et al. 2015). As reported 
in Chapter 4, ATII-LCs display an interesting capacity to distinctively sense the cytotoxicity 
of different nanoscaled materials of biopharmaceutical interest. The success of innovative 
strategies for pulmonary drug delivery will much depend on the choice of appropriated in vitro 
models to deeper understand how the therapeutic molecules interact with alveolar cells and 
the subsequent metabolic responses. In this context, ATII-LCs could be promising candidates to 
achieve the in vitro-in vivo correlation required to reliably predict the clinical performance of 
novel formulations precluding preclinical animal tests.      
However, we are aware that the phenotype expressed by ATII-LCs may not completely 
represent that of the primary system and that ATII-LCs would be still in a partially immature 
state. In this regard, we aimed to optimize our culture methodology in order to provide cells 
with further stimulation, trying to mimic the native environment. For this purpose, advanced cell 
culture techniques, such as differentiating the cells at air-liquid interfaces and over substrates 
simulating the alveolar extracellular matrix, were implemented. The preliminary results shown in 
Chapter 4, suggest that whole cell differentiation may require of a complex synergetic signaling, 
integrating not only physical and chemical factors, but also the active interaction with other cell 
types originally present in the alveolar epithelium.  
In spite of the fact that PS has been intensively investigated during the last 40 years, central 
aspects such as structure-activity correlations or the critical steps in surfactant adsorption and 
spreading are not completely understood. In this PhD Thesis, we have shed some light on the 
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structural determinants that the evolution may have promoted in PS to sustain its indispensable 
functions for the respiratory dynamics. The implementation of both primary ATII cells and 
modeled ATII-LCs could permit to gain further insight into the molecular mechanisms defining 
PS and subsequently the development and production of better clinical surfactant preparations 
with higher resistance to inactivation.







Conclusions
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The experimental work presented in this PhD thesis has shed further light on the structural 
and functional nature of the diverse biological forms of pulmonary surfactant (PS) complexes 
and particularly of its intracellular and freshly secreted states, taking advantage of previously 
established as well as newly developed cellular models of alveolar type II (ATII) cells. In general 
terms, we may conclude that:
1. The structural and functional properties of the PS system varies during the course of its 
biological cycle. Intracellular surfactant stored as lamellar bodies (LBs) in alveolar type II cells 
displays a highly packed and dehydrated state at the phospholipid head group region as well as a 
crystalline-like order. Once exocyted by primary cell cultures into the extracellular medium in the 
form of lamellar body-like particles (LBPs), PS remains in a highly packed/dehydrated state, even 
at supraphysiological temperatures. However, the acyl chains of the phospholipid components 
of LBPs seem to be intrinsically disordered, pointing to the potential existence in freshly secreted 
PS of geometrical configurations different from those of lamellar phases. 
2. Surfactant freshly secreted in the form of LBPs exhibits a remarkable adsorptive activity to 
generate interfacial films and a higher intrinsic resistance to inactivating agents such as serum 
proteins or meconium.
3. The outer membrane of LBPs likely contains a protein-based machinery configuring a gating 
mechanism, which might participate in the initial steps of the adsorption and unravelling of the 
LBPs once reached an air-liquid interface, prompting at first instance the ejection of the inner 
membranes.
4. Native surfactant (NS) material as purified from animal bronchoalveolar lavages (BAL) lacks 
the original structural configuration demonstrated by either LBs/LBPs as well as the boosted 
biophysical surface capabilities of freshly secreted surfactant. In this sense, NS fails to closely 
represent PS at the physiological alveolar environment, compared to freshly secreted PS obtained 
from cell cultures.
5. The diminished structural and functional features of NS compared to freshly secreted LBPs 
are likely the result of the morphological and functional variety of structures that the material 
isolated from BAL encloses. NS contains a mixture of highly active forms coexisting with less 
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active structures, which may possess other potential functions different from surface tension 
reduction. 
6. Decidua-derived mesenchymal stem cells (DMSCs) isolated from human placenta can be 
efficiently differentiated into cells with phenotypical features similar to ATII cells. ATII-like cells 
(ATII-LCs) express genes involved in lung development, alveolar homeostasis as well as those 
encoding for surfactant proteins and their processing enzymes. Surfactant proteins A, B and C are 
efficiently translated into their mature forms and surfactant-related lipids, such as disaturated 
phospholipids, are incremented in ATII-LCs.
7. Surfactant lipids and proteins are assembled into cytoplasmic organelles of ATII-LCs 
resembling LBs. Upon physiological stimulation and mimicking primary cells, ATII-LCs exocyte a 
lipid-rich material, which exhibits faster interfacial adsorption kinetics than standard NS, even in 
the presence of inhibitory agents. 
8. The properties exhibited by ATII-LCs could make them a useful in vitro model for the study 
of the biosynthesis of PS, including protein processing, lipid trafficking as well as the packing and 
storage of surfactant assemblies.
9. ATII-LCs demonstrate sensitivity to the cytotoxic effect of nanostructured pharmaceutical 
preparations and ability to internalize nanoparticles upon exposure by aerosolization, constituting 
a useful tool for the high-throughput screening of novel pulmonary-delivered drugs.  
10. Differentiation of DMSCs into ATII-LCs is not significantly enhanced under the influence of 
an air-liquid interface or components of the alveolar extracellular matrix, in terms of morphology, 
expression of surfactant proteins or barrier properties. Further cell differentiation may require 
of a more complex synergetic signaling, integrating not only physical and chemical factors, but 
also the active interaction with other cell types naturally present in the alveolar environment. 




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